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“Σα βγεις στον πηγαιμό για την Ιθάκη,  
να εύχεσαι νά 'ναι μακρύς ο δρόμος, 
γεμάτος περιπέτειες, γεμάτος γνώσεις...  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“When setting out upon your way to Ithaca, 
wish always that your course be long, 
full of adventure, full of lore... 
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Ca2+ HOMEOSTASIS  
The maintenance of the Ca2+ balance within the physiological range is pivotal for life. 
Ca2+ is the most abundant cation in the human body where it is essential for many 
physiological functions, such as synaptic transmission in neurons, muscle contraction, 
blood clotting, fertilization and bone mineralization. The extracellular Ca2+ concentration 
should, therefore, be tightly regulated as dysregulation leads to severe disorders (57). 
Therefore, Ca2+ homeostasis in humans is achieved through hormonal control of three 
physiological functions: intestinal Ca2+ absorption, renal Ca2+ reabsorption and Ca2+ 
exchange of the bone mass (20, 57).  
 
ACTIVE Ca2+ REABSORPTION IN KIDNEY  
In the kidney, ~8 g Ca2+ is filtered at the glomerulus on a daily basis, of which less than 
2% is excreted into the urine. Ca2+ can pass through renal epithelial tissues and reach 
the blood compartment via two pathways. The major one is by passive paracellular 
reabsorption in the proximal tubules (PT) and the thick ascending limb of Henle (TAL) 
and the second is by active transcellular Ca2+ reabsorption in the distal convoluted 
(DCT), the connecting (CNT) and the cortical collecting duct (CCD) tubules (3, 19, 62) 
(Figure 1A). The distal part of the nephron realizes only ~15% of total renal Ca2+ 
reabsorption. However, it is generally regarded as the site for fine-tuning of the urinary 
Ca2+ excretion, as Ca2+ reabsorption is active here. Active Ca2+ reabsorption allows the 
body to regulate Ca2+ transport independently of the Na+ balance and thus the organism 
can respond immediately to dietary fluctuations of nutritional Ca2+ and adapt to the 
body’s demand during long-lasting situations like growth, development and aging (33, 
39). At the cellular level, active Ca2+ reabsorption is generally envisaged as a three-step 
process consisting of a Ca2+ entry across the luminal or apical membrane via the 
Transient Receptor Potential Vanilloïd 5 (TRPV5) channel, cytosolic diffusion of Ca2+ 
bound to the Ca2+-binding proteins calbindin-D28K and/or calbindin-D9K, and active 
extrusion of Ca2+ across the opposite basolateral membrane by the Na+-Ca2+-exchanger 
1 (NCX1) and/or the Ca2+-ATPase 1b (PMCA1b) (30) (Figure 1B). Importantly, the 
knock-out of TRPV5 (TRPV5-/-) in mice results in a significant hypercalciuria (32), 
demonstrating that TRPV5 is the rate-limiting step of active Ca2+ reabsorption across the 
renal epithelia and therefore, one of the most efficient targets for regulation. 
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Indeed, a tight control of TRPV5 activity is of prime importance for the final 
amount of reabsorbed Ca2+ in the body. TRPV5 regulation occurs at different levels and 
involves: (i) the long-term transcriptional and translational effect of hormones and 
pharmacological agents, (ii) the biophysical properties of the channel, and the effect of 
regulatory proteins acting (iii) on the trafficking of the channel to the plasma membrane 
or (iv) directly on its plasma membrane stabilization and activity. An overview of these 
A Figure 1. Schematic model of the nephron, functional unit of the 
kidney, illustrating the two 
different pathways of renal Ca2+ 
reabsorption. (A) Passive 
paracellular reabsorption in the 
proximal tubules (PT) and the thick 
ascending limb of Henle (TAL) and 
active transcellular reabsorption via 
TRPV5 in distal convoluted (DCT), 
the connecting (CNT) and the 
cortical collecting duct (CCD) 
tubules. (B) Cell model of active 
Ca2+ reabsorption: Ca2+ enters the 
apical side of the epithelial cell 
through the TRPV5,6 channel, binds 
to the cytosolic calbindin-D28K/9K and 
is extruded at the basolateral side 
via the plasma membrane Na+-Ca2+-
exchanger (NCX1) and/or Ca2+-
ATPase (PMCA1b).  
 
B
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four regulatory steps is depicted in the Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 2.  Overview of the different levels at which TRPV5 regulation occurs. 1, the long-term 
transcriptional/translational effect of hormones (PTH, 1,25(OH)2D3, dietary Ca2+, 17β-estradiol); 2, factors 
acting on the biophysical properties of TRPV5 channel (pH, [Ca2+]i) and the effect of regulatory proteins 
acting: 3, on the trafficking of the channel to the plasma membrane (S100A10/annexin2, Rab11a, NHERF2) 
or 4, directly on its plasma membrane stabilization and gating (Ca2+-binding proteins, enzymes).  
 
HORMONAL REGULATION OF TRPV5 ACTIVITY 
TRPV5 is subjected to long-term hormonal regulation of gene transcription and therefore 
translation into protein. Parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3), dietary Ca2+ and 17β-estradiol are the main regulators acting on gene 
transcription of TRPV5 (27, 66, 67).  
PTH together with the active metabolite of vitamin D, 1,25(OH)2D3, are two key 
regulators of the body Ca2+ balance (29). The parathyroid gland senses even slight 
changes of plasma Ca2+ concentration through the Ca2+-sensing receptor and secretes 
accordingly PTH (34). For instance, in response to low plasma Ca2+ concentration, PTH 
is secreted into the circulation and activates the PTH receptor expressed in bone and 
kidney (78). Then, the activated receptor enhances transcellular Ca2+ reabsorption (68). 
In addition, it increases the 1,25(OH)2D3-dependent Ca2+ (re)absorption through 
stimulation of the 25-hydroxyvitamin D3-1α-hydroxylase (1α-OHase) (8), which is the 
enzyme catalysing the conversion of 25-hydroxyvitamin D3 to the active metabolite, 
1,25(OH)2D3. Finally, the stimulation of renal Ca2+ reabsorption by PTH occurs directly 
via the enhancement of TRPV5 expression as recently demonstrated by using 
Chapter 1 
 12 
parathyroidectomized and PTH-supplemented rats (67). 
The mechanism of 1,25(OH)2D3 action is similar to the one of steroid hormones 
and is mediated by the vitamin D receptor (VDR) (18). Several studies report a 
stimulatory effect of 1,25(OH)2D3 on Ca2+ reabsorption (5, 69). Given the importance of 
TRPV5 in active Ca2+ reabsorption, the regulation of this channel by 1,25(OH)2D3 has 
been investigated using two different models of vitamin D deficiency: ablation of the VDR 
or inactivation of the 1α-OHase. In both cases, TRPV5 expression levels are significantly 
decreased compared to wild-type littermates (14, 27, 70). The effect of 1,25(OH)2D3 on 
TRPV5 transcription is strengthened by the elucidation of the human and murine TRPV5 
predicted promoter that contains four putative vitamin D-responsive elements (VDRE) 
(28, 42, 76).  
Several of the aforementioned studies have provided evidence that 1,25(OH)2D3 
regulates TRPV5 channel expression. It is, however, difficult to distinguish the effects of 
hypocalcemia from those of 1,25(OH)2D3 deficiency. Indeed, vitamin D-depleted 
hypocalcemic rats (28) and mice (27) are rescued not only by repletion of 1,25(OH)2D3, 
but also by dietary Ca2+ supplementation. Interestingly, dietary Ca2+ enrichment results 
in the normalization of the reduced TRPV5 expression levels in the 1α-OHase knock-out 
(1α-OHase-/-) mice (27). Thus, induction of TRPV5 transcription by Ca2+ might involve 
the activation of a putative Ca2+-responsive element. Several domains have been 
proposed to function as Ca2+-sensitive transcriptional regulators, including the serum-
responsive element and the cAMP/Ca2+-responsive element (21). However, the 
presence and functionality of putative Ca2+-responsive elements in the TRPV5 promoter 
remain to be investigated.  
It is known that estrogens are involved in bone mineralization (51) and that the 
deleterious effects of estrogens deficiency after menopause leads to a negative Ca2+ 
balance associated with postmenopausal osteoporosis (81). A recent study 
demonstrates that estrogens participate also in the transcriptional regulation of TRPV5. 
In ovariectomized 1α-OHase-/- mice, 17β-estradiol supplementation results in elevated 
renal TRPV5 mRNA and protein levels, accompanied by normalization of the serum Ca2+ 
levels (66). Thus, TRPV5 transcription is controlled by estrogens independently of 
vitamin D. This data suggests that the function of estrogens in maintenance of the Ca2+ 
balance might be at least in part fulfilled by the regulation of TRPV5 channel expression. 
However, since no estrogens-responsive elements have been found in the putative 
TRPV5 promoter region, the mechanism by which estrogens induce TRPV5 mRNA up-
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regulation remains to be elucidated (76).  
Of note, the above-mentioned hormones stimulate Ca2+ reabsorption not only 
through the up-regulation of TRPV5 expression, but also through the coordinated up-
regulation in expression of all the proteins participating in transcellular Ca2+ reabsorption, 
i.e. TRPV6, calbindin-D28K, calbindin-D9K, NCX1 and PMCA1b as summarized in Table 
1. It is postulated that upon hormonal action Ca2+ influx through TRPV5 channel 
increases, and in turn facilitates the regulation down stream Ca2+ reabsorption proteins 
(67). 
 
Table1. Regulation of renal Ca2+ reabsorption proteins by hormones. 
TRPV5 TRPV6 
Calbindin-
D28K 
Calbindin-
D9K NCX1 PMCA1b Ref 
  mR P mR P mR P mR P mR P mR P  
PTH ↑ ↑ = ND ↑ ↑ ↑ ↑ ↑ ND =,↑ ND (12) 
1,25(OH)2D3 ↑ ↑ ND ND ↑ ↑ ↑ ↑ ↑ ND =,↑ ND (10) 
Dietary Ca2+ ↑ ↑ ND ND ↑ ↑ = = ↑ ND ↑ ND (10) 
17β-estradiol ↑ ↑ ND ND ↑ ND ND ND ↑ ND ↑ ND (11) 
mR: mRNA levels; P: protein levels; ↑: up-regulation; =: not significantly different; ND: not determined; Ref: 
reference. 
 
PHARMACOLOGICAL AGENTS AFFECTING TRPV5 
Immunosuppressants like tacrolimus (also called FK506) and cyclosporine A, as well as 
glucocorticoids such as dexamethasone, are known to affect Ca2+ homeostasis. The 
action of these pharmacological agents is associated with an increased bone turnover, a 
negative Ca2+ balance and hypercalciuria (52, 54, 61).  
Hypercalciuria induced by FK506 treatment is attributed to decreased renal Ca2+ 
reabsorption and increased bone resorption (40, 52, 53). A recent study showed that 
administration of FK506 in rats not only induces an increase of renal Ca2+ excretion, but 
also down-regulates the renal mRNA expression of proteins involved in active Ca2+ 
reabsorption including the TRPV5 channel (44). These results, together with the fact that 
serum Ca2+ concentration remained unaltered in the FK506-treated rats, support the 
hypothesis that FK506 induces a primary defect in renal active Ca2+ reabsorption by 
specifically inhibiting the transcription/translation of TRPV5 and calbindin-D28K. 
Similarly, the cyclosporine A-induced hypercalciuria decreased the expression of 
calbindin-D28K (1, 60), but there is no data concerning the regulation of TRPV5 
expression. A different mechanism seems to occur during dexamethasone 
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administration, where TRPV5 expression is increased. This suggests that the stimulation 
of corticoid receptors by dexamethasone enhances TRPV5 in order to counteract the 
negative Ca2+ balance during treatment with this compound (44).   
 
MOLECULAR FEATURES OF TRPV5 CHANNEL 
Understanding of the biophysical properties of TRPV5 is the basis to delineate its 
function. In this respect, a detailed characterization of TRPV5 has been achieved. 
TRPV5 gene is located on human chromosome 7q35 and comprises 15 exons encoding 
a protein of about 730 amino acids (42). The TRPV5 structure shows typical topology 
features of the TRP channels, a large group of cation channels widely distributed (12, 
26). The functional channel complex is a tetramer (32) where four subunits presumably 
form a ring-like structure around a central pore (Figure 3A). Recent studies on the 
TRPV5 homologue TRPV6 showed that ankyrin repeats, located in the channel amino-
terminal tail, are required for physical assembly of functional tetrameric channels (17). 
The ankyrin repeat is a common protein sequence motif present in a large family of 
membrane-associated proteins that connect via their membrane-binding domains to 
diverse proteins, including proteins involved in Ca2+ homeostasis, such as inositol 
triphosphate (IP3) and ryanodine receptors (6, 7). Detailed molecular studies are though 
necessary to delineate the function of TRPV5 ankyrin motifs.  
Each subunit spans the luminal plasma membrane six times and is predicted to form a 
pore region between transmembrane segments five and six (33) (Figure 3B). TRPV5 
together with its closest homologue TRPV6 constitute a distinct class characterized by 
the high Ca2+ selectivity and permeation over Na+, with PCa/PNa values exceeding 100. 
Such high Ca2+ selectivity is unique within the TRP superfamily. Selectivity and 
permeation properties in TRPV5 and TRPV6 are mainly determined by a ring of four 
aspartate residues in the channel pore, similar to the ring of four negative charged 
residues (aspartates and/or glutamates) in the pore of voltage-gated Ca2+ channels (46).  
TRPV5 exhibits inward rectification (Figure 3C) and is constitutively open at low 
intracellular Ca2+ concentrations ([Ca2+]i) and negative or physiological membrane 
potentials. This means that Ca2+ can enter the cell through TRPV5 without the need of 
any stimulus or ligand activation of the channel. However, the activity of the channel is 
regulated by other means such as extracellular pH and intracellular Ca2+.  
Transepithelial Ca2+ reabsoprtion is inhibited during decrease of the pH in the 
apical tubular fluid (63). Furthermore, the acidification of the apical medium inhibits 
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transcellular Ca2+ reabsorption across primary cultures of rabbit CNT and cortical 
collecting duct (CCD) cells (4). Therefore, given the fact that TRPV5 mediates Ca2+ 
reabsorption in CNT and CCD, the pH effect on this channel was investigated in 
Xenopus laevis oocytes expressing TRPV5 where 45Ca2+ uptake was inhibited by 
acidification of the incubation medium (31). Further confirmation is provided by 
electrophysiological measurements showing that the extracellular decrease in pH 
reduces currents through TRPV5 carried by either monovalent or divalent cations (49). It 
is speculated that a glutamate residue preceding the pore region may act as the pH 
sensor of TRPV5, since mutation to glutamine decreases the inhibition of TRPV5 by 
protons (80). Furthermore, TRPV5 is inhibited by intracellular low pH, and this inhibition 
is enhanced by extracellular acidification. The lysine 607 is proposed as the pH sensor 
that mediates this cross-regulation by internal and external pH (79) .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Features of TRPV5 channel. (A) Schematic representation of the molecular assembly of four 
TRPV5 proteins in the tetrameric ring-like structure around the pore of the channel. (B) Model of a single 
TRPV5 subunit spanning six times the plasma membrane with a short hydrophobic stretch between 
transmembrane segments five and six that forms the pore of the channel and ankyrin repeats in the amino-
terminal tail. (C, D) Hallmarks of TRPV5 current. (C) Current/voltage relationships recorded in TRPV5-
transfected HEK293 cells, obtained by a ramp protocol from -100mV to +100mV (see inset, the holding 
potential is +20mV) show inward rectification. (D) Dose-response curve showing the inhibitory effect of 
intracellular Ca2+ on the inward current density of TRPV5 in nominally divalent free solution. 
 
Finally, TRPV5 is subject to Ca2+-dependent feedback inhibition. Elevation of 
A B
C D
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Ca2+ influx through the channel increases [Ca2+]i in a microdomain near the pore which 
reduces the TRPV5 current amplitude (45, 74) (Figure 3D). Considering the high affinity 
mechanism of Ca2+-dependent TRPV5 inhibition, the presence of Ca2+-sensing and/or 
Ca2+-buffering proteins such as calbindins is necessary to maintain the channel activity. 
In addition, recovery of the channel from inhibition occurs by both wash out of 
extracellular Ca2+ (whole cell configuration) or removal of Ca2+ from the inner side of the 
channel (inside-out patches) (45). Recovery of the channel activity is much slower than 
its Ca2+-dependent inhibition suggesting that interaction of the channel with regulatory 
proteins might be involved rather than a rapid direct binding and a slow dissociation of 
Ca2+.  
 
REGULATION OF TRPV5 TRAFFICKING TO THE PLASMA MEMBRANE  
The translocation of TRPV5 from the endoplasmic reticulum/Golgi compartment to the 
plasma membrane is pivotal in the regulation of the channel.  Because TRPV5 is 
constitutively active at physiological membrane potentials, the number of channels and 
their open probability at the cell surface determine the amount of Ca2+ transport into the 
cell. In addition, retrieval of TRPV5 from the plasma membrane might prevent Ca2+ 
overload protecting thus the Ca2+ transporting cells from damage and death. In this 
respect, immunohistochemical studies revealed that besides the apical membrane 
TRPV5 localisation, there is a significant intracellular staining. In this latter compartment, 
TRPV5 could remain in vesicles in order to be inserted in the plasma membrane when 
Ca2+ is needed (28, 39). The targeting of channels in the plasma membrane is often 
mediated by accessory proteins. In this respect, the TRPV5 trafficking process has been 
recently investigated by using the yeast two-hybrid assay and pointed to the following 
accessory proteins: the S100A10-annexin 2 complex (72), the GTPase Rab11a (71), the 
B-box and SPRY-domain-containing protein BSPRY (73) and the PSD95/DLG/ZO-1 
(PDZ) binding domain zinc finger protein Na+-H+ Exchanger Regulating Factor 2 
(NHERF2) together with the serine/threonine kinases SGK1 and 3 (16, 48).  
The S100A10-annexin 2 complex plays an important role in biological processes 
including endocytosis, exocytosis and membrane-cytoskeletal interactions (23). It has 
been recently shown that annexin 2 forms a well-defined heterotetrameric complex with 
S100A10 and associates with the TRPV5 carboxyl-terminal tail. Disruption of the 
S100A10-binding motif in TRPV5 results in abolishment of channel activity. This effect is 
accompanied by a major disturbance in the sub-cellular localization of TRPV5. 
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Furthermore, down-regulation of annexin 2 using small interference RNA (siRNA) 
significantly inhibits TRPV5-mediated currents. Together, these results demonstrate that 
the S100A10-annexin 2 complex is an important component of the trafficking of TRPV5 
and TRPV6 to the plasma membrane (72). 
Rab GTPases have been described to play key roles in cargo trafficking thanks 
to their ability to act as molecular switches between GTP- and GDP-bound states (82). 
Rab11a was initially identified as a TRPV6-interacting protein and then was found to 
bind and co-localize with TRPV5. TRPV5 and TRPV6 selectively interact with the GDP-
bound Rab11a, which contributes to the recruitment of soluble Rab11a to the 
membranous fraction. Co-expression of the GDP-locked Rab11a with the epithelial Ca2+ 
channels results in decreased Ca2+ uptake, caused by impaired TRPV5/TRPV6 
trafficking to the cell surface (71). This data suggests that the complex of TRPV5 with 
the cytosolic GDP-bound Rab11a locates initially to a sub-apical compartment and 
through GTP exchange, TRPV5 is inserted in the plasma membrane. 
PDZ motifs are recognized by PDZ domains that are modular protein interaction 
domains. They can facilitate biological processes including linkage of ion channels to the 
cytoskeleton, as well as targeting of ion channels in correct spatial arrangement in 
relation to each other and specialized regions of the cell (35, 38, 58). Several PDZ 
domains have recently been identified in renal proteins that could interact with apical 
transporters such as the NHE, the Renal Outer Medullary K+ (ROMK) channel, the 
Cystic Fibrosis Transmembrane Regulator (CFTR), the Na+-PO43- (NaPi) transporter and 
TRPV5 (24, 41, 75, 77). It was demonstrated that TRPV5 is the target of a complex 
regulating mechanism involving the PDZ motif protein NHERF2 and SGK1 and 3. The 
concerted action of NHERF2 and the kinases mentioned above markedly up-regulates 
the activity of TRPV5 channel (16, 48). 
 
PROTEINS REGULATING TRPV5 CHANNEL ACTIVITY  
In contrast to other TRP channels that are activated upon ligand binding, the constitutive 
activity of TRPV5, implies the presence of regulatory proteins in order to control its 
activity. Proteins known to play key roles in regulatory mechanisms of ion channel 
activity are ion-binding proteins and enzymes. 
It was mentioned before that TRPV5 is subject to Ca2+-dependent feedback 
inhibition. Consequently, changes in the local Ca2+ concentration at the channel’s inner 
mouth are critical for the TRPV5 activity. Of the Ca2+ that enters the cytosol through a 
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channel, most of it is rapidly bound to various proteins such as calbindins and calmodulin 
(2, 9).  
Calbindin-D28K has been proposed to facilitate the cytosolic diffusion of Ca2+ from 
the apical to the basolateral site of the epithelial cell, acting thus as a Ca2+ buffer in order 
to maintain low intracellular Ca2+ levels (3, 29). For voltage-gated Ca2+ channels, patch-
clamp analysis shows that calbindin-D28K effectively disrupts the channel’s Ca2+-
dependent inhibition in nervous cells (43). Although it is currently unknown whether 
calbindin-D28K could fulfil a similar role in kidney, the co-localization of calbindin-D28K with 
TRPV5 channel (31), suggests a functional interaction between these two proteins. 
Further experiments are needed to delineate the regulatory role of calbindin-D28K in the 
tubular Ca2+ reabsorption.  
Moreover, calmodulin is an important Ca2+ sensor that mediates the regulation of 
various voltage-gated Ca2+ (9) and TRP channels (83). Calmodulin contributes not only 
to Ca2+-dependent inhibition but also to the facilitation of ion channel activity, by 
differential use of its termini (15, 84). First, electrophysiological studies of the P/Q- and 
L-type voltage-gated Ca2+ channels showed that calmodulin binds Ca2+ initially with its 
high Ca2+ affinity carboxyl-terminal lobe inducing Ca2+-dependent facilitation. On the 
other hand, Ca2+ binding to the low Ca2+ affinity amino-terminal lobe results in Ca2+-
dependent inhibition of the channel (15, 84).  Regarding TRP channels, calmodulin is 
involved in the desensitization of TRPV1 (47, 55), the inhibition of TRPV6 (37) and of 
TRP Melastatin 7 (TRPM7) channel kinase activity (56).  
Besides Ca2+-binding proteins, proteins displaying enzymatic activity are 
attractive candidates for the regulation of TRPV5 activity. Previous studies indicated an 
important regulatory role of protein kinase C (PKC) isoforms in hormonal regulation of 
transcellular Ca2+ reabsorption (19, 33). Theoretically, as TRPV5 contains several 
conserved PKC phosphorylation sites, present in the carboxyl-terminus, PKC could 
phosphorylate TRPV5 directly or indirectly via other PKC substrates. In this respect, 
PKC is involved in the activation of two other TRPV members TRPV1 (13) and TRPV4 
(22). However, there is no experimental data showing direct phosphorylation of TRPV5 
or TRPV6 channels. 
Furthermore, two members of the FK506-binding protein (FKBP) immunophilin 
family are involved in TRP channel regulation. FKBPs are characterized by their ability to 
catalyze the cis-trans isomerization of cis-peptidyl-prolyl bonds, as well as by their strong 
affinity to the immunosuppressive drug FK506 (36). In Drosophila melanogaster, 
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FKBP59 inhibits Ca2+ influx through association with the TRP-like channel, TRPL (25). 
The mammalian homologue of FKBP59, FKBP52, and the immunophilin FKBP12 
associate with distinct members of the TRP Canonical (TRPC) channel family (59), but 
there is no functional data addressing a direct effect of FKBPs on TRPC channel activity.  
Finally, epithelial ion channels can be regulated by extracellular enzymes 
residing in the luminal fluid. This extracellular signalling pathway has been initially 
described for the epithelial sodium channel (ENaC), located as TRPV5, at the apical side 
of the distal nephron (64). ENaC can be triggered by the serine protease channel 
activating protease 1 (CAP-1) (11). CAP-1 shows significant similarity with trypsin, 
hepsin, tissue plasminogen activator, urokinase and tissue kallikrein (TK) (65). If we take 
into account the recent finding that TK knock-out (TK-/-) mice display hypercalciuria (50), 
it is tempting to assume a putative regulation of TRPV5 by this serine protease. A recent 
study supports that TRPV5 undergoes through extracellular enzymatic regulation from 
the β-glucuronidase klotho which activates TRPV5 by hydrolysis of its extracellular N-
linked oligosaccharides (10).  
 
OUTLINE OF THE THESIS 
As discussed in the previous paragraphs, accessory proteins of TRPV5 appear as good 
candidates to regulate the activity of this Ca2+ channel. The aim of this thesis was 
therefore to identify auxiliary proteins modulating TRPV5 activity and delineate their 
regulatory action. Four proteins were hence identified based on the microarrays 
technique and on the literature. Chapter 2 describes the microarray assay performed in 
order to screen for genes encoding candidate genes involved in Ca2+ reabsorption. The 
animal model used for that purpose was 1,25(OH)2D3 deficient mice rescued by 
1,25(OH)2D3 repletion or by enrichment for Ca2+ in their diet. Analysis of the gene 
expression data provided information about transcripts important for the Ca2+ balance 
and pointed to candidates for TRPV5 regulation. In chapter 3 the role of the 80K-H 
protein as putative regulator of TRPV5 is examined. The functional interaction of the two 
proteins was studied and several lines of evidence demonstrated that 80K-H is the first 
characterized Ca2+-binding protein facilitating TRPV5 Ca2+ influx. The second candidate 
protein, FKBP52, is presented in chapter 4. The effect of FKBP52 on TRPV5 channel 
was enquired and showed a critical role for the enzymatic activity of FKBP52 in TRPV5 
inhibition. In chapter 5 the molecular basis of hypercalciuria observed in TK-/- mice is 
investigated. This study showed that TK enhanced Ca2+ reabsorption by activating the 
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bradykinin 2 receptor and thus stimulating the cell surface localization of TRPV5 
channel. Further, the role of the Ca2+-binding protein calbindin-D28K on active Ca2+ 
transport is elucidated in chapter 6. The characterization of single and double knock-out 
mice for calbindin-D28K and TRPV5 provided insight into the in vivo relevance of 
calbindin-D28K on TRPV5-mediated transport. Finally, in chapter 7 the outcome of this 
thesis is summarized and discussed. 
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…Τους Λαιστρυγόνες και τους Κύκλωπας, 
τον θυμωμένο Ποσειδώνα μη φοβάσαι,  
τέτοια στον δρόμο σου ποτέ σου δεν θα βρεις, 
αν μέν' η σκέψης σου υψηλή, αν εκλεκτή συγκίνησης 
το πνεύμα και το σώμα σου αγγίζει...  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…Of the Laestrygones and of the Cyclopes, 
of an irate Poseidon never be afraid; 
such things along your way you will not find 
if lofty is your thinking, if fine sentiment 
in spirit and in body touches you... 
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ABSTRACT  
Pseudovitamin D-deficiency rickets (PDDR) is an autosomal disease, characterized by 
undetectable levels of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), rickets and secondary 
hyperparathyroidism. Mice in which the 25-hydroxyvitamin D3-1α-hydroxylase (1α-
OHase) gene was inactivated, presented the same clinical phenotype as patients with 
PDDR, and were used to study the expression profile of renal genes of this Ca2+-related 
disorder using 15K cDNA microarrays. 1α-OHase knock-out mice fed a normal Ca2+ diet 
developed severe hypocalcemia, rickets and died with an average life-span of 12 ± 2 
weeks. Intriguingly, 1α-OHase-/- mice supplemented with an enriched Ca2+ diet were 
normocalcemic and not significantly different from wild-type mice. Microarray technology 
was applied to analyze the genome wide molecular events that occur during the rescue 
by high dietary Ca2+ intake. Inactivation of the 1α-OHase gene resulted in a significant 
regulation of ± 1000 genes, whereas dietary Ca2+ supplementation of the 1α-OHase-/- 
mice revealed ± 2000 controlled genes. Interestingly, 557 transcripts were regulated in 
both situations implicating the involvement in the dietary Ca2+-mediated rescue 
mechanism of the 1α-OHase-/- mice. Conspicuous regulated genes encoded for 
signaling molecules like the PDZ-domain containing protein channel interacting protein, 
FK binding protein type 4, kinases and importantly Ca2+ transporting proteins including 
the Na+-Ca2+ exchanger, calbindin-D28K and the Ca2+ sensor calmodulin. In conclusion, 
dietary Ca2+ intake normalized disturbances in the Ca2+ homeostasis due to vitamin D 
deficiency by regulating a subset of renal genes including well-known renal Ca2+ 
transport protein genes, but also genes not previously identified as playing a role in renal 
Ca2+ handling. 
 
INTRODUCTION 
Vitamin D is a major regulator of Ca2+ and phosphate homeostasis, and is essential for 
proper development and maintenance of bone. The active form of vitamin D, 1α,25-
dihydroxyvitamin D3 (1,25(OH)2D3) is synthesized from its precursor 25-hydroxyvitamin 
D3 by the renal cytochrome P450 enzyme 25-hydroxyvitamin D3-1α-hydroxylase (1α-
OHase). The importance of this enzyme is reflected by severe disorders resulting from 
mutations identified in the gene encoding 1α-OHase including pseudovitamin D-
deficiency rickets (PDDR) also known as vitamin D-dependent rickets type I (VDDR-I). 
Recently, the genetic association of 1α-OHase with PDDR has been confirmed by 
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inactivation of the 1α-OHase gene in mice (9, 21). Two laboratories independently 
generated 1α-OHase knock-out mice strains that represent valuable animal models for 
PDDR since they display undetectable 1,25(OH)2D3 levels, hypocalcemia, secondary 
hyperparathyroidism and failure to thrive (9, 21). The 1α-OHase knock-out mice (1α-
OHase-/-) developed distinct histological evidence of rickets and osteomalacia.  
The absence of vitamin D is expected to cause widespread changes in gene 
expression in the kidney. On one hand, vitamin D receptor (VDR) activation will be 
decreased resulting in altered gene expression. On the other hand, Ca2+ sensing by the 
Ca2+ sensing receptor (CaSR) will be changed due to the hypocalcemia in 1α-OHase 
mice. The importance of VDR activation versus CaSR activation has recently been 
challenged by the observation that many of the phenotypic effects of VDR knock-out 
animals can be prevented by a ‘rescue diet’ with lactose, Ca2+ and phosphate (2, 24, 
26). This observation is supportive for the view that vitamin D becomes relevant at the 
point where an organism is denied an abundant Ca2+ supply.  
In a previous study, we have found indications for these Ca2+-related actions in 
the 1α-OHase-/- knock-out mice (14). This study showed that high dietary Ca2+ intake 
normalizes the expression levels in 1α-OHase-/- of the Ca2+ transport proteins including 
the epithelial Ca2+ channel (TRPV5), calbindin-D28K, Na+-Ca2+ exchanger (NCX1) and 
plasma membrane ATPase (PMCA1b), and contributes in this way to the normalization 
of blood Ca2+ levels (14).   
The aim of the present study was to identify new genes important for the 
maintenance of the Ca2+ balance. The hypothesis is that vitamin D-deficiency results in 
widespread gene expression alterations in the kidney, which are in part due to 
diminished CaSR activation by decreased plasma Ca2+ concentrations. Furthermore, we 
hypothesized that genes, differentially expressed in 1α-OHase-/- mice, could be rescued 
by dietary Ca2+ via a vitamin D-independent mechanism. To address these questions, 
DNA microarray analysis of gene expression was compared between 1α-OHase-/- and 
1α-OHase+/- mice supplemented with dietary Ca2+.  
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MATERIALS AND METHODS  
Animal protocol 
25-hydroxyvitamin D3-1α-hydroxylase knock-out mice were recently generated by 
targeted ablation of exon 8 encoding the heme binding domain of the enzyme (9). 1α-
OHase knock-out mice were genotyped by Southern blot analysis at an age of 3 weeks 
directly after the weaning period as described previously (9). Initial characterization of 
the 1α-OHase knock-out mice demonstrated that there are no significant differences 
between wild-type (1α-OHase+/+) and heterozygous 1α-OHase knock-out mice (1α-
OHase+/-) (9). The heterozygous were, therefore, used as control animals. 1α-OHase+/- 
and homozygous 1α-OHase (1α-OHase-/-) knock-out mice were fed from week 3 to 8 
either a normal diet (1.1 % (w/w) Ca2+, 0.8 % (w/w) phosphorus, 0 % (w/w) lactose), a 
Ca2+-enriched diet (2 % (w/w) Ca2+, 1.25 % (w/w) phosphorus, 20 % (w/w) lactose, 
Harlan Tekled, Wisconsin, MA). Animals (n=6 in each group) were sacrificed at an age 
of 8 weeks and blood and kidney samples were taken. The animal ethics board of the 
University of Nijmegen (Nijmegen) and Shriners Hospital for Children (Montreal) 
approved all animal experimental procedures. 
 
RNA isolation 
RNA was extracted from whole kidney from 4 subjects per group using the TRIzol 
reagent using the procedure recommended by the supplier (Invitrogen Life Sciences, 
Carlsbad, CA). The quality and quantity of the RNA samples was determined with the 
Bioanalyzer (Agilent, Palo Alto, CA) using the Eukaryote Total RNA Nano assay.  
 
Reverse transcription/labeling 
Samples were pooled per group in equal amounts of total RNA per subject. For each 
reaction, 5 μg of total RNA was annealed to 1 μg of Oligo-dT12-18 primer (Invitrogen Life 
Sciences, Carlsbad, CA) at 70ºC for 15 min. Then, reverse transcription was performed 
in a 30-μl reaction containing 200 U SuperScript II reverse transcriptase (Invitrogen Life 
Sciences, Carlsbad, CA), 2 nmol dGTP, dATP and dCTP, 0.5 nmol dTTP (Amersham 
Biosciences Corp, Biscataway, NJ), 1.5 nmol of aminoallyl-dUTP (Amersham 
Biosciences Corp, Biscataway, NJ) at 42ºC for 2 hours. After 2 min at 95ºC, a 20-μl 
mixture of 1 M NaOH (Riedel-de Haën, Seelze, Germany) and 0.5 M of EDTA (pH 8.0; 
Sigma, St Louis, MO) were added and incubated at 65ºC for 30 min to hydrolyze RNA. 
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The reaction was neutralized by adding 25 μl of 1 M of HEPES (pH 7.5; Sigma, St Louis, 
MO). Samples were purified on Microcon-30 columns (Millipore, Billerica, MA) and 
reduced to a volume of 8 μl. Cy3 and Cy5 monofunctional reactive dyes (Amersham 
Biosciences UK Unlimited, Buckinghamshire, UK) dissolved in DMSO (Riedel-de Haën, 
Seelze, Germany) and 1 μl of 0.5 M sodium bicarbonate (pH 9.0; Sigma, St Louis, MO) 
were added to the cDNA samples and incubated at RT for 1 hour. Dyes were quenched 
by incubation with 4.5 μl of 4 M Hydroxylamine (Aldrich Chemicals Co., Milwaukee, MI) 
at RT for 15 min. Labelled samples were purified on Chromaspin-30 columns (BD 
Biosciences Clontech, Palo Alto, CA). Samples from 1α-OHase-/- mice and 1α-OHase+/- 
mice with Ca2+ supplementation were labelled with Cy3 and samples from 1α-OHase+/- 
mice and 1α-OHase-/- mice with Ca2+ supplementation were labelled with Cy5.  
 
Hybridization of cDNA chips 
Mouse NIH 15K cDNA chips (Ontario Microarray Centre, Toronto University, Canada) 
were prehybridized for at least 45 min in a filtered (0.22 micron Minisart-plus filter, 
Sartorius AG, Göttingen, Germany) and preheated buffer (37ºC) containing 1 g bovine 
serum albumin (Sigma, St Louis, MO), 25 ml 20x SSC, 25 ml pure formamide (Merck, 
Darmstadt, Germany), 1 ml 10 % (w/v) sodium dodecyl sulfate (SDS; Bio-Rad 
Laboratories, Hercules, CA), in a total volume of 100 ml. After washing the slides with 
distilled water and isopropanol (Mallinkrodt Baker BV, Deventer, Netherlands), slides 
were spun dry. Slides were then loaded with 100-150 ng labeled cDNA in a filtered (0.22 
micron) and preheated buffer containing 25 % (w/v) formamide (Bio-Rad Laboratories, 
Hercules, CA), 5x SSC (sodium chloride, Riedel-de Haën, Seelze, Germany; sodium 
citrate dihydrate, Merck, Dramstadt, Germany), 0.1 % (w/v) SDS, 200 μg/ml of Herring 
Sperm DNA (Invitrogen Life Sciences, Carlsbad, CA) and tRNA (Roche Molecular 
Diagnostics GmbH, Mannheim, Germany) that had been denatured at 95ºC for 5 min 
and incubated at 42ºC overnight in acclimatized hybridization chambers (Corning 
Incorporated Life Sciences, Acton, MA). Slides were then washed first in 100 ml 1x SSC 
with 0.2 % (w/v) SDS, second, in 0.1x SSC with 0.2 % (w/v) SDS and finally, in 0.1x 
SSC.  
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Scanning/quantification of cDNA chips 
Slides were scanned on the ScanArray 4000XL (BioDiscovery, Marina del Rey, CA) at 
laser intensities of 85-90 and photomultiplier tube sensitivity of 60-65 at a resolution of 
10 μm. Images were quantified using Imagine software (BioDiscovery, Marina del Rey, 
CA). Raw mean intensity data were averaged per duplicate spot and normalized on 
median ratios on the chip by correcting the Cy5 values. Spots with both Cy3 and Cy5 
intensities below background plus two times the standard deviation of the background 
signal and spots with intensities exceeding 45000 were excluded from further analysis. 
Genes were considered significantly regulated when log2 transformed ratios were ≥0.7 or 
≤-0.7.  
 
Clustering Analysis and Gene Ontology Annotations 
Hierarchical clustering of microarray data was performed using the Expression Profiler 
tool EPCLUST (Jaak Vilo, EBI). Average linkage (average distance, UPGMA) clustering 
based on correlation measure-based distance was performed on data for which ratios 
were >0.7 or <-0.7 in at least one comparison. Ratios of the genes were coupled to the 
Biological Processes classification of the Gene Ontology Consortium (GO Consortium) 
(4) using proprietary software and Access 2000 (Microsoft Corporation, Redmond, WA). 
For each Biological Process category, the total number of annotated genes and the 
percentage of significantly changed genes were counted, and the average ratio was 
calculated. Interesting categories were defined as groups containing at least 5 genes 
and that had either a mean overall ratio of >0.3 or <0.3 or had at least 20 % of the genes 
of that group changed significantly.  
 
Serum Ca2+ measurements 
Serum Ca2+ concentrations were measured using a colorimetric assay kit as described 
previously (15).  
 
Statistical analysis 
The serum Ca2+ data were expressed as the mean ± SEM. Overall statistical significance 
was determined by analysis of variance (ANOVA). In the case of significance (p<0.05), 
individual groups were compared by contrast analysis according to Scheffé. 
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RESULTS 
Phenotypical characterization of the 1α-OHase-/- mice 
Inactivation of the 1α-OHase gene in mice resulted in severe hypocalcemia with serum 
Ca2+ concentrations around 1.2 mM, whereas 1α-OHase+/- mice, which are not 
distinguishable from 1α-OHase+/+ mice, displayed normal plasma Ca2+ concentrations 
(Figure 1). 1α-OHase-/- mice fed a regular Ca2+ diet containing 1.1 % (w/w) Ca2+ 
developed rickets and died with an average life-span of 12 ± 2 weeks (data not shown). 
Interestingly, supplementation of these mice with an enriched Ca2+ diet containing 2 % 
(w/w) Ca2+ normalized plasma Ca2+ concentrations that were not significantly different 
from 1α-OHase control mice (Figure 1). This latter diet resulted in a normal 
development and life-span of these supplemented mice. 
 
 
 
 
 
 
 
 
 
 
Gene expression profiles of 1α-OHase-/- mice compared with 1α-OHase+/- mice 
Around 1000 genes were differently regulated in 1α-OHase-/- mice versus the 1α-
OHase+/- mice, whereas roughly 2000 genes were significantly regulated by dietary Ca2+ 
in the vitamin D-deficient mice. Interestingly, 557 transcripts, that account for 4 % of the 
total number of 15.000 scanned genes, were regulated under both conditions. This is 
demonstrated in the Venn diagrams in Figure 2A. Moreover, only minor changes in 
expression were induced by dietary Ca2+ in 1α-OHase+/- mice. Figure 2B,C shows the 
numbers of up- and down-regulated genes in all the experimental conditions and 
includes an overview of the gene expression profile of each condition separately and in 
combination.  
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Figure 1. The effect high dietary Ca2+
intake on the serum Ca2+ 
concentration in 1α-OHase-/- mice. 
Values are presented as means ± SEM 
(n=6). *P<0.05, significant different from 
1α-OHase+/+ and 1α-OHase+/- mice fed a 
normal Ca2+ diet containing 1.1 % (w/v) 
Ca2+. #P<0.05, significant different from 
1α-OHase-/- mice on normal Ca2+ diet 
containing 1.1 % (w/w) Ca2+. 
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Next, we performed a hierarchical clustering of the three comparisons in the 
present study: 1α-OHase-/- versus 1α-OHase+/-, 1α-OHase-/- versus 1α-OHase-/- 
supplemented with Ca2+ and 1α-OHase+/- compared to 1α-OHase+/- treated with Ca2+ 
(Figure 3). A large portion of the expression profiles of knock-out versus 1α-OHase+/- 
and 1α-OHase-/- versus 1α-OHase-/- treated with Ca2+ were similarly regulated, but there 
were also some genes differentially regulated. The comparison of 1α-OHase-/- mice 
versus 1α-OHase-/- mice treated with Ca2+ and 1α-OHase+/- mice compared to 1α-
OHase+/- mice supplemented with Ca2+ yielded far less similarity, but a distinct group of 
genes was co-regulated.  
Figure 4 shows representative differential expression of 1α-OHase-/- versus 1α-
OHase+/- mice in an intensity-dependent fashion with Cy3/Cy5 scatter plots. Up-
regulated and down-regulated genes formed two distinct populations that clearly 
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Figure 2. Number of genes regulated when 
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1α-OHase+/- mice (red) and 1α-OHase-/- 
mice with Ca2+ supplementation (white) 
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Figure 3. Hierarchical clustering of all 
three comparisons (1α-OHase-/- mice 
versus 1α-OHase+/- mice, 1α-OHase-/- mice 
versus 1α-OHase-/- mice treated with Ca2+ 
and 1α-OHase+/- mice compared to 1α-
OHase+/- mice fed the enriched Ca2+-diet). 
Genes that are significantly up- (red) or down-
regulated (green) are shown.  
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differentiate from the non-regulated genes. Of interest is the group of genes (depicted in 
green and red) that were inversely regulated as a consequence of 1α-OHase gene 
inactivation (Figure 4A) and dietary Ca2+ supplementation in the vitamin D-deficient 
state (Figure 4B). Genes depicted in yellow were regulated in a similar direction in the 
described comparisons.  
 
 
 
Figure 4. Differential expression patterns depicted in an intensity-dependent fashion using Cy3/Cy5 
scatter plots. Regulated genes by inactivation of the 1α-OHase gene (A) and supplementation by dietary 
Ca2+ in the vitamin D-deficient state (B) form two distinct populations of genes. Genes that are regulated in 
two conditions (when 1α-OHase+/- mice are compared with 1α-OHase-/- mice and when 1α-OHase-/- 
supplemented with dietary Ca2+) are shown above the 0.7 log2 line (up-regulated in both comparisons) and 
below the -0.7 log2 line (down-regulated in both comparisons). Genes that are regulated in opposite 
directions in both comparisons are shown are shown as large black dots.  
 
Gene expression changes specifically related to Ca2+ supplementation 
Further analysis of the genes that were inversely regulated by dietary Ca2+ 
supplementation and 1,25(OH)2D3 deficiency provides information about interesting 
candidates involved in the 1,25(OH)2D3-independent rescue mechanism by dietary Ca2+ 
(Table 1). Two important cDNA transcripts, known to encode for Ca2+ transporting 
proteins in the distal part of the nephron, calbindin-D28K and the Na+-Ca2+ exchanger 
(NCX1), were down-regulated in the 1α-OHase-/- mice and up-regulated by dietary Ca2+ 
in the 1,25(OH)2D3-deficient animal. Previously, these genes were analyzed by 
quantitative RT-PCR in the same animal model and were found to be regulated in a 
similar manner (14). Analysis of other genes that were significantly regulated revealed 
several genes previously unknown to be involved in the Ca2+ homeostasis. New 
candidates include the Ca2 +-related genes like FK506 binding protein 4, calmodulin and 
several ion transporters, i.e. the K+ channel protein Kcnq1, the Na+-H+ exchanger and 
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the voltage-dependent Ca2+ channel α1 subunit. Several kinases and kinase substrates 
controlling distinct signalling pathways were regulated by dietary Ca2+ as well as a 
channel-interacting PDZ domain protein (Table 1).  
 
Table 1. Summary of candidate genes identified using cDNA microarrays. 
 
Regulation (Log2 
ratios)  
Function group 
 
Gene name 
-/- vs 
+/- 
-/-Ca2+ 
vs -/- 
 
GenBank 
Accession 
No 
     
Calcium-related Calbindin-D28K -0.86 0.83 D26352 
 Calmodulin-I 0.81 -0.85 U16850 
     
Immunology FK506 binding protein 4 -0.93 1.26 NM010219 
     
Matrix/structural 
proteins Putative  membrane protein GENX-3745 gene 0.82 -0.74 AJ270952 
 Putative  membrane protein 1190006A08Rik -0.77 1.28 XM129531 
     
Protein 
synthesis/translation 
control 
Poly(A) binding protein  II (Pabpn1) 0.99 -0.88 U93050 
     
Receptor/channe/ 
transporter Kcnq1 gene for potassium channel protein (Tssc8) 0.74 -1.36 NM008434 
 Voltage-dependent  calcium channel alpha1 subunit (Cacn4) -0.84 1.03 D43746 
 Voltage-dependent anion  channel 1 (Vdac1) -0.77 0.99 NM011694 
 Sodium/calcium exchanger Slc8a1 (NCX1) -1.18 1.57 NM011406 
     
Signalling/ 
communication 
Sodium/hydrogen exchanger, isoform 3 regulator 1 
(NHERF-1) Slc9a3r1 -0.91 1.23 NM012030 
 Serine/threonine kinase  (Stk18) 0.90 -1.03 L29479 
 Guanylate kinase 1 (Guk1) 0.88 -0.84 NM008193 
 Channel-interacting PDZ  domain protein (Cipp) 0.84 -0.72 NM172696 
 v-crk-associated tyrosine  kinase substrate (Crkas) 0.79 -0.71 NM009954 
 Protein kinase C substrate 80K-H (Prkcsh) -0.84 0.92 NM008925 
 G protein-coupled receptor kinase 5 (GRK5) 0.83 -0.96 AF040756 
Depicted genes are reversely regulated by inactivation of the 1α-OHase gene and supplementation by 
dietary Ca2+ in the vitamin D-deficient state. The log2 ratios represent the change in expression when 1α-
OHase-/- mice are compared to 1α-OHase+/- mice and when 1α-OHase-/- mice are supplemented with Ca2+. 
(the complete data set of the regulated genes is accessible via 
(URL:http://www.genomics.med.uu.nl/pub/bb/kidney/). 
 
Additional analysis was performed to study genes that followed the Ca2+ 
availability in 1α-OHase-/- and 1α-OHase+/- mice. Although 1α-OHase+/- mice did not 
show elevated levels of serum Ca2+ (Figure 1), several genes were found to be down-
regulated in 1α-OHase-/- mice without dietary supplementation and up-regulated when 
1α-OHase+/- mice were supplemented with Ca2+ (Table 2). These genes are thought to 
be interesting candidates that are controlled by Ca2+ irrespective of the vitamin D state of 
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the animal. Among them were genes involved in MAPK/tyrosine kinase signaling and 
genes that are responsive to intracellular Ca2+ concentrations (Table 2). Subsequently,  
 
Table 2. List of genes that are regulated by the Ca2+ availability in 1α-OHase-/- and 1α-OHase+/- mice  
with their corresponding ratios.  
Regulation (Log2 ratios) Symbol Gene name Process 
 -/- vs -/- 
Ca2+ 
 +/- Ca2+ vs 
+/- 
GenBank 
Accession No
p70 (s6k) / p85 
(s6k) 
p70/p85 s6 kinase MAPK signalling / cell 
proliferation / growth 
-1.20 0.77 AJ000654 
Pbef pre-B-cell colony-enhancing factor activation in lymphocytes -0.84 0.77 BC018358 
ECH1 enoyl coenzyme A hydratase 1 fatty acid beta-oxidation -1.12 0.50 NM_016772 
Fu FUSED serine/threonine kinase  -0.72 0.58 O35625 
Gsta4 glutathione S-transferase, alpha 4 antioxidative reponse -1.56 0.98 NM_010357 
BMP-1 bone morphogenetic protein development -0.95 0.51 AK004995 
P4HA1 prolyl 4-hydroxylase alpha(I)-subunit Matrix/bone formation -1.23 0.59 BC009654 
Snta1 syntrophin, acidic 1 neuronal differentiation -0.77 0.56 NM_009228 
GC-globulin vitamin D-binding protein (GC)   -0.88 1.14 BC010762 
UGT1  UDP glucuronosyltransferase detoxification -1.34 0.96 BC012716 
APC4 anaphase-promoting  complex 
subunit 4 
cell cycle -1.29 0.55 Q9UJX5 
RARRES2 / 
TIG2 
retinoic acid receptor responder 
(tazarotene induced) 2  
  -1.04 1.11 NM_002889 
BNIP3 / NIP3 BCL2/adenovirus E1B 19  kDa-
interacting protein 1 
calcium storage -1.19 0.77 X82564 
JAG1 jagged 1 (Alagille  syndrome) differentiation 0.69 -0.77 NM_000214 
HSD17B4 hydroxysteroid 17-beta  
dehydrogenase 4 
testosterone biosynthesis -0.76 0.54 NM_008292 
The log2 ratios represent the change in expression when supplemented with Ca2+ in 1α-OHase-/- mice and in 
1α-OHase+/- mice. 
 
Table 3. List of genes that are significantly regulated by inactivation of the 1α-OHase gene and not 
 by dietary Ca2+ supplementation with their corresponding ratios.  
Regulation (log2 ratios) Symbol Gene name Process 
-/- vs +/- -/- vs -/-Ca 
GenBank 
Accession No
ATP6g1 ATPase H+-transporting lysosomal proton 
pump 
proton transport -0.72 -0.049 NM_004888 
Abcc3 ATP binding cassette sub-family C 
(CFTR/MRP) 
ion transport 0.79 0.46 NM_029600 
Calb3 Calcium binding protein D9K Ca2+ transport -1.37 -0.003 NM_009789 
Cdk4 Cyclin-dependent kinase 4 signalling 0.76 0.54 NM_009870 
ECM1 Extracellular matrix protein 1 adhesion 0.70 0.41 NM_007899 
SLC7A Cation amino acid transporter amino acid transport 1.21 0.26 NM_003982 
COL3A COL3A1 gene for collagen bone -0.84 0.49 XM_129745 
KCNN4 K+ small conductance Ca2+ activated 
channel 
K+ channel 0.89 -0.67 NM_008433 
Hsp86-1 Heat shock protein Hsp86-1 chaperone -0.98 -0.56 XM_109307 
P2RX4 P2b4c receptor unit ATP-gated ion channel 1.00 0.64 AJ251461 
D7RP2e Kidney testosteron-regulated RP2 signalling -0.77 -0.23 NM_033080 
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The log2 ratios represent the change in expression when 1α-OHase-/- mice are compared with 1α-OHase+/- 
and 1α-OHase-/- mice versus 1α-OHase-/- mice supplemented with Ca2+. 
 
genes regulated by the 1α-OHase gene inactivation, but not sensitive to dietary Ca2+ 
supplementation, were identified and depicted in Table 3. Typical genes regulated by 
vitamin D only were identified in several function groups including Ca2+ transport proteins 
and ion transporters. 
 
Analysis using Gene Ontology Consortium functional classification of genes 
Differentially regulated genes were grouped into functional profiles using Gene Ontology 
Consortium annotation. In both the comparison of the 1α-OHase-/- with the 1α-OHase+/- 
mice and the comparison of the 1α-OHase-/- mice with the 1α-OHase-/- mice receiving 
the high Ca2+ diet, alterations in some functional categories could be identified. Of all 
307 categories of biological processes, 109 had 5 or more genes that were represented 
on the cDNA chip. Of these, 14 processes were considered to be changed in the 1α-
OHase-/- mice versus 1α-OHase+/- mice and 32 processes in 1α-OHase-/- mice versus 
1α-OHase-/- mice supplemented with Ca2+ comparison. Eleven categories were 
overlapping in both comparisons (Figure 5). Inactivation of the 1α-OHase gene and 
supplementation of Ca2+ in 1α-OHase-/- mice resulted in a regulation of genes involved in 
protein biosynthesis. Remarkably, a subset of the biological processes were regulated in 
a similar fashion in both comparisons. Biological processes such as glycolysis, 
peroxidase reaction, hydrogen transport, tricarbolic acid cycle, iron homeostasis and 
lymph gland development were decreased in 1α-OHase-/- mice and reactivated through 
dietary Ca2+ supplementation. Genes involved in muscle development and induction of 
apoptosis were slightly up-regulated due to the absence of 1,25(OH)2D3 which were not 
affected by Ca2+ supplementation of the 1α-OHase-/- mice. 
 
DISCUSSION 
In the present study, we demonstrated that dietary Ca2+ intake is an important regulator 
of the Ca2+ homeostasis in vitamin D-deficient 1α-OHase-/- mice ultimately normalizing 
blood Ca2+ levels. Microarray analysis revealed that high dietary Ca2+ intake restores the 
disturbed genetic profile observed in 1α-OHase-/- mice, which is accompanied by a 
functional rescue of these 1,25(OH)2D3-deficient animals. Gene expression analysis 
showed simultaneous regulation of genes with potential importance for Ca2+ handling 
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that were not previously identified as such and a subset of genes that were regulated by 
dietary Ca2+ independently of vitamin D3. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. A subset of regulated functional gene groups based on Gene Ontology with differential 
regulation due to 1α-OHase inactivation or Ca2+ supplementation. Displayed GO groups contained at 
least 5 genes, had either a mean overall ratio of at least 0.3 or had at least 20 % of the genes changed 
significantly in both comparisons. Box plots indicate the quartiles of the ratios.  
 
Recently, St-Arnaud and colleagues generated an 1α-OHase knock-out strain 
that represents a valuable animal model for PDDR since these mice display all the 
clinical symptoms observed in patients including hypocalcemia and rickets (9). These 
pathological symptoms in the 1α-OHase-/- mice resulted in an early death with an 
average life-span of 12 weeks. Normalization of the plasma Ca2+ concentrations by 
dietary Ca2+ supplementation was associated with a functional rescue of the 1α-OHase-/- 
mice that made the recovered mice phenotypically undistinguishable from wild-type 
mice. A previous study indicated that the Ca2+ transport proteins including TRPV5 
(previously named ECaC1), calbindin-D28K and NCX1 were down-regulated in the 1α-
OHase mice (14). Interestingly, the expression of these proteins was normalized by 
dietary Ca2+ supplementation.  
The present analysis demonstrated that known Ca2+ transport proteins 
represented on the cDNA microarray, including calbindin-D28K and NCX1, were regulated 
by dietary Ca2+. Dietary Ca2+ supplementation in the 1α-OHase-/- mice had a maximum 
effect on NCX1 expression suggesting that this basolateral extrusion protein is an 
important mechanism in the process of transcellular Ca2+ reabsorption. In line with these 
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findings are functional studies in cell model systems demonstrating that basolateral 
extrusion of Ca2+ is mainly achieved by NCX1 (6, 25). Interestingly, calbindin-D9K was 
not regulated by dietary Ca2+ supplementation. The expression of this Ca2+ binding 
protein was solely controlled by vitamin D in line with previous studies (14). 
St-Arnaud and colleagues investigated recently bone histology and 
histomorphometry in 1α-OHase-/- mice supplemented with Ca2+ confirming that the 
rickets and osteomalacia were prevented (10). The Ca2+ rescue diet also restored the 
biomechanical properties of the bone tissue within normal parameters. Blood 
biochemical analysis revealed that the Ca2+ diet corrected the secondary 
hyperparathyroidism. This points at an important role for the decreased prevailing 
calcium levels per se, independent of PTH and vitamin D. This significant effect of 
hypocalcemia could indicate a decrease in CaSR activation. The CaSR is an important 
gateway by which extracellular Ca2+ can affect a variety of second messenger systems, 
such as the phopsholipases PLA2 and PLC, adenylate cyclase and mitogen-activated 
protein kinases (MAPKs). The downstream actions of CaSR on gene expression involve 
a large number of cellular processes, most notably secretory pathways of hormones, 
channels and transporters (e.g. the thiazide-sensitive NaCl-cotransporter, K+ channels 
and aquaporin-2) and apoptosis-related genes. In various clinical conditions associated 
with a disturbed Ca2+ homeostasis vitamin D analogues are administered. The treatment 
of choice for PDDR and for patients with chronic renal failure is long-term replacement 
therapy with 1,25(OH)2D3. Notably, the currently applied strategy of vitamin D and Ca2+ 
supplementation to patients with chronic renal failure has been associated with 
undesirable effects, such as vascular calcification and calciphylaxis. It would be 
interesting to compare the normalization of plasma Ca2+ levels by Ca2+ supplementation 
with the treatment with vitamin D analogues in these patient groups. 
Hierarchical cluster analysis of the 15K cDNAs demonstrated a remarkable 
overlap in the expression profiles between inactivation of the 1α-OHase gene compared 
to 1α-OHase-/- mice with supplementation of dietary Ca2+ whereas only a minor overlap 
was observed between 1α-OHase-/- with 1α-OHase+/- mice. Interestingly, several 
transcripts, unknown to be involved in Ca2+ homeostasis, were significantly regulated. 
Previous studies from our group have shown that TRPV5, not present on the microarray 
chip, facilitates the rate-limiting step in the process of transcellular Ca2+ transport (16). 
With respect to the gatekeeper function of this apical Ca2+ influx channel, it will be 
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interesting to discuss three regulated cDNAs encoding a channel-interacting PDZ 
domain protein (CIPP), FK506 binding protein 4 and calmodulin (CaM). 
CIPP was found to interact with several ion channels including the acidic sensing 
ion channel ASIC3 and the inward rectifying potassium channel Kir (3, 18). CIPP is a 
PDZ domain-containing protein that contains four PDZ domains. Interestingly, TRPV5 
contains both in the amino and carboxyl-termini type I (S/T-X-V/L) PDZ-interacting 
domains, that are similar to the carboxyl-terminal sequence of the ASIC3 protein (27). 
PDZ-containing proteins can indeed influence the cell surface expression of ion channel 
proteins by, for instance, affecting their insertion, endocytosis and recycling (8, 19). 
The second transcript, FK506 binding protein 4 (FKBP4), has been implicated as 
an important regulaton of ion channel activity. Of interest, the transient receptor 
potential-like channel (TRPL), a Ca2+-permeable cation channel found in Drosophila 
photoreceptor cells that shares 25 % homology and an identical structural topology with 
TRPV5, is modulated by FKBP4 (12). Intriguingly, renal transplant recipients receiving 
the immunosuppressive drug FK506 (also known as tacrolimus), which is the substrate 
for FKBP4, had strongly reduced renal calbindin-D28K protein levels and increased urine 
Ca2+ excretion (13, 23). Furthermore, the treatment caused intratubular calcification (1). 
The data suggest a link between the observed regulation of FKBP4 in the present study 
and the molecular regulation of Ca2+ reabsorption in the distal part of the nephron.  
The third interesting candidate regulated on the chip was CaM. CaM is a major 
cellular sensor of Ca2+ signalling and interacts with numerous proteins associated with 
cellular second messenger systems (5, 22). Changes in intracellular Ca2+ concentration 
regulate CaM in various distinct ways. First, at the cellular level, by directing its 
subcellular distribution. Second, at the molecular level, by promoting different modes of 
association with many target proteins. Third, by directing a variety of conformational 
states in CaM that result in target-specific activation. Based on the present study a fourth 
point can be added in which Ca2+ regulates the genomic expression of CaM. CaM-
dependent regulation of protein kinases illustrates a potential mechanism by which Ca2+-
sensing proteins can recognize and generate affinity as well as specificity for effectors in 
a Ca2+-dependent manner. It has been demonstrated that CaM interacts with several 
Ca2+ channels including voltage-gated Ca2+ channels (28), but also members of the TRP 
family (7, 20). Niemeyer et al. identified a new CaM binding site in the carboxyl-terminus 
of the TRPV5 homologue TRPV6 (20). These investigators showed that Ca2+-dependent 
calmodulin-binding to TRPV6 facilitates channel inactivation, which was counteracted by 
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PKC-mediated phosphorylation of this putative CaM binding site. Based on the observed 
genomic regulation of CaM it will be of interest to investigate whether this Ca2+ sensor 
interacts with TRPV5. The afore-mentioned genes were reversely regulated by 
inactivation of the 1α-OHase gene and normalized in expression by dietary Ca2+, which 
raises the attractive hypothesis that these putative candidates regulate Ca2+ 
reabsorption in general and in particular TRPV5 activity, and thereby, restoring the 
hypocalcemia and subsequently other pathological symptoms in the vitamin D-deficient 
mice. 
In addition to the previously discussed reversely regulated genes, a subgroup of 
genes was regulated by dietary Ca2+ independent of the vitamin D status. These genes 
were found to be up- or down-regulated by Ca2+ in 1α-OHase+/- and 1α-OHase-/-. An 
interesting candidate is MAP kinase (p70/p85 s6 kinase), an enzym that has been 
implicated in many cellular signaling processes including voltage-operated Ca2+ 
channels (11). Furthermore, cDNAs encoding proteins, that are involved in activation of 
MAP kinase, are co-regulated like syntrophin. Anchoring of ion channels at specific 
subcellular sites is critical for signaling, but the mechanisms underlying channel 
localization and clustering are largely unknown. Molecules such as ankyrin and 
syntrophin, that bind ion channels, may be important to maintain a high channel density 
at the plasma membrane (17). 
Apart from normalizing plasma Ca2+ levels by Ca2+ supplementation in 1α-
OHase-/- mice, PTH levels were also normalized. Ca2+-induced effects could, therefore, 
be secondary to a change in the circulating PTH levels. The third comparison of Ca2+ 
supplementation in 1α-OHase+/- mice with normal 1,25(OH)2D3 and PTH levels suggests 
that these genes are regulated by Ca2+, irrespective of the 1,25(OH)2D3 and PTH state. 
In conclusion, the present study demonstrated that high dietary Ca2+ is an 
important regulator of Ca2+ homeostasis in a vitamin D-deficient status. Using microarray 
analysis we have demonstrated that dietary Ca2+ normalizes a large part of the renal 
gene expression changes resulting from the absence of 1α-OHase. We also identified 
novel genes and biological pathways that are regulated in the Ca2+-mediated rescue of 
1α-OHase-/- mice. Subsequent studies on these potential targets will provide insight in 
the molecular rescue mechanisms of dietary Ca2+ supplementation.  
 
 
 
Chapter 2 
 44 
ACKNOWLEDGEMENTS 
This work was supported by the Dutch Organization of Scientific Research (Zon-Mw 
016.006.001, Zon-Mw 902.18.298), the Dutch Kidney Foundation (C10.1881 and 
NSN6013) and by the Shriners of North America. R. St-Arnaud is a ‘chercheur-boursier’ 
from the Fonds de la Recherche en Santé du Québec. The research of BB is supported 
by a fellowship of the Dutch Academy of Arts and Sciences. 
 
REFERENCES 
1. Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, and Steiner S. 
Decrease in kidney calbindin-D28kDa as a possible mechanism mediating cyclosporine A- and FK-
506-induced calciuria and tubular mineralization. Biochem Pharmacol 53: 723-731, 1997. 
 
2. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, and Demay MB. Rescue of 
the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion 
homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140: 4982-
4987, 1999. 
 
3. Anzai N, Deval E, Schaefer L, Friend V, Lazdunski M, and Lingueglia E. The multivalent PDZ 
domain-containing protein CIPP is a partner of acid-sensing ion channel 3 in sensory neurons. J 
Biol Chem 277: 16655-16661, 2002. 
 
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, 
Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, 
Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene ontology: tool for the unification 
of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000. 
 
5. Ashby MC and Tepikin AV. Polarized calcium and calmodulin signaling in secretory epithelia. 
Physiol Rev 82: 701-734, 2002. 
 
6. Bindels RJ, Ramakers PL, Dempster JA, Hartog A, and van Os CH. Role of Na+/Ca2+ exchange 
in transcellular Ca2+ transport across primary cultures of rabbit kidney collecting system. Pflugers 
Arch 420: 566-572, 1992. 
 
7. Boulay G. Ca2+-calmodulin regulates receptor-operated Ca2+ entry activity of TRPC6 in HEK-293 
cells. Cell Calcium 32: 201-207, 2002. 
 
8. Chevesich J, Kreuz AJ, and Montell C. Requirement for the PDZ domain protein, INAD, for 
localization of the TRP store-operated channel to a signaling complex. Neuron 18: 95-105, 1997. 
 
9. Dardenne O, Prud'homme J, Arabian A, Glorieux FH, and St-Arnaud R. Targeted inactivation of 
the 25-hydroxyvitamin D3-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of 
pseudovitamin D-deficiency rickets. Endocrinology 142: 3135-3141, 2001. 
 
10. Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, and St-Arnaud R. Correction of the 
abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues 
the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase 
(CYP27B1). Bone 32: 332-340, 2003. 
 
11. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, and Greenberg ME. Signaling to the nucleus by an 
L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294: 333-
339, 2001. 
 
12. Goel M, Garcia R, Estacion M, and Schilling WP. Regulation of Drosophila TRPL channels by 
immunophilin FKBP59. J Biol Chem 276: 38762-38773, 2001. 
 
Gene Profiling of 1α-OHase Mice 
 45
13. Harding MW, Galat A, Uehling DE, and Schreiber SL. A receptor for the immunosuppressant 
FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758-760, 1989. 
 
14. Hoenderop JG, Dardenne O, van Abel M, van der Kemp AW, Van Os CH, St-Arnaud R, and 
Bindels RJ. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-
dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice. Faseb J 16: 1398-
1406, 2002. 
 
15. Hoenderop JG, De Pont JJ, Bindels RJ, and Willems PH. Hormone-stimulated Ca2+ 
reabsorption in rabbit kidney cortical collecting system is cAMP-independent and involves a phorbol 
ester- insensitive PKC isotype. Kidney Int 55: 225-233, 1999. 
 
16. Hoenderop JG, Nilius B, and Bindels RJ. Molecular mechanisms of active Ca2+ reabsorption in 
the distal nephron. Ann Rev Physiol 64: 529-549, 2002. 
 
17. Kim E, Niethammer M, Rothschild A, Jan YN, and Sheng M. Clustering of Shaker-type K+ 
channels by interaction with a family of membrane-associated guanylate kinases. Nature 378: 85-
88, 1995. 
 
18. Kurschner C, Mermelstein PG, Holden WT, and Surmeier DJ. CIPP, a novel multivalent PDZ 
domain protein, selectively interacts with Kir4.0 family members, NMDA receptor subunits, 
neurexins, and neuroligins. Mol Cell Neurosci 11: 161-172, 1998. 
 
19. Li HS and Montell C. TRP and the PDZ protein, INAD, form the core complex required for 
retention of the signalplex in Drosophila photoreceptor cells. J Cell Biol 150, 2000. 
 
20. Niemeyer BA, Bergs C, Wissenbach U, Flockerzi V, and Trost C. Competitive regulation of 
CaT-like-mediated Ca2+ entry by protein kinase C and calmodulin. Proc Natl Acad Sci U S A 98: 
3600-3605, 2001. 
 
21. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, and Goltzman D. Targeted 
ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, 
reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 98: 7498-7503, 2001. 
 
22. Saimi Y and Kung C. Calmodulin as an ion channel subunit. Annu Rev Physiol 64: 289-311, 2002. 
 
23. Siekierka JJ, Hung SH, Poe M, Lin CS, and Sigal NH. A cytosolic binding protein for the 
immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. 
Nature 341: 755-757, 1989. 
 
24. Song Y, Kato S, and Fleet JC. Vitamin D receptor (VDR) knockout mice reveal VDR-independent 
regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133: 374-
380, 2003. 
 
25. Van Baal J, Yu A, Hartog A, Fransen JA, Willems PH, Lytton J, and Bindels RJ. Localization 
and regulation by vitamin D of calcium transport proteins in rabbit cortical collecting system. Am J 
Physiol 271: F985-993, 1996. 
 
26. van Cromphaut S, Dewerchin M, Hoenderop JG, Stockmans I, van Herck E, Kato S, Bindels 
RJ, Collen D, Carmeliet P, Bouillon R, and Carmeliet G. Active duodenal calcium absorption in 
vitamin D receptor-knock out mice: functional and molecular aspects. Proc Natl Acad Sci U S A 98: 
13324-13329, 2001. 
 
27. van de Graaf SF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, Gerke V, Staub O, 
Nilius B, and Bindels RJ. Functional expression of the epithelial Ca2+ channels (TRPV5 and 
TRPV6) requires association of the S100A10-annexin 2 complex. Embo J 22: 1478-1487, 2003. 
 
28. Zuhlke RD, Pitt GS, Deisseroth K, Tsien RW, and Reuter H. Calmodulin supports both 
inactivation and facilitation of L-type calcium channels. Nature 399: 159-162, 1999. 
 
 
 
Chapter 2 
 46 
 
 
 
 
 
 
 
 
Chapter     3 
 
 
 
 
80K-H as a new Ca2+ sensor regulating the activity of the 
epithelial Ca2+ channel TRPV5 
 
 
Dimitra Gkika1, Frank Mahieu2, Bernd Nilius2, Joost G.J. Hoenderop1 and René 
J.M. Bindels1 
 
1Department of Physiology, Nijmegen Centre for Molecular Life Sciences, 
Radboud University Nijmegen Medical Centre, The Netherlands. 
2Department of Physiology, Campus Gasthuisberg, KU Leuven, Belgium.  
 
 
 
 
 
 
 
 
 
 
Journal of Biological Chemistry 279: 26351-26357, 2004 
Chapter 3 
 48 
…Τους Λαιστρυγόνες και τους Κύκλωπας,  
τον άγριο Ποσειδώνα δεν θα συναντήσεις,  
αν δεν τους κουβανείς μες στην ψυχή σου,  
αν η ψυχή σου δεν τους στήνει εμπρός σου... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…Neither Laestrygones nor Cyclopes, 
nor wild Poseidon will you ever meet, 
unless you bear them in your soul, 
unless your soul has raised them up in front of you... 
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ABSTRACT  
The epithelial Ca2+ channel TRPV5 constitutes the apical Ca2+ entry pathway in the 
process of active Ca2+ reabsorption. Ca2+ influx through TRPV5 is tightly controlled by 
modulators of Ca2+ homeostasis, including 1,25-dihydroxyvitamin D3 and dietary Ca2+. 
However, little is known about intracellular proteins that interact with TRPV5 and directly 
regulate the activation of this channel. The present study identified by the use of cDNA 
microarrays 80K-H as the first protein involved in the Ca2+-dependent control of the 
epithelial Ca2+ channel TRPV5. 80K-H was initially identified as a protein kinase C 
substrate, but its biological function remains to be established. We demonstrated a 
specific interaction between 80K-H and TRPV5, co-localization of both proteins in the 
kidney and similar transcriptional regulation by 1,25-dihydroxyvitamin D3 and dietary 
Ca2+. Furthermore, 80K-H directly bound Ca2+ and inactivation of its two EF-hand 
structures totally abolished Ca2+ binding. Electrophysiological studies using 80K-H 
mutants showed that three domains of 80K-H (the two EF-hand structures, the highly 
acidic glutamic stretch and the HDEL sequence) are critical determinants for TRPV5 
activity. Importantly, inactivation of the EF-hand pair reduced the TRPV5-mediated Ca2+ 
current and increased the TRPV5 sensitivity to intracellular Ca2+, accelerating the 
feedback inhibition of the channel. None of the 80K-H mutants altered the TRPV5 
plasma membrane localization nor the association of 80K-H with TRPV5, suggesting that 
80K-H has a direct effect on TRPV5 activity. In conclusion, we report a novel function for 
80K-H as a Ca2+-sensor controlling TRPV5 channel activity. 
 
INTRODUCTION 
The maintenance of the body Ca2+ balance is of crucial importance for many vital 
physiological functions including neuronal excitability, muscle contraction and bone 
formation. The recent identification of two novel members of the transient receptor 
potential (TRP) superfamily, TRPV5 and TRPV6, has provided new insight at the 
molecular mechanisms controlling the extracellular Ca2+ balance (13, 15, 31). TRPV5 
and TRPV6 are Ca2+-selective channels involved in transcellular Ca2+ transport across 
vitamin D3-sensitive epithelia, such as kidney, intestine and placenta (16, 38). 
Furthermore these two channels possess unique functional characteristics among the 
highly heterogeneous group of TRP channels (5). They exhibit a constitutively activated 
Ca2+ permeability, a high Ca2+ selectivity and a Ca2+-dependent feedback mechanism 
regulating channel activity (29, 40).  
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TRPV5 activity is controlled by various regulatory mechanisms ranging from long-
term transcriptional modulations to short-term direct physical interactions with 
intracellular factors. TRPV5 is regulated at the transcriptional level by 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3), dietary Ca2+ and 17β-estradiol (11, 37, 38). Previous 
studies have shown that these hormones and dietary Ca2+ normalize the hypocalcemia 
in 25-hydroxyvitamin D3-1α-hydroxylase (1α-OHase) knock-out mice, which is 
accompanied by an up-regulation of TRPV5 mRNA expression levels. Furthermore, 
TRPV5 modulation occurs at the post-translational level by controlling translocation of 
the channel from intracellular pools to the plasma membrane. Recently, the S100A10-
annexin 2 complex was demonstrated to modulate the functional plasma membrane 
distribution of TRPV5 by direct association to the carboxyl (C)-terminal tail of the 
channel. Down-regulation of annexin 2 inhibited TRPV5-mediated currents in TRPV5-
transfected cells (39). Finally, the terminal tails of the channel contain potential 
regulatory motifs, such as protein kinase C (PKC) phosphorylation sites, PDZ motifs and 
ankyrin repeats (16). This suggests a regulatory role for the intracellular tails of TRPV5 
in the (in)activation or the trafficking of the channel. In line with this observation, 
Niemeyer et al. (27) demonstrated that TRPV6 is competitively regulated by PKC and 
calmodulin.   
The aim of the present study was to identify novel regulators of Ca2+ reabsorption 
via TRPV5. To this end, cDNA microarray experiments were performed to identify 
candidates that exhibit a similar transcriptional regulation to well known proteins involved 
in Ca2+ transport. Analysis of the data pointed to a PKC substrate, 80K-H, of which the 
biological function remains unclear. The putative role of this protein in active Ca2+ 
reabsorption was investigated by immunohistochemical, biochemical and 
electrophysiological analysis of 80K-H interacting with TRPV5. 
 
MATERIALS AND METHODS  
DNA constructs and cRNA synthesis 
TRPV5 constructs were generated as described previously (39). The coding sequence of 
80K-H wild type protein was amplified from total mouse kidney cDNA material, cloned 
into the pCINeo/IRES-GFP vector (36) as an EcoRI-NheI fragment and subsequently 
subcloned into the pGEX6p-2 vector (Amersham Pharmacia Biotech AB, Uppsala, 
Sweden) and the pT7Ts vector (20). Using in vitro mutagenesis (QuickChange Site-
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Directed Mutagenesis kit, Stratagene, La Jolla, Canada), three mutants of 80K-H were 
generated in the pCINeo/IRES GFP vector: one mutant by alanine substitution of the first 
two aspartates of each EF-hand structure (80K-HEF), the second mutant by deletion of a 
stretch containing 21 glutamates (80K-HΔGlu) and the third mutant by deletion of the C-
terminal sequence HDEL (80K-HΔHDEL). The obtained mutants were subsequently 
subcloned into the pT7Ts and pGEX6p-2 vectors. All constructs were verified by 
sequence analysis. pTLN and pT7Ts constructs were linearized and cRNA was 
synthesized in vitro using SP6 and T7 RNA polymerase, respectively (14).  
 
Real-time quantative PCR 
80K-H mRNA expression level was quantified by real-time quantitative PCR in kidney of 
8 weeks old mice (strain C57BL/6) that had received a dietary supplementation with 100 
pg/g body weight 1,25(OH)2D3 or 2 % w/v Ca2+ (instead of 1.1 % w/v for normal diet) 
(11). The primers used were 5’-GTC CCA ATG GCA GCT TTC A-3’ and 5’-CCC GGC 
TGG AGA GGA TGT A-3’ and the probe 5’-TGC ACC AAC ACT GGG TAC AAG CC C 
T-3’. Probes were labelled with the quencher dye 6-carboxytetramethylrhodamine (3'-
ends) and the reporter dye 6-carboxyfluorescein (5'-ends) (Biolegio, Malden, The 
Netherlands). The expression level of hypoxanthine-guanine phosphoribosyl transferase 
(HPRT) was used as an internal control (37).  
 
RT-PCR analysis 
Total RNA from mouse brain, eye, salivary tissue, thymus, heart, lung, liver, spleen, 
pancreas, stomach, duodenum, colon, kidney, prostate, testis, uterus, skin, skeletal 
muscle and bone was isolated using TRIzol (GIBCOBRL, Life Technologies, Breda, The 
Netherlands). Total RNA (2 μg) was subjected to reverse transcription using Moloney 
murine leukemia virus reverse transcriptase and a PCR reaction for 80K-H was 
performed in a species-conserved region using the primers 5’-TAC GTC TAC CGG CTT 
TGC C-3’ and 5’-AGG TAC TCA CAG CGA CTG GG-3’. 
 
Immunohistochemistry 
Immunohistochemistry was performed as described (12). Briefly, mouse kidney sections 
were incubated for 16 h at 4 ºC with affinity purified guinea pig antiserum against TRPV5 
(1:100) and rabbit antiserum against 80K-H (1:500) (1). To visualize TRPV5 and 80K-H, 
goat anti-guinea pig Alexa 488 conjugated antibody (1:300), a goat anti-rabbit Alexa 488 
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and Alexa 594 conjugated antibodies (1:300) (Molecular Probes, Eugene, USA) were 
used. All negative controls, including sections incubated with pre-immune serum or 
conjugated antibodies solely, were devoid of any staining. 
 
GST-TRPV5 fusion protein and interaction assays 
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and GST-fusion 
proteins were expressed and purified according to the manufacturer’s protocol 
(Amersham Pharmacia Biotech AB, Uppsala, Sweden). [35S]methionine-labeled 80K-H, 
80K-HEF and 80K-HΔGlu, were prepared using a reticulocyte lysate and added to GST or 
GST-TRPV5 fusion proteins immobilized on glutathion-Sepharose 4B beads (Amersham 
Pharmacia Biotech AB, Uppsala, Sweden) in PBS containing 1 % v/v Triton X-100. After 
2 h incubation at room temperature, the beads were washed extensively and bound 
proteins were eluted with SDS-PAGE loading buffer, separated on 10 % w/v SDS-PAGE 
gels and visualized by autoradiography.  
 
Injection of Xenopus oocytes and co-immunoprecipitation 
Xenopus laevis oocytes were co-injected with 5 ng HA tagged TRPV5 and 20 ng 80K-H 
cRNA and after 48 h, injected and non-injected oocytes were subjected to total 
membrane isolation by centrifugation (7). The membrane fraction was incubated on ice 
for 60 min in lysis buffer (10 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5 % v/v NP-40, 1 mM 
CaCl2, 10 % w/v sucrose) and. After centrifugation of the lysates, supernatants were 
incubated with anti-HA antibody (Sigma, St. Louis, MO, USA) or rabbit anti-80K-H 
antibody immobilized on protein A-agarose beads (Kem-En-Tec A/S, Kopenhagen, 
Denmark) in the presence of 1 % w/v BSA (bovine serum albumin) for 16 h at 4 °C. 
Samples were washed three times with washing buffer (10 mM Tris-HCl pH 7.6, 500 mM 
NaCl, 0.5 % v/v NP-40 and 1 mM CaCl2). Immunoprecipitated proteins were eluted with 
SDS-PAGE loading buffer, separated on 10 % w/v SDS-PAGE gel and analyzed by 
immunoblotting using rabbit anti-80K-H (1:10000) and anti-HA (1:4000) antibodies, 
respectively. 
 
45Ca2+ binding assay 
In order to study direct Ca2+ binding properties of 80K-H, GST-fused 80K-H proteins 
migrated on 12 % w/v SDS-PAGE gel and were blotted to nitrocellulose membrane. 
Blotted proteins were visualized with Ponceau S staining (Sigma, St. Louis, MO, USA). 
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45Ca2+ binding was performed as described by Maruyama et al. (25). Briefly, 
nitrocellulose membranes were thoroughly washed and incubated for 10 min with 1 
μCi/ml 45CaCl2 (Perkin Elmer Life Sciences, Boston MA, USA). After washing the 
membrane was dried and 45Ca2+ binding was visualized by autoradiography.  
 
Biotinylation assay 
TRPV5, 80K-H, 80K-HEF, 80K-HΔGlu and 80K-HΔHDEL pCINeo/IRES-GFP constructs were 
transfected transiently in human embryonic kidney 293 (HEK293) cells. Cells were 
washed twice with ice-cold PBS containing 1 mM MgCl2 and 0.5 mM CaCl2 (PBS-CM) 48 
h after transfection and surface biotinylation was performed by incubating the cells twice 
for 20 min at 4 °C with 1 mg/ml Sulfo-NHS-SS-Biotin (Pierce, Rockford, IL, USA). 
Subsequently, cells were incubated for 5 min with quenching solution (50 mM NH4Cl in 
PBS-CM) at 4 °C and rinsed twice with cold PBS-CM. Cells were lysed with 1 ml of lysis 
buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.6, 5 mM EDTA, 0.5 % v/v Triton X-100, 0.2 
% w/v BSA) for 1 h on ice. Lysates were added to 30 µl immunopure streptavidin beads 
(Pierce, Rockford, IL, USA).  After incubation for 16 h at 4 °C, the beads were washed 
twice with PBS-CM, twice with lysis buffer, and once with 10 mM Tris-HCl pH 7.5. 
Finally, biotinylated proteins were eluted with SDS-PAGE loading buffer, separated on 
10 % w/v SDS-PAGE gel and analyzed by immunoblot with guinea pig antiserum against 
TRPV5 (1:1500) and rabbit antiserum against 80K-H (1:10000). 
 
Electrophysiology 
The full-length cDNAs encoding TRPV5 and 80K-H mutants were transiently transfected 
in HEK293 and patch-clamp experiments were performed in the whole cell configuration, 
as described previously (39). Monovalent cation currents were measured in ‘nominal 
divalent-free solutions’ (DVF) where Ca2+ and Mg2+ were omitted from Krebs solution. 
For measuring the Ca2+ currents, Krebs was used with 10 mM CaCl2 instead of 1 mM 
CaCl2. The internal (pipette) solution contained (in mM) 10 BAPTA, 20 CsCl, 100 Cs-
aspartate, 1 MgCl2, 10 BAPTA, 4 Na2ATP, 10 HEPES-CsOH pH 7.2. The Ca2+ 
concentration in the pipette was adjusted to 10 nM, 20 nM, 50 nM, 100 nM, 250 nM or 1 
μM by adding 0.747, 1.391, 2.880, 4.457, 6.682 or 8.916 mM CaCl2 respectively in the 
presence of 10 mM BAPTA, as calculated by the CaBuf program (G. Droogmans, KU 
Leuven) (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/cabuf.zip). All experiments were 
performed at room temperature (20-22 oC). Reported current densities were calculated 
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from the current at –80 mV during the ramp protocol for the Na+-currents or at the peak 
amplitude in the step protocol respectively. The software package ASCD (G. 
Droogmans, Leuven) was used for analysis of the whole-cell data. All current amplitudes 
in the dose-response curves were normalised to –80 mV with 10 mM BAPTA in the 
pipette solution and fitted with a modified Hill function. (Origin 7.0 software, OriginLab 
Corporation, Northampton, MA, USA)  
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical 
significance was determined by analysis of variance (ANOVA). In case of significance 
(P<0.05), individual groups were compared by Student’s t-test. 
 
RESULTS 
Identification of 80K-H as a gene regulated by 1,25(OH)2D3 and dietary Ca2+  
Mice in which the renal 1α-OHase enzyme catalyzing the 1,25(OH)2D3 synthesis was 
inactivated, exhibited undetectable levels of 1,25(OH)2D3 resulting in severe 
hypocalcemia (6). We performed a microarray analysis on kidney cDNA of these 
1,25(OH)2D3-deficient mice, which were rescued by 1,25(OH)2D3 supplementation or by 
dietary Ca2+ (10, 11). Analysis of the gene expression data provided information about 
RNA transcripts important for the maintenance of the Ca2+ balance and pointed to the 
80K-H protein which is a PKC substrate containing two putative Ca2+ binding sites. 80K-
H was significantly down-regulated at the mRNA level in the absence of 1,25(OH)2D3 
(179 % compared to control values in the presence of 1,25(OH)2D3 when the control 
values is set as 100%) and up-regulated by dietary Ca2+ supplementation (189 % 
compared to the 1,25(OH)2D3-deficient mice). The regulation of 80K-H at the 
transcription level was confirmed by quantitative real-time PCR analysis (from 100 % to 
157 ± 12 % and 155 ± 7 %, respectively, P<0.05). 
  
Localization of 80K-H in Ca2+-transporting epithelia  
Tissue distribution of 80K-H was first investigated by reverse transcription PCR on 
mouse tissues using primers located in a species-conserved region within the 80K-H C-
terminal tail. The expected 80K-H amplicon of 242 bp was detected in all tissues, 
including Ca2+-transporting epithelia such as kidney and duodenum (Figure 1A). 
Localization of 80K-H was further studied by immunohistochemistry of mouse kidney and 
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duodenum sections. In kidney, immunopositive staining for 80K-H and TRPV5 was 
present along the apical membrane of distal convoluted and connecting tubules (Figure 
1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interaction of 80K-H with TRPV5 
To examine the association of 80K-H with TRPV5, immunoprecipitation experiments 
were performed using the Xenopus laevis oocytes expression system. Thus, membrane 
extracts of Xenopus laevis heterologously expressing TRPV5 and 80K-H were first 
immunoprecipitated with anti-80K-H antibody and the precipitated proteins were 
analysed by immunoblotting. The two specific bands of HA-tagged TRPV5, 
corresponding to the core and the non-glycosylated proteins (17), were detected in the 
precipitated complex (Figure 2A). Likewise, this interaction was confirmed in the reverse 
manner by immunoprecipitation of TRPV5 from membrane extracts using the anti-HA 
antibody and subsequent immunoblotting with the anti-80K-H antibody (Figure 2B). 
Ca2+-dependency of 80K-H association with TRPV5 was investigated by GST pull-down 
Figure 1. Localization and 
tissue distribution of 80K-H. (A) 
RNA was extracted from several 
mouse tissues and 80K-H 
expression was determined by 
RT-PCR. The 80K-H specific band 
was amplified in all analyzed 
tissues at the expected height of 
242bp. (B) Immunohistochemical 
analysis of 80K-H and TRPV5 in 
mouse kidney sections. Kidney 
sections were co-stained with 
antibodies against 80K-H and 
TRPV5.  
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assays in the presence (1 mM CaCl2) and absence (5 mM EDTA) of Ca2+. 80K-H protein 
bound specifically to TRPV5 in both conditions since no interaction was observed with 
GST alone (Figure 2C). Immunoblot analysis of mouse kidney lysates did not result in a 
specific immunopositive signal (data not shown) which is probably due to the relatively 
low abundance of these channels (28). Endogenous immunoprecipitation of the two 
proteins was, therefore, not possible. 
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Figure 2. Interaction of 80K-H with 
TRPV5. cRNA of 80K-H and HA-
tagged TRPV5 was co-injected in 
Xenopus laevis oocytes, and total 
membrane extracts were used for 
immunoprecipitation and subsequent 
immunoblot analysis. 
Immunoprecipitation was performed 
using beads to which the anti-80K-H 
(A) or the anti-HA (B) antibody was 
bound (IP), and co-
immunoprecipitation of the 80K-H and 
TRPV5 proteins was detected by 
immunoblot analysis (Blot) using the 
respective antibody for each protein. 
The specific bands of each protein are 
depicted with black arrows on the side 
of the blots. (C) The Ca2+ dependency 
of the 80K-H binding to TRPV5 was 
investigated by a GST pull-down 
assay. GST-fused TRPV5 C-terminal 
proteins were immobilized on 
glutathion-Sepharose 4B beads and 
subsequently incubated with in vitro 
translated [35S]methionine-80K-H in 
the presence and the absence of Ca2+. 
GST alone was used as a negative 
control.  (D) Mapping of 80K-H 
interaction domain in TRPV5. GST-
fusion proteins corresponding to 
various truncations of the TRPV5 C-
terminal tail were assayed for 80K-H 
binding in a GST pull-down 
experiment. The 80K-H binding site 
was localized between amino acids 
598 and 608 of TRPV5. 
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Mapping of the 80K-H binding site in TRPV5 
To determine the 80K-H binding site in TRPV5 a series of deletion mutants between the 
positions 598 and 680 of the TRPV5 C-terminal tail was constructed. Truncated forms of 
TRPV5 were expressed as GST-fusion proteins and tested for their interaction with in 
vitro translated 80K-H protein using pull-down experiments (Figure 2D). The interaction 
between the two proteins was abolished when TRPV5 was truncated at position 603, 
whereas truncations at positions 680 up to 608 did not disturb the interaction with 80K-H. 
The sequence of TRPV5 protein corresponding to the binding site of 80K-H was 
restricted to the short region between the positions 598 and 608.  
 
Ca2+ binding capacity of 80K-H 
80K-H contains two putative EF-hand structures and a highly negatively charged 
glutamate stretch that might be a Ca2+ interacting region (2). Ca2+ binding properties of 
80K-H were investigated by performing a 45Ca2+ overlay assay, using 80K-H wild type 
and mutants of the two putative Ca2+-related regions (Figure 3A). The first mutant was 
generated by substitution of the critical aspartates for alanine residues that impair Ca2+ 
coordination in the two EF-hands (80K-HEF mutant). The second mutant was generated 
by excision of the glutamate stretch (80K-HΔGlu mutant). Pull-down experiments 
demonstrated that mutation of 80K-H, in the regions described above, did not disturb 
binding to the TRPV5 C-terminal tail (Figure 3B).   
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Figure 3. TRPV5 binding analysis 
of the 80K-H mutants. (A) 
Schematical representation of the 
80K-H structure containing the two 
EF-hand structures (clear boxes), 
the glutamate stretch (diagonal 
dashed box), the HDEL sequence 
(black box) and the putative PKC 
phosphorylation sites (vertical lines), 
as well as the truncated regions of 
the protein by point mutation (stars) 
or deletion (scissors). (B) The 
binding of 80K-H mutants to TRPV5 
was analyzed by GST pull-down 
experiments. Immobilized C-terminal 
tail of TRPV5 GST-fusion protein 
was incubated with in vitro translated 
[35S]methionine-80K-H proteins 
(80K-H, 80K-HEF, 80K-HΔGlu). GST 
alone was used as a negative 
control. 
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Subsequently, GST-fused proteins of 80K-H were separated by SDS-PAGE followed by 
immunoblot analysis. An equal expression level of 80K-H proteins was verified by 
Ponceau S staining. After incubation with 45CaCl2, the capacity of the blotted proteins to 
bind 45Ca2+ was determined (Figure 4). The amino acid substitutions in the two EF 
hands of 80K-H abolished the Ca2+ binding, whereas deletion of the glutamate stretch 
did not interfere with Ca2+ binding. GST protein alone was used as a negative control. 
 
 
 
 
 
 
 
 
 
 
 
Cell surface associated expression of 80K-H and TRPV5   
TRPV5 plasma membrane expression was examined in HEK293 cells transfected with 
TRPV5 and 80K-H with a biotinylation method using sulfo-NHS-SS-biotin. TRPV5 was 
expressed at the plasma membrane of HEK293 cells when transfected alone and 
together with 80K-H. Co-expression of TRPV5 and 80K-H mutants (Figure 5A right 
panel) did not affect significantly the amount of TRPV5 expression on the plasma 
membrane fraction. Non-transfected cells were used as a negative control (Figure 5A). 
In the same experiment the association of 80K-H with TRPV5 channels located in the 
plasma membrane was studied. Interestingly, 80K-H and mutants were detected in the 
biotinylated membrane fraction when co-expressed with TRPV5 (Figure 5B). The 
endogenously and heterologously expressed 80K-H was not detected at the plasma 
membrane fraction in the absence of TRPV5, despite their abundant expression in the 
cell lysates (Figure 5B right panel). Thus, it could be assessed that the expression of 
80K-H at the plasma membrane depends on the presence of TRPV5.  
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Figure 4. Ca2+ binding analysis of 80K-H 
mutants. Purified GST-fused 80K-H, 80K-HEF 
and 80K-HΔGlu proteins were separated by 
SDS-PAGE and electrophoretically 
transferred to nitrocellulose membrane. Equal 
levels in protein expression were visualized 
with Ponceau S staining (left panel) and Ca2+ 
binding capacity was demonstrated by 
incubation of the blot with 45CaCl2 as 
described under “Materials and Methods” 
followed by autoradiography (right panel). 
GST-protein was used as a negative control. 
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Effect of mutations in 80K-H on TRPV5 channel activity 
The effect of endogenous 80K-HWT and mutants on TRPV5 activity was determined by 
whole cell patch-clamp analysis in transiently transfected HEK293 cells (Figure 6). 
TRPV5 conducted Na+ and Ca2+ currents in line with previous results, including large 
monovalent currents, strong inward rectification and high Ca2+ selectivity over Na+ (40). 
Cells expressing either TRPV5 alone or in combination with 80K-HWT displayed similar 
current densities and electrophysiological properties (data not shown), indicating that 
expression of 80K-HWT does not alter channel activity of TRPV5. Co-expression of 
TRPV5 with the 80K-HEF, 80K-HΔGlu, 80K-HΔHDEL mutants had no significant effect on 
shape nor amplitude of the current in nominally DVF solution (P>0.8, P>0.8 and P>0.1 
respectively, compared to 80K-HWT) (Figures 6A and 6C). In the presence of 
extracellular Ca2+, TRPV5 becomes Ca2+-selective and the inward Ca2+ currents exhibit 
pronounced inactivation during hyperpolarizing steps (Figure 6B). In contrast to 
endogenous 80K-HWT, the 80K-H mutants had profound effects on the TRPV5 currents 
measured in the presence of 10 mM extracellular Ca2+ (Figure 6B). Both 80K-HEF and 
80K-HΔGlu reduced the peak inward current by approximately 60 % (P<0.05 for both) 
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Figure 5. Cell surface expression 
of TRPV5 and 80K-H. HEK293 
cells were transfected with TRPV5 
alone or in combination (+) with 
80K-H, 80K-HEF, 80K-HΔGlu or 80K-
HΔHDEL. The extracellular parts of 
the proteins were biotinylated, 
precipitated with streptavidin-
agarose beads (streptavidin-bound) 
and immunoblotted for TRPV5 (A) 
and 80K-H (B). A sample of the 
lysed cells (lysates) was 
immunoblotted in parallel to 
visualize the amount of proteins 
expressed. Both non-transfected 
cells (NT) and cells transfected only 
with 80K-H (B right panel) did not 
show any cell surface expression.  
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(Figures 6B and 6D). These mutants had no effect on the extent of Ca2+ current 
inactivation, which was quantified as the ratio between the peak current and the current 
at the end of the 3 seconds voltage-step (Figure 6E). 80K-HΔHDEL did not affect the peak 
inward current (P>0.9), but significantly delayed the Ca2+ current inactivation (P<0.5) 
(Figures 6B, 6D and 6E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Effect of 80K-H mutants on TRPV5 activity. (A) Whole-cell current-voltage relations measured 
from 400 ms voltage ramps (interval 5 s) in nominally DVF solution in HEK293 cells over-expressing either 
TRPV5 alone (80K-HWT) or TRPV5 in combination with the indicated 80K-H mutants. (B) Inward Ca2+ 
currents measured with 10 mM extracellular Ca2+ during a 3 seconds step to –100 mV from a holding 
potential of +70 mV. (C) Average current densities at –80 mV in nominally DVF solution for cells expressing 
either TRPV5 alone (80K-HWT) or TRPV5 in combination with the indicated 80K-H mutants. (D) Average 
peak current density during the voltage step in 10 mM Ca2+. (E) Comparison of the averaged ratio of the 
Ca2+ current at the beginning and the end of the 3 seconds voltage step in 10 mM extracellular Ca2+ for 
TRPV5 alone or in combination with the different 80K-H mutants. P<0.05, significant from 80K-HWT control 
currents. 
 
Modulation of TRPV5 sensitivity for intracellular Ca2+ by 80K-HEF 
Currents through TRPV5 are inhibited by increasing the intracellular Ca2+ concentration 
([Ca2+]i) (29). A 40 % reduction was observed in TRPV5 expressing cells dialyzed with a 
solution containing 50 nM free Ca2+ when compared to an intracellular solution 
containing 10 mM BAPTA and no added Ca2+ (Figure 7A). In contrast, the currents of 
cells co-expressing TRPV5 and 80K-HEF in nominally DVF solution were nearly blocked 
with 50 nM Ca2+ in the pipette, indicative of a higher sensitivity to intracellular Ca2+ than 
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cells expressing TRPV5 solely (Figure 7B). Figure 7C displays normalized inward Na+ 
currents as a function of [Ca2+]i for cells expressing TRPV5 in the absence and presence 
of 80K-HEF. Ca2+ concentrations for half-maximal inhibition (IC50) of inward current were 
72 ± 12 nM and 12 ± 2 nM for TRPV5 alone and in combination with 80K-HEF, 
respectively. All other 80K-H mutants had no significant effect on the Ca2+ sensitivity of 
TRPV5 (data not shown). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The present study demonstrates a new function for the 80K-H protein as Ca2+-
dependent regulator of TRPV5 channel activity. This conclusion is based on the 
following observations: i) 80K-H and TRPV5 genes are similarly controlled by common 
regulators of Ca2+ homeostasis; ii) 80K-H and TRPV5 co-localize in the distal part of the 
nephron; iii) 80K-H forms a heteromeric complex with TRPV5 along the plasma 
membrane and a distinct region of the TRPV5 C-terminal tail is important for this binding; 
iv) the two EF-hand structures of 80K-H control TRPV5 activity in a Ca2+-dependent way. 
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Figure 7. Mutation of the EF hand 
structure in 80KH increases the Ca2+ 
sensitivity of TRPV5. Current-voltage 
relations in nominally DVF solution 
measured in cells expressing TRPV5 
alone (A) or co-expressed with 80K-HEF 
(B) and dialysed with pipette solution 
containing either <1 nM or 50 nM free 
Ca2+. Dose-response curves showing the 
effect of intracellular Ca2+ on the inward 
current density in nominally DVF solution 
(C). Values were normalized to the 
average current density measured with 
pipette solution containing 10 mM 
BAPTA and no added Ca2+ (1279 ± 208 
pA/pF, n = 27 for TRPV5 and 1502 ± 243 
pA/pF, n = 10 for 80K-HEF).  
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Function of 80K-H  
To date, 80K-H biological function is poorly understood and there are no indications for a 
role in Ca2+ homeostasis or ion channel regulation. However, several studies propose a 
role in cell activation pathways through receptors located at the plasma membrane. 80K-
H was initially identified as a PKC substrate and subsequently associated with 
intracellular signalling (9). Tyrosine residues of 80K-H are phosphorylated upon ligand 
binding to the fibroblast growth factor (FGF) receptor 3 and activate the mitogen-
activated protein kinase pathway (8, 19). 80K-H is also implicated in signalling and auto-
regulation of the advanced glycosylation end products (AGE) receptor (22), which 
participates in endocytic and cell-activation pathways and are linked to nephropathy in 
type 1 diabetic patients (32). In addition, 80K-H homologous proteins have been 
identified, such as the vacuolar system-associated protein 60 which plays a role in 
membrane-trafficking events (3) and the non catalytic β subunit of the endoplasmic 
reticulum (ER) enzyme glucosidase-II GIIβ involved in the protein folding via 
deglycosylation (1, 35).  
 
80K-H gene expression is regulated by 1,25(OH)2D3 and dietary Ca2+  
80K-H was identified using cDNA microarray analysis as a transcript down-regulated in 
1,25(OH)2D3-deficient mice (10). Normalization of the severe hypocalcemia in these 
mice by 1,25(OH)2D3 or dietary Ca2+ supplementation was accompanied by an increase 
of the 80K-H mRNA expression. These two key regulators of Ca2+ (re)absorption are 
important for the transcriptional modulation of renal proteins participating in the 
mechanism of transcellular Ca2+ transport, including the epithelial Ca2+ channel TRPV5, 
calbindin-D28K, Na+/Ca2+ exchanger NCX1 and the Ca2+-ATPase PMCA1b (11).  
 
80K-H interacts with TRPV5 
80K-H was ubiquitously expressed in mouse tissues and displayed consistent co-
localization with TRPV5 along the apical membrane of distal convoluted and connecting 
tubules (12, 23).  Co-localization of 80K-H and TRPV5 in the same cellular 
compartments substantiates the physiological relevance of the demonstrated interaction 
between these two proteins. Indeed, a short peptide sequence between the amino acids 
598 and 608 of the TRPV5 C-terminal tail is necessary for 80K-H binding. This particular 
region of TRPV5 is highly conserved among all identified species (16). This domain 
could play an important role in the regulation of the channel via protein-protein 
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interactions, since also the S100A10-annexin 2 complex binds here (39). Biotinylation 
assays on cells co-expressing 80K-H and TRPV5 confirmed cell surface expression of 
both proteins. This observation, together with the binding data, demonstrates the 
participation of 80K-H in a heteromeric complex with TRPV5 that is located at the 
plasma membrane. Importantly, 80K-H was not expressed at the plasma membrane in 
the absence of TRPV5, indicating a unique role of this protein in TRPV5-expressing 
tissues. Likewise, a tissue-dependent activity could explain the implication of 80K-H in 
diverse biological processes, ranging from vesicular transport and ER quality control to 
receptor signalling and channel regulation (1, 22, 35).  
 
Critical regions in 80K-H for TRPV5 activity 
80K-H sequence analysis predicts several potential threonine and tyrosine 
phosphorylation sites, two EF-hand domains, a highly acidic domain and a potential ER 
targeting sequence (1). The overall structure of 80K-H (Figure 3A) suggests two 
potential Ca2+ interacting motifs including a pair of EF-hand motifs and the acidic stretch 
of glutamates. In this study, we demonstrated that 80K-H coordinates Ca2+ with the EF-
hand pair, while the highly negatively charged poly-glutamate stretch does not account 
for Ca2+ binding. Thus, 80K-H can be distinguished from ER proteins that contain similar 
acidic stretches with low Ca2+ affinity (26). In this respect, deletion of the 80K-H putative 
ER targeting signal (HDEL) did not disturb routing of the 80K-H-TRPV5 complex to 
plasma membrane. 80K-HΔHDEL had no effect on TRPV5-mediated Ca2+ currents, but 
surprisingly increased the fraction of open channels. At this point, it is difficult to explain 
the action of the HDEL motif as a delay factor in the decay of TRPV5 Ca2+ currents. 
These data can not exclude the possibility that the HDEL sequence constitutes an ER 
retention or retrieval signal (18), but they clearly support the hypothesis that motifs like 
the yeast HDEL or the respective mammalian KDEL are not sufficient for ER localization 
(30). Mutation of the EF-hand pair and the acidic glutamate region of 80K-H resulted in a 
dramatic decrease of TRPV5-mediated Ca2+ influx without disturbing the association of 
80K-H to TRPV5. Additionally, the plasma membrane localization of 80K-H and TRPV5, 
together with the fact that the Na+ current density was not altered, excludes the 
possibility of a routing defect. Previous findings have also indicated other EF-hand 
proteins, such as calmodulin, to be involved in the activation and inactivation process of 
ion channels and most interestingly, TRP channels (27, 33). Moreover the enriched 
glutamate stretch could provide an acidic milieu essential for phosphorylation of the  
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80K-H PKC substrate. Evolutionary and functional studies showed that variation in 
length and acidity of similar domains are related to the degree of phosphorylation 
needed for receptor desensitization (24, 34).  
 
80K-H as Ca2+ sensor  
A major question that emerges from this study is how 80K-H controls the TRPV5-
mediated Ca2+ influx. Electrophysiological studies demonstrated that Ca2+ influx through 
TRPV5 induces a feedback inhibition controlled by the ambient Ca2+ concentration in a 
micro domain near the inner mouth of the channel (29). 80K-HEF significantly reduced 
the amount of intracellular Ca2+ needed for the induction of TRPV5 feedback inhibition, 
but did not delay the recovery of the channel. Therefore, 80K-H could act as Ca2+-
sensing subunit of TRPV5 and facilitate Ca2+ influx through TRPV5 after binding Ca2+. In 
addition, our findings indicate a role for the glutamate stretch and the HDEL sequence of 
80K-H in the inactivation and restoration processes of TRPV5 Ca2+ currents, but this 
needs further investigation. 80K-H could have a multifaceted mechanism regulating 
TRPV5 Ca2+-mediated influx. A dual function has also been proposed for the Ca2+ 
sensor calmodulin according to which calmodulin mediates both Ca2+-dependent 
facilitation and inactivation of L-type Ca2+ channels (21). Finally, if we take into account 
the involvement of 80K-H in signal transduction cascades a Ca2+-sensing role of this 
PKC substrate can be postulated. Ca2+ sensors (calmodulin and troponin C), in contrast 
to Ca2+ buffers (parvalbumin, calretinin and calbindin-D28K), do not only bind Ca2+ next to 
the inner mouth of channels, but also activate various downstream effectors (4). 
In conclusion, our findings describe 80K-H as a new Ca2+ sensor and regulator of 
the epithelial Ca2+ channel TRPV5. This novel functional feature of 80K-H could also 
apply to other Ca2+-related physiological processes given the wide tissue distribution and 
the functional diversity of 80K-H.  
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…Να εύχεσαι νά 'ναι μακρύς ο δρόμος.  
Πολλά τα καλοκαιρινά πρωία  
να είναι που με τι ευχαρίστησι, με τι χαρά  
θα μπαίνεις σε λιμένας πρωτοειδωμένους·  
να σταματήσεις σ' εμπορεία Φοινικικά,…  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…Wish always that your course be long; 
that many there be of summer morns 
when with such pleasure, such great joy, 
you enter ports now for the first time seen; 
that you may stop at some Phoenician marts,… 
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ABSTRACT 
In kidney, the epithelial Ca2+ channel TRPV5 constitutes the apical entry pathway in the process 
of active Ca2+ reabsorption. The regulation of Ca2+ influx through TRPV5 is of crucial 
importance, since it determines the final amount of Ca2+ excreted in the urine. The present study 
identifies FKBP52 as an auxiliary protein of TRPV5, inhibiting the channel activity. FKBP52 
shows specific interaction with TRPV5 and both proteins co-localize in the distal part of the 
nephron. On the functional level, FKBP52 decreases Ca2+ influx through TRPV5 as 
demonstrated in radioactive 45Ca2+ uptake measurements and electrophysiological studies on 
TRPV5-overexpressing human embryonic kidney 293 cells. On the other hand, gene-silencing 
of FKBP52 or administration of the FKBP52 blocker, FK506, enhances Ca2+ influx through 
TRPV5. The inhibitory action of FKBP52 on TRPV5 activity is blunted by mutation of its peptidyl-
prolyl cis-trans isomerase domain, showing that the FKBP52 catalytic property is critical for 
channel activity. In conclusion, these results suggest that FKBP52 plays an important role in the 
regulation of TRPV5 and thus in the process of Ca2+ reabsorption. 
                                                                           
INTRODUCTION 
FKBP52 (also designed as FKBP59, p59 or Hsp56) is a widely expressed cytosolic enzyme 
which belongs to the FK506-binding proteins (FKBPs) subfamily of immunophillin proteins (11, 
18, 24). FKBPs are characterized by their ability to catalyze the cis-trans isomerization of cis-
peptidyl-prolyl bonds, as well as by their strong affinity to the immunosuppressive drug FK506 
(18). The peptidyl-prolyl cis-trans isomerase (PPIase) activity of FKBP52 plays an important role 
in diverse cellular processes and in particular in the translocation of steroid receptors to the 
nucleus through dynein association (7, 27). Besides its function as a chaperone, FKBP52 is 
involved in ion regulation such as Cu2+ efflux (25), while its Drosophila homologue inhibits Ca2+ 
influx through association with the transient receptor potential (TRP) channel, TRPL (10, 28). 
Concerning the mammalian TRP channels, it was recently demonstrated that FKBP52 
associates with TRPC1, -C4, -C5 orthologues (10, 28), while there is no functional data 
addressing the effect of FKBP52 on these channels.  
In kidney, the TRP channel TRPV5 mediates Ca2+ reabsorption in the distal part of the 
nephron and determines the final amount of Ca2+ excreted in the urine (15, 17). Therefore, a 
tight control of TRPV5 expression, trafficking to the plasma membrane and/or gating of the 
channel is important for the amount of reabsorbed Ca2+ in the kidney (8). There is growing 
interest in the identification of accessory proteins regulating TRPV5 activity. The S100A10-
annexin 2 complex modulates TRPV5 trafficking towards the plasma membrane by direct 
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association to the carboxyl (C)-terminal tail of the channel (30). On the other hand, the 80K-H 
protein binds to the channel and acts as a Ca2+ sensor that facilitates Ca2+ influx through the 
TRPV5 channel (9).  
The aim of the present study was to assess whether FKBP52 is a regulator of TRPV5.  
To this end, we demonstrated by immunohistochemical, biochemical and functional analysis 
that FKBP52 inhibits TRPV5-mediated Ca2+ influx via its PPIase activity.  
 
MATERIALS AND METHODS 
DNA constructs and cRNA synthesis  
TRPV5 constructs were generated as described previously (30). FKBP52 was cloned in a 
pCMV-Sport6 vector (clone IRAKp961i125Q2) by the RZPD (Deutsches Ressourcenzentrum 
fuer Genomforschung, Berlin, Germany) and then subcloned into the pCINeo/IRES-GFP (29), 
pGEX6p-2 (Amersham Pharmacia Biotech AB, Uppsala, Sweden) and the pT7Ts (19) vectors. 
The FD67DV mutant of FKBP52 was generated by in vitro mutagenesis (QuickChange site-
directed Mutagenesis kit, Stratagene, La Jolla, California) with the primer set 5’- 
CTAGATGGCACAAAGGATGTCTCCAGTCTGGACCGC-3’, 5’-GCGGTCCAGACTGGAGACAT 
CCTTTGTGCCATCTAG-3’ (the underlined sequence shows the mutated codons). All 
constructs were verified by sequence analysis. pT7Ts constructs were linearized and cRNA was 
synthesized in vitro using T7 RNA polymerase as described previously (16). 
 
Experimental animals  
Young adult male Wistar rats were randomly assigned to either the control group animals 
receiving vehicle only (N=5),  or FK506 (N=5) (21). TRPV5 knock-out (TRPV5-/-) mice were 
generated as described previously (17). Kidney cortex was sampled and immediately frozen in 
liquid nitrogen. Subsequently, samples were stored at -80°C until further processing. The 
animals were kept in a light- and temperature-controlled room with ad libitum access to standard 
pelleted diet and water. The animal ethics board of the Radboud University Nijmegen approved 
all experimental procedures. 
 
Real-time quantitative PCR  
FKBP52 mRNA expression level was quantified by real-time quantitative PCR in a mouse cDNA 
panel including kidney, brain, heart, muscle, duodenum, jejunum, ileum, cecum, colon, bone 
and in renal tissue from control and FK506 treated rats. Total RNA was isolated using TRIzol 
(GIBCOBRL, Life Technologies, Breda, The Netherlands) from which 2 μg were subjected to 
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reverse transcription using Moloney murine leukemia virus reverse transcriptase. The following 
primers were used: the forward 5’-GAGTGGACATCAGCCCCAA-3’ and the reverse 5’-
TGTGCCTGTACCCTCTCTCTTG-3’. The probe (5’-CAGGACGAGGGCGTGCTCAAGGT-3’) 
was labelled with the reporter dye 6-carboxyfluorescein (5'-end) and the quencher dye 6-
carboxytetramethylrhodamine (3'-end) (Biolegio, Malden, The Netherlands). The mRNA 
expression level of hypoxanthine-guanine phosphoribosyl transferase (HPRT) was used as an 
internal control.  
 
Immunohistochemistry  
Immunohistochemistry was performed as previously described (14). Briefly, rabbit kidney PLP-
treated sections were incubated for 16 hours at 4 ºC with guinea pig anti-TRPV5 (14) and 
mouse anti-FKBP52 antibodies (Stressgen, Victoria, Canada). To visualize the proteins 
corresponding secondary Alexa 488/594-conjugated antibodies (Molecular Probes, Eugene, 
USA) were used. 
 
Trypan-blue exclusion assay  
Cell suspension was mixed with an equal volume of 0.4 % (w/v) isotonic trypan-blue solution. 
Total number of non-viable cells was counted after 2 minutes in a Fuchs-Rosenthal 
haemocytometer using a light microscope. 
 
Co-immunoprecipitation  
HEK293 cells were transfected with pCINeo/TRPV5-IRES-GFP and lysed after 48 hours in 
sucrose buffer containing 20 mM Hepes/Tris pH 7.4, 5 mM EDTA, 135 mM NaCl, 0.3 % (v/v) 
NP-40, and 10 % (w/v) sucrose. Lysates were centrifuged at 13,000 g for 1 hour and the protein 
concentration of the supernatants was determined with the BioRad protein assay (BioRad 
laboratories GmbH, München). Equal amounts of the lysates were incubated with guinea pig 
anti-TRPV5 antibody immobilized on protein A-agarose beads (Kem-En-Tec A/S, Kopenhagen, 
Denmark) for 16 hours at 4 °C. After three washing steps with sucrose buffer, 
immunoprecipitated proteins were eluted with SDS-PAGE loading buffer, separated on 12 % 
w/v SDS-PAGE gels. TRPV5 and FKBP52 protein expression was detected by immunoblotting 
using guinea pig anti-TRPV5 (14) and mouse anti-FKBP52 (Stressgen, Victoria, Canada) 
respectively.   
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Immunoblot analysis 
Cells were lysed in sucrose buffer containing 20 mM Hepes/Tris pH 7.4, 5 mM EDTA, 135 mM 
NaCl, 0.3 % (v/v) NP-40, and 10 % (w/v) sucrose and were centrifuged at 13,000 g for 1 hour. 
After the determination of the supernatants protein concentration, equal amounts of the lysates 
were subjected to SDS-PAGE electrophoresis (10-12 % w/v). Immunoblots were incubated 
overnight at 4°C with primary antibodies including mouse anti-FKBP52 (Stressgen, Victoria, 
Canada), goat anti-FKBP52 (Santa Cruz Biotechnology, California, USA) and guinea pig anti-
TRPV5 in 1 % (w/v) non-fat dry milk. After washing, immunoblots were incubated at room 
temperature with the corresponding secondary antibody IgG peroxidase sheep anti-mouse 
(Jackson ImmunoResearch Laboratories, West Grove, USA), rabbit anti-goat (DakoCytomation, 
Denmark) or anti-guinea pig (Sigma, St Louis, MO, USA) respectively. The specificity of the two 
commercial FKBP52 antibodies was confirmed by immunoblot analysis (data not shown). Both 
antibodies recognized an abundant band of ~ 60 kDa, while the polyclonal antibody (Santa Cruz 
Biotechnology, California, USA) displayed an additional but weak band (lower than 25 kDa) that 
could be FKBP12 as suggested previously (10). Importantly, monoclonal antibody (Stressgen, 
Victoria, Canada), that only recognized the single band, was used in immunohistochemistry, 
immunoprecipitation and siRNA assays.  
 
Glutathione S-transferase fusion proteins and pull-down assay  
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and Glutathione S-transferase 
(GST)-fusion proteins were expressed and purified according to the manufacturer’s protocol 
(Amersham Pharmacia Biotech AB, Uppsala, Sweden). GST-fused TRPV5 N- and C-terminal 
tails constructs were generated as described previously (30). [35S]methionine-labeled TRPV5 or 
FKBP52, was prepared using the reticulocyte lysate system in the presence of canine 
microsomal membranes (Promega) and added to GST, GST-fused FKBP52 or GST-fused 
TRPV5 N- and C-terminal tails fusion proteins immobilized on glutathion-Sepharose 4B beads 
(Amersham Pharmacia Biotech AB, Uppsala, Sweden) in PBS containing 0.3 % v/v Triton X-
100. After 2 hours incubation at room temperature, the beads were washed extensively and 
bound proteins were eluted with SDS-PAGE loading buffer, separated on 10 % w/v SDS-PAGE 
gels and visualized by autoradiography.  
 
Small interference (si) RNA  
The mammalian expression vector, pSUPER (5) was used for expression of siRNA in Human 
Embryonic Kidney (HEK) 293 cells. The gene-specific insert specifies a 19-nucleotide sequence 
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5’-GAGAGAGGGCACAGGTACA-3’ corresponding to nucleotides 114-133 downstream of the 
transcription start site of human FKBP52, which was separated by a 9-nucleotide non-
complementary spacer (5’-TTCAAAGA-3’) from the reverse complement of the 19-nucleotide 
sequence. HEK293 cells were co-transfected with pSUPER-FKBP52 and pCINeo/IRES GFP-
TRPV5 or empty pCINeo/IRES-GFP while the pSUPER-luciferase construct was used as a 
control. The gene-specific insert for luciferase specifies the 19-nucleotide sequence 5’-
CTTACGCTGAGTACTTCGA-3’. Three days after transfection cells were sorted for GFP 
expression by flow cytometry (FACS) using an Epics Elite flow cytometer (Coulter, Miami, FL, 
USA). The GFP-positive cells were used for the functional analysis. One day later measured for 
their functional activity using the 45Ca2+ uptake assay. FKBP52 protein expression was detected 
by immunoblotting using the mouse anti-FKBP52 (Stressgen, Victoria, Canada). 
 
45Ca2+ uptake assay  
HEK293 cells were transfected with pCINeo/TRPV5-IRES-GFP or co-transfected with 
pCINeo/TRPV5-IRES-GFP and wild-type or mutated FKBP52 constructs. Ca2+ uptake was 
determined two days after transfection whereas co-transfected cells were first sorted for GFP by 
FACS. For the assays where FK506 was used, TRPV5-transfected cells were incubated 
overnight with 10, 100, and 1000 nM of FK506 (Fujisawa Pharmaceutical Co., Osaka, Japan). 
Ca2+ uptake was determined by incubation in uptake medium (110 mM NaCl, 5 mM KCl, 1.2 mM 
MgCl2, 0.1 mM CaCl2, 10 mM Na-acetate, 2 mM NaH2PO4, 20 mM HEPES/Tris, pH 7.4 
supplemented with 10 µM felodipine, 10 µM methoxy-verapamil and 1 mM BaCl2) for 10 minutes 
at room temperature. Radioactive Ca2+ (1 µCi/ml 45CaCl2) was applied to the cells. Each well 
was washed extensively in stop buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 0.5 mM CaCl2, 
1.5 mM LaCl3, 10 mM Na-acetate, 20 mM HEPES/Tris, pH 7.4) at 4 °C, incubated with 0.05 % 
w/v SDS, and counted for radioactivity using liquid scintillation.  
 
Electrophysiology and solutions  
Patch-clamp experiments were performed in the tight seal whole-cell configuration at room 
temperature (20–25°C) using an EPC-9 patch-clamp amplifier controlled by the Pulse software 
(HEKA Electronics). Patch pipettes had resistances between 3 and 5 MΩ after filling with the 
standard intracellular solution. Cells were held at 20 mV, and voltage ramps of 450 milliseconds 
duration ranging from -100 to +100 mV were applied every 5 seconds. Cell capacitance and 
access resistance were monitored continuously using the automatic capacitance compensation 
of the Pulse software. Current densities were obtained by dividing the current amplitude 
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measured at -80 mV by the cell capacitance. Ca2+-dependent inactivation was studied using a 3 
seconds voltage step to –100 mV from a holding potential of +70 mV. The inactivation rate was 
assessed by the time for 10 % decay of the current. The standard extracellular solution (Krebs) 
contained 150 mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM HEPES/NaOH, pH 7.4 and 10 mM 
glucose. The concentration of Ca2+ ranged between 1 and 10 mM. Divalent free (DVF) solutions 
did not contain added divalent cations, whereas trace amounts of divalent cations were 
removed with 100 µM EDTA. The standard internal (pipette) solution contained 20 mM CsCl, 
100 mM Cs-aspartate, 1 mM MgCl2, 4 mM Na2ATP, 10 mM BAPTA, 10 mM HEPES/CsOH, pH 
7.2. Cells were kept in a nominal Ca2+-free medium to prevent Ca2+ overload and exposed for a 
maximum of 5 minutes to a Krebs solution containing 1.5 mM Ca2+ before sealing the patch 
pipette to the cell.  
 
Transcellular Ca2+ transport in primary culture of rabbit kidney connecting tubule and cortical 
collecting duct  
Rabbit kidney connecting tubules (CNT) and cortical collecting ducts (CCD) were 
immunodissected from kidney cortex of New Zeeland White rabbits (~0.5 kg) using antibody 
R2G9 and then placed in primary culture on permeable filters (0.33 cm2; Costar, Cambridge, 
MA, USA) as described previously in detail (4). At confluence, monolayers of rabbit CNT/CCD 
cells growing on permeable filters were incubated overnight with 10, 100 and 1000 nM of FK506 
at the apical and the basolateral side. The next day filters were washed twice and preincubated 
in PSS buffer containing 140 mM NaCl, 2 mM KCl, 1 mM K2HPO4, 1 mM MgCl2, 1 mM CaCl2, 5 
mM glucose, 5 mM L-alanine, 5 µM indomethacin, 10 mM Hepes/Tris, pH 7.4, for 15 minutes at 
37°C. Subsequently, the filters were incubated in PSS (100 μl to apical and 600 μl to basolateral 
compartment). After 90 minutes transepithelial Ca2+ transport was measured by using a 
colorimetric assay kit as described (4). Transepithelial potential difference and resistance were 
checked before and after transport measurement to confirm cell confluence and integrity of the 
monolayer.  
 
Statistical analysis  
Values are expressed as means ± SE. Overall statistical significance was determined by 
analysis of variance (ANOVA). In case of significance, differences between the means of two 
groups were analyzed by unpaired t-test, while multiple comparisons between groups were 
performed by Bonferroni posthoc tests. P values <0.05 were considered significant. The 
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statistical analyses were performed using the SPSS software (SPSS Inc, Chicago, Illinois, 
USA). 
 
RESULTS 
FKBP52 tissue distribution and localization  
FKBP52 expression was investigated at the mRNA level by quantitative real time PCR analysis, 
showing a higher abundance in kidney and heart in comparison to other tissues (Figure 1A). 
Subsequently, the localization of FKBP52 was analyzed in kidney. Immunohistochemical 
staining of rabbit kidney sections showed partial co-localization of FKBP52 with TRPV5 in DCT 
and CNT, nephron segments known to be responsible for active transepithelial Ca2+ transport 
(Figure 1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interaction of FKBP52 with TRPV5  
In order to assess the FKBP52 interaction with TRPV5, HEK293 cells were transfected with 
TRPV5 or the empty-vector and cell lysates were subsequently subjected to 
immunoprecipitation using the TRPV5 antibody. The endogenous FKBP52 was co-
immunoprecipitated with TRPV5 from these cells lysates, as represented by the immunopositive  
Figure 1. Expression profile and 
localization of FKBP52. (A) RNA was 
extracted from mouse tissues and after 
reverse transcription, the relative FKBP52 
expression was determined by real time PCR 
analysis. FKBP52 mRNA expression was 
normalized for the respective HPRT values. 
(B) Immunohistochemical localization of 
FKBP52 (green) and TRPV5 (red) in rabbit 
kidney sections. In the merged picture the 
partial co-localization of the two proteins is 
depicted in yellow.  
 
A
B
0
0.2
0.4
0.6
0.8
kid
ne
y
br
ain
he
art
mu
sc
le
du
od
en
um
jej
un
um
ile
um
ce
cu
m
co
lon bo
ne
FK
B
P5
2 
m
R
N
A
 e
xp
re
ss
io
n
(F
K
B
P5
2 
co
pi
es
/H
PR
T 
co
py
)
TRPV5FKBP52 merge
FK
B
P5
2 
m
R
N
A
 e
xp
re
ss
io
n
(F
K
B
P5
2 
co
pi
es
/H
PR
T 
co
py
)
Chapter 4 
 78 
band of ~59 kDa (Figure 2A). The expression of both proteins in the cell lysates was 
also verified as shown in the two upper panels. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. FKBP52 binds the TRPV5 channel. (A) Interaction of FKBP52 with TRPV5 as demonstrated by 
co-immunoprecipitation in HEK293 cells transfected with TRPV5 or mock. Equal amount of cell lysates were 
subjected to immunoprecipitation using the TRPV5 antibody and co-immunoprecipitation of the endogenous 
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FKBP52 was detected by immunoblot analysis using the FKBP52 antibody (IP). Total lysates were analyzed 
for TRPV5 and FKBP52 protein expression (lysates). (B) Direct interaction of FKBP52 and TRPV5 was 
confirmed by GST-pull down assay. In vitro translated [35S]methionine-TRPV5 associated with the GST-
fused FKBP52 in the presence (1 mM CaCl2) and the absence (10 mM EGTA/ no CaCl2 added) of Ca2+. (C) 
Binding of GST-fused FKBP52 was not altered by the addition of FK506. (D) GST-fused TRPV5 N- and C-
terminal tails were incubated with in vitro translated [35S]methionine-FKBP52 demonstrating no binding of 
FKBP52.  
 
The interaction between FKBP52 and TRPV5 was further substantiated using 
GST pull-down assays. FKBP52 was expressed as a GST-fusion protein and analyzed 
for its interaction with the in vitro translated full-length 35S-methionine-TRPV5 in the 
presence (1 mM CaCl2) or absence of Ca2+ (10 mM EGTA) and with different 
concentrations of FK506. FKBP52 bound to TRPV5 in a Ca2+ (Figure 2B) and FK506 
(Figure 2C) independent manner. No interaction was observed with GST alone 
indicating the specificity of the interaction. To determine the role of TRPV5 tails in the 
binding with FKBP52, the GST-fused N- and C-terminal tails of TRPV5 were analyzed 
for their interaction with the in vitro translated FKBP52. Both tails did not interact with 
FKBP52 (Figure 2D).  
 
Effect of FKBP52 knock-down on Ca2+ influx 
The role of FKBP52 in Ca2+ influx through TRPV5 was investigated using the pSUPER 
siRNA system. HEK293 cells were co-transfected with the pSUPER-FKBP52 
(siFKBP52) and TRPV5. The pSUPER-luciferase (siLuc) construct was used as a 
negative control for the suppression of FKBP52, and the empty vector (mock) as a 
control for TRPV5 transfection. Application of FKBP52 siRNA significantly reduced 
FKBP52 protein expression, whereas no effect was observed in the siLuc-transfected 
cells demonstrating the specificity of the FKBP52 gene-silencing (Figure 3A). 45Ca2+ 
uptake assay was performed to determine the effect of FKBP52 suppression on TRPV5 
activity. Expression of siFKBP52 (closed bars) enhanced 45Ca2+ influx through TRPV5, 
whereas no effect was observed for the siRNA control, siLuc (open bars), or the mock-
transfected cells (Figure 3B).  
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Modulation of TRPV5 currents by FKBP52 
To study whether FKBP52 affects TRPV5 channel kinetics, HEK293 cells were co-
transfected with TRPV5 and FKBP52 and analyzed by the whole cell patch-clamp 
technique. Both the Ca2+ and Na+ currents were significantly inhibited by FKBP52 over-
expression (Figure 4). Measurements in nominally DVF solution (100 μM EDTA) 
revealed that the current-voltage relation of currents remained unchanged (Figure 4A), 
whereas a significant reduction in macroscopic currents was observed (Figure 4B). 
Application of a hyperpolarizing voltage step to -100 mV from a holding potential of +70 
mV showed a decreased Ca2+ peak current, whereas no significant differences were 
observed on the Ca2+-dependent inactivation (a hallmark of the channel) (Figure 4 C,D). 
Inactivation of TRPV5 Ca2+ currents at negative membrane potentials was assessed by 
comparing the time of 10 % inactivation in cells co-expressing TRPV5 and FKBP52. 
Time of 10 % inactivation was not significantly different for Ca2+ currents in cells co-
expressing FKBP52 and TRPV5 compared to cells expressing TRPV5 only 
(32 ± 12 milliseconds, N=20 versus 38 ± 5 milliseconds, N=15, respectively, P> 0.05).  
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Figure 3. Enhancement of TRPV5 
activity by siRNA-mediated gene-
silencing of FKBP52. HEK293 cells were 
co-transfected with the pSUPER-FKBP52 
(siFKBP52) construct together with TRPV5 
or the empty vector (mock). The pSUPER-
Luciferase (siLuc) construct was used as a 
control for the specificity of FKBP52 gene-
silencing. (A) Immunoblot analysis for 
FKBP52 on lysates from co-transfected 
HEK293 cells demonstrated suppression of 
the FKBP52 protein. TRPV5 expression 
was not altered by the FKBP52 protein 
suppression. (B) 45Ca2+ uptake was 
measured in HEK293 cells as shown in 
figure 3A. Cells co-transfected with the 
siFKBP52 and TRPV5 showed an 
increased 45Ca2+ influx compared to 
siLuc/TRPV5-transfected cells. The closed 
bars represent cells transfected with 
siFKBP52, while the open bars are used for 
the siRNA control, siLuc. Values are 
expressed as means ± SE. (N=4). *P<0.01 
significantly different from the respectively 
mock-transfected cells. #P<0.02 
significantly different from siLuc TRPV5-
transfected cells. 
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Role of the FKBP52 PPIase activity in TRPV5-mediated Ca2+ influx 
The enzymatic activity of FKBP52 was abolished by double mutation of two highly 
conserved amino acidic residues (FD67DV mutant) as described previously (22). The 
FD67DV mutant and wild-type FKBP52 were co-transfected in HEK293 cells with TRPV5 
and functionally analyzed using the 45Ca2+ uptake assay. The FD67DV mutant reverted 
the inhibitory effect of FKBP52 on TRPV5-mediated Ca2+ influx (Figure 5A). Immunoblot 
analysis of the cell lysates demonstrated that both FKBP52 wild-type and the mutant 
FD67DV are equally expressed and do not interfere with the TRPV5 expression (Figure 
5B). 
 
Effect of FK506 on TRPV5 activity  
The immunosuppressant FK506, known to bind and inhibit FKBP52 enzymatic activity, 
was assessed for its effect on TRPV5-mediated Ca2+ influx. First, the dose-dependent 
relationship of FK506 was determined in HEK293 cells demonstrating that overnight 
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Figure 4. Inhibition of TRPV5 activity 
by FKBP52 over-expression. HEK293 
cells were co-transfected with TRPV5 
and FKBP52, or/and empty, and were 
analyzed by patch-clamp. (A) Current-
voltage relations measured from 450 
milliseconds voltage ramps in nominally 
DVF solution in HEK293 cells over-
expressing either TRPV5 and empty 
vector or TRPV5 in combination with 
FKBP52. (B) Average current densities at 
–80 mV in nominally DVF solution for 
cells co-expressing either TRPV5 and 
empty vector or TRPV5 in combination 
with FKBP52. Cells co-transfected with 
TRPV5 and FKBP52 displayed 
significantly decreased Na+ currents at -
80 mV (-1997 ± 260 pA/pF versus - 2882 
± 325 pA/pF (N=20)). (P<0.001 versus 
TRPV5 control currents). (C) Inward Ca2+ 
currents measured with 10 mM 
extracellular Ca2+ during a 3 seconds 
step to –100 mV from a holding potential 
of +70 mV. (D) Average peak current 
density during a voltage step to -100 mV 
in 10 mM Ca2+. Cells co-transfected with 
TRPV5 and FKBP52 displayed 
significantly decreased Ca2+ peak current 
- 160 ± 22 versus -250 ± 25 pA/pF 
(N=20). *P<0.005, versus TRPV5 control 
currents.  
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incubation with high concentrations (in the range of 10 nM to 100 M) diminishes the 
cell viability (Figure 6A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Then, HEK293 cells transiently transfected with TRPV5 were incubated overnight with 
10 nM of FK506 and tested for their 45Ca2+ uptake. Incubation with FK506 resulted in 
significantly increased 45Ca2+ influx in TRPV5-transfected cells (Figure 6B). To further 
substantiate this effect, FK506 action was evaluated in kidney primary cultures. The 
primary cultures of rabbit CNT/CCD cells form confluent monolayers that exhibit many 
characteristics of the original polarized epithelia, including a PTH- and vitamin D-
stimulated transepithelial Ca2+ transport (4). Overnight incubation of 10 nM FK506 
significantly stimulated transcellular Ca2+ transport in these primary kidney cells (Figure 
6C). Measurements of the transepithelial resistance across the cell monolayer showed 
that higher concentrations (1 μM and 100 μM) of FK506 disturbed the integrity of the 
confluent cell monolayer. 
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Figure 5. FKBP52 inhibitory effect on 
45Ca2+ influx through TRPV5 depends on 
the PPIase activity of FKBP52. (A) 
HEK293 cells were co-transfected with 
TRPV5 and the empty vector (TRPV5), or 
the FKBP52 construct (FKBP52/TRPV5) or 
the catalytic inactive FKBP52 mutant 
(FD67DV/TRPV5). The inhibitory effect of 
FKBP52 on TRPV5-mediated 45Ca2+ influx 
was abolished by FD67DV. Data are 
expressed as means ± SE (N=5). *P<0.01 
significantly different from mock-transfected 
cells. # P<0.02 significantly different from 
TRPV5-transfected cells. (B) Immunoblot 
analysis for FKBP52 was performed on the 
lysates of HEK293 cells co-transfected with 
TRPV5 and the empty vector (TRPV5), or 
the FKBP52 construct (FKBP52/TRPV5) or 
the catalytic inactive FKBP52 mutant 
(FD67DV/TRPV5) that were applied in the 
functional assay of the figure 5A. The 
results demonstrated equal expression of 
wild-type and mutated FKBP52 and 
immunostaining for TRPV5 showed equal 
expression of the channel.  
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Regulation of FKBP52 in kidney 
To estimate the putative effect of FK506 on FKBP52 transcription, renal mRNA 
expression was determined by quantitative real time PCR in rats treated with FK506 (1 
mg/day) or vehicle for seven days. The results demonstrated that FK506 has no 
significant effect on FKBP52 mRNA expression compared to control (0.32 ± 0.03 versus 
0.28 ± 0.02 copies FKBP52/HPRT). In addition, the FKBP52 protein expression was 
measured in renal total lysates from TRPV5-/- mice. Immunoblot analysis for FKBP52 
showed a 63 ± 11 % decrease in TRPV5-/- mice compared to the control littermates 
(Figure 7).  
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Figure 6. FK506 stimulatory 
effect on Ca2+ influx of TRPV5-
expressing HEK293 and primary 
CNT/CCD cells. (A) HEK293 cells 
were incubated overnight with 
FK506 at a concentration between 
0 to 100 μM. The effect of FK506 
on cell viability was counted by the 
trypan-blue exclusion assay. (B) 
TRPV5-transfected HEK293 cells 
were incubated overnight with 0 or 
10 nM FK506. 45Ca2+ uptake 
measurements showed a 
stimulatory effect of FK506 on 
45Ca2+ influx. (C) TRPV5-
expressing monolayers of rabbit 
CNT/CCD primary cell cultures 
were incubated overnight with 
FK506 at a concentration of 0 to 
100 μM. 10 nM of FK506 showed 
increased Ca2+ transport upon 
FK506 treatment whereas higher 
concentrations disturbed the cell 
monolayer resulting in reduced 
Ca2+ transport. Data are 
expressed as means ± SE (N=4). 
*P<0.01 versus control cells.  
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Figure 7. Regulation of FKBP52 expression. (A) Immunoblotting of FKBP52 in total kidney homogenates 
of TRPV5-/- and wild-type littermates. 10 μg of total protein was loaded per lane and each lane represents 
the renal homogenate from an individual mouse. (B) The intensity of the immunopositive bands were 
quantified by densitometry. FKBP52 expression is depicted as a percent ratio to wild-type mice. Data are 
expressed as means ± SE. *P<0.05 versus control mice. 
 
DISCUSSION 
The present study demonstrated that FKBP52 binds and co-localizes with the epithelial 
Ca2+ channel TRPV5 in the distal part of the nephron. FKBP52 reduced TRPV5 activity 
as indicated by the functional analysis using FKBP52 siRNA and co-expression studies 
in HEK293 cells. This inhibitory action was reverted by abrogation of the PPIase activity 
in FKBP52, as well as by administration of the FKBP52 blocker, FK506. Our findings 
suggest that the immunophilin FKBP52 is a TRPV5 auxiliary protein regulating channel 
activity. 
FKBP52 transcription was strongly stimulated by two majors regulators of the 
Ca2+ homeostasis: vitamin D3 and dietary Ca2+ (12), in line with the regulation observed 
for TRPV5 (13). We showed here that renal FKBP52 expression is diminished in TRPV5-
/- mice further supporting a functional coupling between both proteins. Indeed, knock-
down of the FKBP52 protein expression by siRNA gene-silencing, as well as inhibition of 
FKBP52 enzymatic activity by binding to FK506, increased Ca2+ influx through TRPV5. 
In addition, expression of the FKBP52 protein reduced TRPV5-mediated Ca2+ and Na+ 
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currents, suggesting that FKBP52 decreases the number of functional channels at the 
plasma membrane. In this regulatory process, it seems that the enzymatic activity of 
FKBP52 plays a critical role, since inactivation of FKBP52 PPIase activity abolished its 
effect on TRPV5 activity. FKBP52 ability to modify its substrates by catalyzing the cis-
trans isomerization of proline residues is often a rate limiting step in protein folding (26). 
Moreover, it is possible that FKBP52 operates through multiple targets to regulate the 
function of the channel, considering that it contains putative ATP, GTP and calmodulin 
binding sites (6, 20).  
Consistent with our findings on the FKBP52 inhibitory role in TRPV5 Ca2+ influx, 
is a previous study that identified the FKBP52 Drosophila homologue, FKBP59, as a 
physiological regulator of TRPL channel activity (10). FKBP59 interacts directly with the 
highly conserved TRPL sequence 701LPPPFNVLP709 and inhibits Ca2+ influx. In 
Drosophila (10) as well as in mammals (28) the proline residue of the first LP-motif, 
located next to mouth of the channel pore, plays a crucial role in this association. 
Conspicuously, TRPV5 contains such an LP motif next to the pore region at the amino 
acidic position 551-552, where the FKBP52 binding site is located. The FK506 drug has 
been shown to mimic the LP-dipeptide (23) and to disrupt the FKBP52 interaction with 
TRPCs (28). However, FK506 did not interrupt the FKBP52-TRPV5 association 
suggesting an alternative mechanism. This would mean that FK506 binds TRPV5 and 
modulates its activity without displacing the association of FKBP52, similar to the 
mechanism previously described for the regulation of the Drosophila homologues 
FKBP59 and TRPL (10). The physiological relevance of the latter hypothesis needs 
further confirmation since it is based on in vitro experiments. 
FKBP52 is expressed along the apical region of DCT and CNT tubules together 
with TRPV5. In addition, FKBP52 was also localized in the cytosol. This finding together 
with the stimulatory effect of FK506 drug on Ca2+ influx observed in primary CNT/CCD 
renal cells further substantiated the physiological relevance of FKBP52 in active 
transepithelial Ca2+ transport. Our results imply that while high concentrations of FK506 
are toxic for the cells, submicromolar concentrations (10 nM) stimulate transcellular Ca2+ 
transport. This dose-dependent effect could explain the nephrotoxicity observed in 
patients treated with the immunosuppressive drug FK506 (2, 3). On the other hand, it 
has been previously demonstrated that the hypercalciuric effect of FK506 is mediated 
through the decreased expression of calbindin-D28K (1) and TRPV5 (21). Contrary to the 
reduction in TRPV5 expression upon FK506 administration, we showed that FKBP52 
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expression is not altered under the same conditions. To this regard the reduction of the 
TRPV5/FKBP52 ratio is reminiscent of transient expression in HEK293 cells where an 
excess of FKBP52 inhibits TRPV5-mediated Ca2+ influx. Certainly, given the complexity 
of the in vivo situation, the FK506-induced hypercalciuria awaits further investigation 
particularly concerning the putative role of other FKBP proteins.  
In conclusion, FKBP52 participates in active transepithelial Ca2+ transport along 
the distal part of the nephron by reducing TRPV5 activity. This inhibitory effect on 
TRPV5 is mediated by the enzymatic PPIase activity of FKBP52 and is reverted by 
FK506 administration. 
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…και τες καλές πραγμάτειες ν' αποκτήσεις,  
σεντέφια και κοράλλια, κεχριμπάρια κ' έβενους,  
και ηδονικά μυρωδικά κάθε λογής,  
όσο μπορείς πιο άφθονα ηδονικά μυρωδικά·  
σε πόλεις Αιγυπτιακές πολλές να πας,  
να μάθεις και να μάθεις απ' τους σπουδασμένους... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…to purchase there the best of wares, 
mother-of-pearl and coral, amber, ebony, 
hedonic perfumes of all sorts 
as many such hedonic perfumes as you can; 
that you may go to various Egyptian towns 
to learn, and learn from those schooled there... 
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ABSTRACT 
The Transient Receptor Potential Vanilloid 5 (TRPV5) channel determines urinary Ca2+ 
excretion and is therefore critical for Ca2+ homeostasis. Interestingly, mice lacking the 
serine protease tissue kallikrein (TK) exhibit robust hypercalciuria comparable to the 
Ca2+ leak in TRPV5 knock-out mice. Here, we delineated the molecular mechanism 
through which TK stimulates Ca2+ reabsorption. Using TRPV5-expressing primary 
cultures of renal Ca2+ transporting epithelial cells, we showed that TK activates Ca2+ 
reabsorption. The stimulatory effect of TK was mimicked by bradykinin (BK) and could 
be reversed by application of JE049, a BK receptor type 2 antagonist. A cell permeable 
analog of DAG increased TRPV5 activity via protein kinase C activation of the channel 
since mutation of TRPV5 at the putative PKC phosphorylation sites S299 and S654 
prevented the stimulatory effect of TK. Cell surface labeling revealed that TK enhances 
the amount of TRPV5 channels at the plasma membrane by delaying its retrieval. In 
conclusion, TK stimulates Ca2+ reabsorption via the BK-activated PLC/DAG/PKC 
pathway and the subsequent stabilization of the TRPV5 channel at the plasma 
membrane. 
 
INTRODUCTION 
The overall Ca2+ balance is regulated by a homeostatic mechanism tightly controlling the 
concerted actions of intestinal Ca2+ absorption, exchange of Ca2+ from bone and renal 
Ca2+ reabsorption. In kidney, Ca2+ can cross the epithelial cells and reach the blood 
compartment via two pathways: passive (paracellular) and active (transcellular) Ca2+ 
transport. Active Ca2+ transport takes place in the distal convoluted (DCT) and the 
connecting (CNT) tubules (20). Although it accounts only for ~15 % of total renal Ca2+ 
reabsorption, it is generally considered the site for fine-tuning of urinary Ca2+ excretion. 
Furthermore, active Ca2+ transport is the primary target for regulation by calciotropic 
hormones, including 1,25-dihydroxyvitamin D3 and parathyroid hormone (PTH), enabling 
the organism to regulate Ca2+ reabsorption to the body’s demand.  
The Transient Receptor Potential Vanilloid 5 (TRPV5) channel is expressed 
along the apical membrane of DCT and CNT and represents the rate-limiting step in 
renal transcellular Ca2+ reabsorption (20). Inactivation of TRPV5 in mice (TRPV5-/-) 
abolishes active Ca2+ reabsorption in kidney resulting in severe hypercalciuria (21). To 
compensate this renal Ca2+ leak, TRPV5-/- mice exhibit increased intestinal Ca2+ 
hyperabsorption. In addition, the bone structure of these mice was significantly disturbed 
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as illustrated by a reduced trabecular and cortical bone thickness (21). Hence, these 
data demonstrate the key function of TRPV5 in active Ca2+ reabsorption and its essential 
role in the body Ca2+ homeostasis.  
Interestingly, hypercalciuria was recently observed in tissue kallikrein-deficient 
(TK-/-) mice (33).  TK is a serine protease produced in the CNT (13), where it co-localizes 
with TRPV5 (21). Proteolytic enzymes such as TK are synthesized as inactive 
precursors or zymogens, to prevent unwanted protein degradation and to enable spatial 
and temporal regulation of enzymatic activity. The precursor of TK is converted to the 
mature active form before entering the luminal tubular compartment. Trypsin, plasma 
kallikrein, plasmin and thermolysin can cleave in vitro the pre-TK but the endogenous 
activator is still unknown (28). Once activated, TK is excreted and can process low 
molecular weight kininogen to release kinin which acts through kinin receptors such as 
the bradykinin (BK) 2 receptor (B2R) (3). Remarkably, recent studies show that TK can 
as well directly activate the B2R independently of BK release (16). At the functional level, 
TK is involved in the Na+ balance and in the pathophysiology of hypertension (8). 
However, the molecular events that link TK to Ca2+ balance are at present unknown.  
The aim of this study was, therefore, to elucidate the molecular mechanism of 
hypercalciuria observed in TK-/- deficient mice. To this end, the relation between TK 
expression and hypercalciuria was investigated in vivo using TK-/- and TRPV5-/- mice. 
Subsequently, the effect of TK on transcellular Ca2+ transport was examined in primary 
cultures of DCT/CNT cells. Finally, the signaling pathway through which TK acts on Ca2+ 
transport and its effect on TRPV5 surface expression was delineated in TRPV5-
expressing cells.  
 
MATERIALS AND METHODS  
Animal experiments 
TK knock-out mice (TK-/-) were produced as previously described (30, 33) and fed ad 
libitum two Na+ diets containing 0.3 % or 3 % (w/w) for 14 days. Subsequently, 24-hour 
urine was collected from TK-/- and wild-type (TK+/+) mice housed in metabolic cages and 
blood was obtained by orbital puncture. Measurements of biological parameters in the 
animals plasma and urine were performed as previously described (33). Urinary Na+, 
Ca2+ and Mg2+ excretion were expressed as ratios to urinary creatinine excretion to take 
into account the variations in urine collection. The generation of TRPV5 knock-out mice 
(TRPV5-/-) has been described previously (21). At the age of 4 weeks, mice were fed ad 
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libitum two diets containing 0.02 % or 2 % (w/w) Ca2+ for 5 weeks and were 
subsequently placed in metabolic cages. 24-hour urine samples were collected and 
subjected to trichloroacetic acid (TCA) precipitation. The animal ethics board of the 
Radboud University Nijmegen approved all animal experimental procedures. 
 
Urine protein precipitation by TCA 
10 % of the 24-hour urine volume collected of TRPV5-/- mice was centrifuged at 200 g for 
10 minutes at 4°C to remove cell debris. Proteins in the urine were precipitated using 
ice-cold TCA (Acros organics, New Jersey, USA). The TCA mixture was centrifuged at 
13,000 g for 10 minutes at 4°C, and the pellet was subsequently washed with 300 μl 
acetone. Next, the pellet was air-dried for approximately 3 minutes, dissolved in Laemmli 
buffer containing 0.1 M DTT and 150 mM Tris (pH 8.8) by immunoblot analysis for the 
expression of TK using a rabbit anti-TK antibody (Calbiochem, San Diego, CA, USA). 
Immunopositive bands were scanned using an imaging densitometer to determine pixel 
density (Molecular Analyst Software, BioRad Laboratories, Hercules, CA). 
 
DNA constructs and cell culture 
The TRPV5 pCINeo/IRES-GFP constructs were generated as described previously (38). 
Single and combined protein kinase C (PKC) mutants were generated by alanine 
substitution of the six putative phosphorylation sites of TRPV5 (S144A, S299A, S316A, 
S654A, S664A, S698A) using in vitro mutagenesis (QuickChange Site-Directed 
Mutagenesis kit, Stratagene, La Jolla, CA, USA). The B2R pcDNA3 was a kind gift from 
Prof G. Erdös, MD (Department of Pharmacology, University of Illinois, Chicago, USA). 
Human Embryonic Kidney (HEK) 293 cells were transfected at 70 % of confluency using 
polyethylenimine (Polysciences, Inc., Warrington, USA) or Lipofectamin 2000 (Invitrogen 
Life Technologies, Breda, The Netherlands). After 48-60 hours, cells were used for 
45Ca2+ uptake assays, patch-clamp and/or biotinylation experiments. Prior to the assays, 
cells were incubated for 1 hour in serum-free medium containing the particular 
compound.  
 
Transcellular Ca2+ transport in renal primary cultures  
CNT/CCD tubules were immunodissected from kidney cortex of New Zeeland White 
rabbits (~0.5 kg) using antibody R2G9 and then placed in primary culture on permeable 
filters (0.33 cm2; Costar, Cambridge, MA, USA) as described before (4). At confluence, 
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monolayers were used for the transepithelial Ca2+ transport assay as previously 
described (4). Transepithelial potential difference and resistance were checked before 
and after transport measurement to confirm the integrity of the monolayer.  
 
45Ca2+ uptake assay 
HEK293 cells were transfected with TRPV5 pCINeo/IRES-GFP or pCINeo/IRES-GFP 
cDNA. Ca2+ uptake was determined in uptake medium (110 mM NaCl, 5 mM KCl, 1.2 
mM MgCl2, 0.1 mM CaCl2, 10 mM Na-acetate, 2 mM NaH2PO4, 20 mM HEPES-Tris, pH 
7.4 supplemented with 10 µM felodipine, 10 µM methoxy-verapamil, 1 mM BaCl2 and 1 
µCi/ml 45CaCl2) for 10 minutes at room temperature (20–25°C). Each well was washed 
extensively with stop buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 0.5 mM CaCl2, 1.5 
mM LaCl3, 10 mM Na-acetate, 20 mM HEPES-Tris, pH 7.4) at 4 °C, incubated with 0.05  
% w/v SDS, and the lysates were counted for radioactivity using liquid scintillation.  
 
Electrophysiology and solutions 
Patch-clamp experiments were performed as described previously (39) in the tight seal 
whole-cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). 
Two voltage protocols were used: a ramp, to establish the current-voltage (I-V) relation 
in nominally divalent free solution (DVF) solution and a hyperpolarizing step protocol, to 
measure the Ca2+-dependent inactivation. Na+ current densities were calculated from the 
current at -80 mV during the ramp protocols, while the Ca2+ peak values were extracted 
from the current at -100 mV during the step protocol. The analysis and display of patch-
clamp data were performed using Igor Pro software (WaveMetrics, Lake Oswego, USA).  
 
Cell surface labeling with biotin 
HEK293 cells were transfected with 15 µg HA-TRPV5 pCINEO/IRES-GFP or 
pCINEO/IRES-GFP in poly-L-lysine (Sigma, St Louis, MO, USA) coated 10 cm dishes. 
60 hours after transfection, cells were incubated during one hour with 100 nM TK and 1 
μM JE049. The biotinylation assay was performed as described previously (7) using the 
NHS-LC-LC-biotin (Pierce, Etten-Leur, The Netherlands). For the half-life assay, the 
biotinylation assay was pursued as described above. For the time point 0, cells were 
collected from plates and lysed with 1 ml lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 
7.5, 5 mM EDTA, 1 % v/v NP-40), immediately after biotinylation. Other plates of cells 
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were further cultured for 1, 3, 6 or 12 hours, then washed once with ice-cold PBS (pH 
7.4), and subsequently homogenized in 1 ml lysis buffer, followed by 
immunoprecipitation using neutravidin beads (Pierce, Etten-Leur, The Netherlands). 
TRPV5 immunoprecipitates were visualized using the guinea pig anti-TRPV5 antibody 
(19). 
 
Compounds 
TK, BK, phorbol 12-myristate 13-acetate (PMA), and 1-oleoyl-acetyl-sn-glycerol (OAG) 
were purchased from (Sigma, St Louis, MO, USA). U73122 and U73343 were purchased 
from Upjohn Laboratories (Kalamazoo, MI, USA). JE049, formerly known as icatibant or 
HOE140, which was a kind gift of Dr. J. Pünter (Aventis Pharma Deutschland GmbH, 
Frankfurt, Germany).  
 
Statistical analysis 
In all experiments, the data is expressed as mean ± S.E.M. Overall statistical 
significance was determined by analysis of variance (ANOVA). In case of significance, 
differences between the means of two groups were analyzed by unpaired t-test, while 
multiple comparisons between groups were performed by Bonferroni posthoc tests. 
P<0.05 were considered significant. The statistical analyses were performed using the 
SPSS software (SPSS Inc, Chicago, Illinois, USA).  
 
RESULTS 
TK expression levels inversely correlate with urinary Ca2+ excretion  
The effect of urinary TK expression modulation on urinary Ca2+ excretion was 
investigated by using wild-type (TK+/+) and knock-out (TK-/-) mice fed a 0.3 % (w/w) 
(normal) and 3 % (w/w) Na+ (high) diet. Urinary Ca2+ excretion was significantly 
decreased in TK+/+ mice on normal Na+ diet compared to mice on high Na+ diet (p<0.05, 
n=12 mice) (figure 1A). Inversely, Ca2+ excretion of TK-/- mice on normal Na+ diet was 
higher by 40 ± 13 % than in TK+/+ mice (p<0.05, n=12 mice), but remained constant on a 
high Na+ diet (p>0.2, n=12 mice) (figure 1A). On the high Na+ diet, there was no 
difference in urinary Ca2+ excretion between TK+/+ and TK-/- mice. Body weight, food 
intake, urinary creatinine as well as plasma values of Ca2+, creatinine and protein 
concentrations did not differ between mice genotypes on either diet (table 1). 
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TK is up-regulated in TRPV5-/- mice 
The amount of TK excreted in the urine was determined by TCA protein precipitation of 
24-hour urine collected from TRPV5+/+ and TRPV5-/- mice fed either a 0.02 % (w/w) (low) 
or a 2 % (w/w) (high) Ca2+ diet. Immunoblot analysis of the TCA-precipitate showed the 
specific TK band migrating at ~40 kDa (figure 1B). Semi-quantitative densitometry of the 
TK corresponding band demonstrated that urinary TK excretion increased in TRPV5-/- 
mice compared to TRPV5+/+ littermates on low Ca2+, whereas the high Ca2+ diet did not 
affect TK excretion between TRPV5-/- and TRPV5+/+ genotypes (figure 1C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TK stimulates Ca2+ transport in renal primary cells cultures 
The effect of TK on transcellular Ca2+ transport was evaluated in primary cultures of 
CNT/CCD cells. Application of 100 nM TK to the apical side of the monolayer 
significantly stimulated Ca2+ transport compared to non-treated monolayers, while no 
effect was observed when TK was added on the basolateral side (figure 2A). 
Figure 1. TK expression in relation 
to calcium excretion. (A) 24-hour 
Ca2+ excretion normalized for 
creatinine excretion (UCa2+/UCr) in wild-
type (TK+/+, closed bars) and knockout 
(TK-/-, open bars) mice fed a 0.3 % w/w 
or 3 % w/w Na+ diet. Data are 
expressed as means ± S.E.M (n=12 
mice). *p<0.05 versus TK+/+ mice on 
the same diet. #p<0.05 versus same 
genotype mice on the lower diet. (B) 
Immunoblotting of TK in TCA-
precipitates of 24-hour urine from wild-
type (TRPV5+/+) and TRPV5-/- mice fed 
with 0.02 % and 2 % w/w Ca2+ diet. (C) 
The intensity of the immunopositive 
bands was quantified by densitometry 
and TK expression was depicted as a 
percent ratio to TRPV5+/+ mice (closed 
bars) fed with 0.02 % w/w Ca2+ diet. 
Data are expressed as means ± S.E.M 
(n=4 mice). *p<0.05 versus TRPV5+/+ 
mice on the same diet.  
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Table 1. Phenotypic characterization of TK+/+ and TK-/- mice on 0.3 and 3 % (w/w) Na+ diets.  
 0.3 % (w/w) Na+ 3 % (w/w) Na+ 
 TK+/+ TK-/- TK+/+ TK-/- 
     
Weight (g) 23.8 ± 1.0 24.5 ± 0.8 24.6 ± 1.0 23.8 ± 0.4 
Food intake (g/24 h) 2.68 ± 0.64 2.09 ± 0.5 1.91 ± 0.32 2.18 ± 0.34 
     
Plasma values     
Total Ca2+ (mM) 2.05 ± 0.06 1.96 ± 0.07 2.01 ± 0.08 2.07 ± 0.08 
Creatinine (µM) 10.5 ± 1.0 9.3 ± 0.9 9.5 ± 2.1 9.0 ± 2.2 
Protein (g/L) 46.3 ± 0.9 44.9 ± 0.9 49.3 ± 1.0 44.8 ± 1.0 
     
Urine values     
Volume (ml/24 h) 1.47 ± 0.20 1.36 ± 0.26 3.47 ± 0.89* 2.18 ± 0.34 
Creatinine excretion (µmol/24 h) 4.94 ± 0.42 4.56 ± 0.37 4.79 ± 0.39 4.71 ± 0.38 
UNa+/UCr (mmol/mmol) 39.6 ± 2.5 33.9 ± 2.4 292.5 ± 38.3* 223.2 ± 23.8* 
*p< 0.05 vs same genotype on 0.3 % Na diet (n=12 mice). 
 
TK action was mimicked by apical addition of 100 nM trypsin, which like TK displays 
serine protease activity, (figure 2B) as well as 1 μM BK (figure 2C). Interestingly, the 
stimulatory effect on Ca2+ transport of both BK and TK was inhibited by apical application 
of 1 μM JE049, a B2R antagonist (figure 2C). Basolateral treatment of trypsin, BK or 
JE049 did not affect transcellular Ca2+ transport of the cell monolayer (data not shown). 
 
TK enhances TRPV5 channel activity 
The stimulatory effect of TK on Ca2+ transport was further examined in TRPV5-
transfected HEK293 cells. Incubation of TRPV5-transfected cells with 100 nM TK 
enhanced 45Ca2+ influx in a dose-dependent manner with a maximal stimulation at 500 
nM and an EC50 of 6 ± 0.04 nM (figure 3A) whereas no effect was observed in mock-
transfected cells (data not shown).  
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Further, TK action on TRPV5 channel activity was investigated by the whole-cell patch-
clamp technique in TRPV5-expressing HEK293 cells. Pre-incubation with 100 nM TK 
increased with 166 ± 16 % the inward Ca2+ current compared to non-treated, control 
(CTRL) cells, in response to the step protocol (p<0.05, n=15 cells) as depicted in figure 
3C. The Ca2+-dependent inactivation of TRPV5 currents remained unchanged (figure 
3B). Measurements in DVF solution showed no change in the I-V relation of the currents 
(figure 3D) while a significant increase of 149 ± 17 % in Na+ inward currents (p<0.05, 
n=15 cells) was observed (figure 3E).  
 
TK increases TRPV5-mediated currents via the B2R 
Since BK mimicked TK in Ca2+ transport in primary cultures of DCT/CNT, the 
effect of BK on TRPV5-expressing HEK293 cells was further studied. Prior to functional 
analysis, B2R expression was confirmed in HEK293 cells by immunoblot analysis. B2R-
transfected HEK293 cells were used as control.  
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Figure 2. TK stimulatory effect 
on transepithelial Ca2+ 
transport. (A) Monolayers of 
rabbit CNT/CCD primary cell 
cultures were incubated with 100 
nM of TK at the apical, basolateral 
or both sides. (B) Primary cells 
were subsequently treated apically 
with 100 nM trypsin, or TK. (C) 1 
μM BK and 100 nM TK were 
applied at the apical side of the 
filters in the presence (open bars) 
or the absence (closed bars) of 1 
μM JE049, a B2R antagonist. In 
all experiments no treated cells 
were used as control (CTRL) and 
net apical to basolateral Ca2+ 
transport was measured. Data is 
expressed as means ± S.E.M. 
(n=4 wells). *p<0.05 versus CTRL.  
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Figure 3. Effect of TK on TRPV5-transfected HEK293 cells. (A) HEK293 cells were transfected with 
TRPV5 and treated for 1 hour with TK in concentrations ranging from 0.05 to 5000 nM. Treated cells were 
measured for their 45Ca2+ uptake. Values are expressed as means ± S.E.M. (n=6 wells). (B) Averaged Ca2+ 
currents measured with 10 mM Ca2+ in the extracellular solution during a 3 seconds step to -100 mV from a 
holding potential of +70 mV in TRPV5-transfected HEK293 cells treated (dotted trace) or non-treated (solid 
trace) with 100 nM TK. (C) Average density of the Ca2+ peak current measured as in (B), was 500 ± 60 
pA/pF (n=15 cells) for TK treated cells compared to 300 ± 50 pA/pF (n=15 cells) for CTRL cells. (D) Current-
voltage relations measured from 450 milliseconds voltage ramps in nominally DVF solution in TRPV5-
transfected HEK293 cells treated (dotted trace) or non-treated (solid trace) with TK. (E) Average Na+ current 
density at -80 mV in nominally DVF solution were 745 ± 85 pA/pF (n=15 cells) for TK treated cells compared 
to 500 ± 55 pA/pF for CTRL cells (n=15 cells). *p<0.05 versus CTRL. 
 
Cells were lysed and equal amounts of total protein were immunoblotted. In both 
conditions, mock and B2R-transfected HEK293 cells, B2R was detected as an 
immunopositive band of ~69 kDa (figure 4A). Subsequently, TRPV5-transfected 
HEK293 cells were incubated for 1 hour with BK and functionally characterized by patch-
clamp measurements in comparison to non-treated cells (CTRL). Interestingly, BK 
treatment resulted in a significant increase of 146 ± 14 % in both Ca2+ (figure 4C) and 
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Na+ (figure 4E) currents (p<0.05, n=12 cells) compared to CTRL cells, without affecting 
neither the Ca2+-dependent inactivation (figure 4B) nor the I-V relation (figure 4D). 
Because the different treatments of TRPV5-expressing HEK293 cells affected both Na+ 
and Ca2+ current amplitudes leaving unaffected the other current properties, further on, 
only the Ca2+ currents are depicted to demonstrate the effect of particular compounds. 
Incubation of TRPV5-transfected cells with 1 μM JE049 reversed the stimulatory effect of 
TK on TRPV5-mediated currents. The Ca2+-dependent inactivation of Ca2+ currents 
remained unchanged for cells treated with TK or TK and JE049 (figure 4F). Ca2+ current 
amplitudes measured from the step protocol were significantly lower, 285 ± 50 pA/pF, for 
the JE049-treated cells (p<0.05, n=11 cells) compared to TK treated cells (figure 4G).  
 
TK stimulates TRPV5-mediated currents via the PLC-dependent PKC pathway  
To elucidate in detail the mechanism through which TK enhances TRPV5 activity, the 
following strategies were followed. First, the pre-treatment with 10 µM of the PLC 
inhibitor, U73122, for 10 minutes abolished the TK stimulatory effect on TRPV5-
mediated Ca2+ currents whereas 10 µM of its inactive analogue U73343 had no effect 
(p<0.05, n=10 cells) (figure 5A). Then, TRPV5-transfected cells were incubated for 1 
hour with 10 µM OAG, a DAG analogue. OAG mimicked the stimulatory effect of TK on 
TRPV5-mediated Ca2+ currents (p<0.05, n=10 cells) (figure 5B). Next, the effect of TK 
on the sextuple PKC phosphorylation-deficient mutant was tested. In HEK293 cells 
expressing this mutant, the stimulatory effect of TK was abolished (figure 5C). 
Subsequently, the PKC phosphorylation sites were individually mutated into an alanine 
residue. TK increased Ca2+ currents of all single PKC mutants (p>0.2), except of S299A 
and S654A (p<0.05, n=12 cells) (figure 5D). Furthermore, in order to determine which 
PKC isoforms are involved in this process, cells were incubated for 24 hours with 1 µM 
of phorbol ester (phorbol 12-myristate 13-acetate-PMA) to down-regulate the PMA-
sensitive PKC isoforms expressed in HEK293 cells as previously described (6). Then, 
the cells incubated with PMA were treated as aforementioned with 100 nM TK for 1 hour. 
TK was still able to significantly increase with 164 ± 14 % (p<0.05, n=14 cells) TRPV5-
mediated Ca2+ currents (figure 5E). One batch of PMA non-incubated (NT) cells were 
used as control for the effect of PMA on TRPV5 currents and PMA incubation left 
unaffected TRPV5-mediated currents.  
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Figure 4. TK stimulation of TRPV5 activity is mediated by B2R. (A) B2R transfected cells and mock cells 
were lysed and equally loaded on gel. Immunoblot analysis of the samples shows the B2R expression.  (B) 
Inward Ca2+ currents in TRPV5-transfected HEK293 cells treated (dotted trace) or non-treated (solid trace) 
with 1 µM BK measured with the step protocol as in Figure 3B (C) Amplitude of Ca2+ peak current for BK 
treated cells was 353 ± 35 pA/pF and for control cells 243 ± 25 pA/pF (n=12 cells for each condition). (D) 
Current-voltage relations measured from voltage ramps in nominally DVF extracellular solution from non-
treated CTRL (solid trace) and BK (dotted trace) treated cells. (E) Average Na+ current for cells treated with 
BK was 615 ± 49 pA/pF and for CTRL cells 460 ± 46 pA/pF. (F) Inward Ca2+ currents measured with 10 mM 
Ca2+ in the extracellular solution during the voltage step to -100 mV from control non-treated cells (solid 
trace), cells treated with TK (dotted trace), and cells treated with both TK and 1 µM of the B2R antagonist 
JE049 (dashed trace). Inactivation of currents remained unchanged. (G) Average peak Ca2+ current from 
cells treated with TK and JE049 was 285 ± 45 pA/pF and for CTRL cells 300 ± 50 pA/pF compared to 500 ± 
55 pA/pF measured from TK treated cells. *p<0.05 versus CTRL. #p<0.05 versus TK treated cells. 
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Figure 5. TK action is mediated by the DAG/PKC-dependent PLC signalling pathway. TRPV5 
expressing cells were incubated for 1 hour with 100 nM TK and subsequently treated as described below. 
(A) 10 minutes incubation with 10 μM of the PLC inhibitor U73122 reverted the average Ca2+ currents 
amplitude of the TK treated cells to values similar to CTRL cells, contrary to its inactive form U73343 which 
let the TK effect unaltered (n=10 cells). (B) Ca2+ current of pre-treated cells for 1 hour with 10 μM OAG Ca2+ 
currents was 355 ± 30 pA/pF and for CTRL cells 191 ± 25 pA/pF. (C) Average Ca2+ currents for cells 
expressing TRPV5 mutated for all its six PKC phosphorylation sites were 123 ± 36 pA/pF and TK treated 
cells were 113 ± 25 pA/pF (n=10 cells for each condition). (D) Point mutation of the PKC phosphorylation 
sites S299 and S654 did not affect Ca2+ currents in comparison with the other four PKC mutants upon TK 
treatment.  Data are expressed as percentage of Ca2+ currents measured from cells expressing PKC-TRPV5 
point mutants treated with 100 nM TK normalized to non-treated CTRL cells (n=12 cells for each mutant). 
(E) 24-hours incubation with 1 µM PMA was used to down-regulate the PMA-sensitive PKC isoforms in 
TRPV5-transfected cells. In both cases, non-treated (NT), or 24-hours incubation with PMA, TK (black bars) 
was still able to significantly increase TRPV5-mediated Ca2+ currents compared to control cells (white bars) 
(n=14 cells for each condition) *p<0.05 versus CTRL.  
 
TK increases cell surface expression of TRPV5 by delaying the channel retrieval  
The effect of TK on the amount of TRPV5 channel expressed at the plasma membrane 
was investigated in HEK293 cells. TRPV5-transfected cells were incubated with 100 nM 
of TK alone or in combination with 1 µM JE049 for 1 hour and then subjected to cell 
surface biotinylation.  
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Figure 6. TK affects TRPV5 plasma membrane expression. (A) TRPV5-transfected HEK293 cells were 
treated with 100 nM TK with or without 1 μM JE049. Treated and not treated cells were subjected to cell 
surface biotinylation and after lysis precipitated with neutravidin-agarose beads. TRPV5 expression was 
analyzed by immunoblot for the plasma membrane fraction (left panel) and for the total cell lysates (right 
panel). As negative control, mock cells were used and for TRPV5 transfected cells biotin was omitted in the 
procedure. (B), (C) For cell surface half-life analysis, TK treated or non-treated TRPV5-transfected cells 
were first subjected to biotinylation. Then, the cells were immediately homogenized (time point 0), or further 
cultured for 1, 3, 6, 12 hours. Subsequently, the further-cultured cells were lysed, following 
immunoprecipitation with neutravidin beads. The TRPV5 expression on plasma membrane (B) and total 
lysates (C) was visualized using the guinea pig anti-TRPV5 antibody in the immunoblot.  
 
Biotinylated cell lysates were precipitated with neutravidin beads and immunoblotted for 
TRPV5. Mock-transfected and non-biotin-treated cells were used as a negative control. 
TK treatment enhanced TRPV5 expression in the biotinylated fraction, whereas JE049 
completely abolished this effect (figure 6A left panel). Importantly, TRPV5 was equally 
expressed in total cell lysates from all tested conditions (figure 6A right panel). The 
observed increase in cell surface expression of TRPV5 by TK may be the result of either 
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an enhanced trafficking from the Golgi apparatus to the cell surface, or a reduction in the 
retrieval from the plasma membrane. The kinetics of cell-surface appearance was 
measured among HEK293 cells using cell-surface biotinylation. After a 2-hour TK 
treatment, the retrieval of TRPV5 channel from the plasma membrane was decreased by 
70.7, 46.3, and 16.8 % (p<0.05, n=3 blots) at the time points of 1, 3 and 6 hours, 
respectively (figure 6B). TRPV5 expression in total cell lysates was identical in all tested 
conditions (figure 6C). These results demonstrated that TK increases cell surface 
expression of TRPV5 by delaying the channel retrieval from the plasma membrane. 
 
DISCUSSION 
The present study delineates the molecular mechanism of hypercalciuria observed in TK-
/- mice. TK stimulates TRPV5-mediated Ca2+ reabsorption by activating the B2R and 
subsequently the DAG/PKC pathway resulting in the stabilization of the TRPV5 channel 
units at the cell surface. This conclusion is based on the following experimental 
observations. (i) Ca2+ excretion in the urine of mice is inversely related toTK expression 
amount. (ii) TK stimulates Ca2+ transport in CNT/CCD primary cultures whereas this 
increase is blocked by the B2R antagonist JE049. (iii) TK effect is mediated by the 
PLC/DAG-pathway resulting in the activation of the two TRPV5 PKC sites S299 and 
S654. (iv) TK enhances Ca2+ transport by increasing TRPV5 abundance at the plasma 
membrane.  
Here, we demonstrated that TK acts as an autocrine/paracrine hormone and 
stimulates transcellular Ca2+ reabsorption in a dose dependent way. As shown in the 
mice models, reduction in TK expression leads to increased urinary Ca2+ excretion 
reflecting low tubular Ca2+ reabsorption. TK can be thus proposed as a new component 
of Ca2+ homeostasis and it would be therefore interesting to study how the Ca2+ 
reabsorption is regulated in humans with a genetically reduced TK activity. In this 
respect, a loss-of-function polymorphism of the TK gene in which the active-site arginine 
at position 53 is changed into a histidine (R53H), reduces by 50-60 % TK activity (36). 
The partial genetic deficiency in TK activity of the R53H subjects is associated with a 
form of arterial dysfunction (2). TK is well known as a vasodilator factor of renal cortical 
blood vessels through BK production, while abnormalities of TK levels has long been 
documented in the pathogenesis of hypertension (for review (8)). It is tempting thus, to 
speculate that TK stimulation of TRPV5-mediated Ca2+ reabsorption plays a role in TK 
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hypotensive action, since urinary Ca2+ leak has been correlated with higher baseline 
systolic and diastolic blood pressures (29).  
Furthermore, as demonstrated here TK activates TRPV5-mediated Ca2+ transport 
via the B2R receptor. The physiological relevance of this latter is substantiated by the 
co-localization of the B2R with TK (12) and this latter with TRPV5 (21) in luminal CNT 
membranes. However, B2R-/- mice showed no change in urine Ca2+ excretion (33), 
suggesting that compensation mechanisms could mask the TK effect on Ca2+ balance in 
these mice. The B2R belongs to the seven-transmembrane domain G protein-coupled 
receptor superfamily (17) and signals via Gαq protein with consequent activation of PLC. 
PLC catalyzes the hydrolysis of phosphatidylinositol-4,5-biphosphate (PIP2) in inositol 
triphosphate (IP3) and DAG (5). Commonly, IP3 releases Ca2+ from the endoplasmic 
reticulum stores, while DAG mainly activates PKC (5). Certainly, our results show that 
TRPV5 activation requires PIP2 breakdown by following B2R stimulation and relies on 
DAG as a down-stream effector. Subsequently, DAG increases TRPV5 activity via PKC 
phosphorylation of the channel since deficient mutants of TRPV5 phosphorylation at 
positions S299 and S654 lack the TK effect. This is the first study demonstrating that 
TRPV5 is activated through its PKC phosphorylation sites. Among the six predicted 
phosphorylation sites in TRPV5 sequence, two serines, S299 and S654 are critical for 
TRPV5 activation by TK. Importantly, TRPV5 closest homologue, TRPV6, did not 
respond to TK (data not shown). Since the second serine (S654) is not conserved in 
TRPV6, one could conclude that both serines are critical for the TRPV5 stimulation by 
TK. In addition, the 24 hours incubation with PMA is known to down-regulate the α, β, 
and ε isoforms of PKC but not PKCζ  (14). This latter PKC isoform is involved in TK 
increase of TRPV5 currents since the TK effect was here identical for PKC-depleted with 
PMA treatment and control cells. Interestingly, active Ca2+ transport stimulation involves 
phorbol-ester-insensitive PKC isotypes (18) among which the isotype PKCζ can be 
activated by B2R (9).  
Previous studies showed that TRP channels can be activated by different 
signaling molecules of the PLC pathway. For example, the three canonical TRP 
members TRPC3, 6 and 7 are characterized by their sensitivity  to DAG (22). 
Alternatively, the vanilloid and melastatine members of TRP family, TRPV1 (10), TRPV5 
(25), TRPM4 (32), TRPM5 (27), TRPM7 (35) and TRPM8 (26) can be directly regulated 
by PIP2. For TRPV5 activation mechanisms by PIP2 (25) and by DAG/PKC as 
demonstrated here, one should consider that in vivo, both pathways could be balanced 
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to adjust TRPV5 activity to physiological fluctuations. In addition, the Ca2+ entering the 
cell through TRPV5 could prevent the electrostatic interaction between the negatively 
charged PIP2 and the channel by screening the negative charge on the lipid head group, 
as proposed for Mg2+ and TRPM7 (24).  
The stimulation of Ca2+ transport through TRPV5 upon TK action could be the 
result of an increase in the open probability of the channel or in the expression of TRPV5 
at the plasma membrane. The surface biotinylation analysis showed that TK increases 
the amount of TRPV5 channels at the plasma membrane. Thus, the PKC activation of 
TRPV5 following the TK application would tip the balance between constitutive 
exocytosis and endocytosis in favor of the former leading to the accumulation of TRPV5 
in the cell surface. Similarly, the epidermal growth factor prevents the internalization of 
plasma membrane TRPC3 (37). However, the accumulation of channels at the cell 
surface can also occur by increased incorporation into the plasma membrane. Indeed, 
PKC potentiation of TRPV1 promotes the recruitment of a channel vesicular pool to the 
cell surface (31). This exocytosis process of TRPV1 is dependent on the soluble N-
ethylmaleimide-sensitive-factor attachment proteins receptor (SNARE) (31), known to 
act as membrane recognition molecules and acceptors for vesicle trafficking, docking 
and fusion (11). It would be interesting to investigate the role of similar scaffold in the 
assembly of TRPV5 and PKC upon TK treatment, considering that such signaling 
pathways are currently believed to function in spatially distinct microdomains (1). For 
instance, the A-kinase-anchoring protein, AKAP, has been described to coordinate the 
subcellular localization of second messenger-regulated enzymes, such as PKC in order 
to modulate the activity of K+ channel, KCNQ/M, upon agonist stimulation via Gq-
coupled pathway (23). 
The aforementioned data support that the plasma membrane cycling of TRPV5 
protein provides a mechanism for channel regulation. A tight control of TRPV5 activity is 
of primordial importance for body Ca2+ homeostasis, since TRPV5 constitutes the fine-
tuned Ca2+ entry step in transcellular Ca2+ transport (20). Besides the hormonal 
regulation of TRPV5, accessory proteins play a  role in modulating channel trafficking 
and activity (15, 38). Together with a recent report on the β-glucuronidase klotho (7), our 
study introduces a new mechanism of TRPV5 regulation which is based on extracellular 
enzymatic activation. TK and klotho co-localize with TRPV5 in the distal part of the 
nephron where they activate the channel from the luminal side. A comparable enzymatic 
regulation is described for the epithelial Na+ channel, ENaC, present in CNT, by the 
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channel activating proteases, CAP-1, CAP-2 and CAP-3 (34). However, what 
differentiates TK action on channel activity from the protease CAP and the 
glucuronidase klotho is that TK stimulates TRPV5 indirectly via the activation of B2R 
which then induces a redistribution of TRPV5 channels towards the plasma membrane. 
On the contrary, CAPs which are membrane-bound serine proteases, act directly on the 
channel’s gating by enhancing the open probability of ENaC (40) and stimulate therefore 
Na+ absorption in ENaC-expressing epithelia.   
 
 
 
Figure 7. Schematic diagram of TK stimulatory effect on TRPV5 channel. TK activates the B2R and 
subsequently PLC, leading to the hydrolysis of PIP2 in IP3 and DAG. DAG induces subsequently the 
phosphorylation of TRPV5 through PKC-dependent mechanism with consequent stabilization of TRPV5 
channel in the plasma membrane. The increased number of channels at the plasma membrane is the result 
of less channel retrieval ensuing enhanced Ca2+ transport through TRPV5. 
 
In conclusion, our data demonstrated that TK reduces Ca2+ excretion in the urine 
by an autocrine/paracrine stimulation of TRPV5-mediated Ca2+ transport explaining the 
hypercalciuria in TK-/- mice. Figure 7 summarizes the molecular pathway connecting TK 
to TRPV5 stimulation, as elucidated in the present study. TK sensitizes the B2R and 
through the PLC derived-messenger DAG activates the PKC phosphorylation sites S299 
and S654 of TRPV5. Subsequently, Ca2+ influx through TRPV5 is enhanced by the 
accumulation and stabilization of the channel at the plasma membrane. Thus, TK-
directed translocation of TRPV5 channels constitutes a mechanism by which cells can 
fine-tune Ca2+ reabsorption. 
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…Πάντα στον νου σου νάχεις την Ιθάκη.  
Το φθάσιμον εκεί είν' ο προορισμός σου.  
Αλλά μη βιάζεις το ταξίδι διόλου.  
Καλλίτερα χρόνια πολλά να διαρκέσει·  
και γέρος πια ν' αράξεις στο νησί,  
πλούσιος με όσα κέρδισες στον δρόμο, 
μη προσδοκώντας πλούτη να σε δώσει η Ιθάκη... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…Your mind should ever be on Ithaca. 
Your reaching there is your prime goal. 
But do not rush your journey anywise. 
Better that it should last for many years, 
and that, now old, you moor at Ithaca at last, 
a man enriched by all you gained upon the way, 
and not expecting Ithaca to give you further wealth... 
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ABSTRACT 
The epithelial Ca2+ channel TRPV5 facilitates Ca2+ entry during active Ca2+ reabsorption. 
In this process cytosolic Ca2+ remains at low non-toxic concentrations since the Ca2+ 
influx is rapidly buffered by calbindin-D28K. Subsequently, calbindin-D28K-bound Ca2+ is 
shuttled towards the basolateral Ca2+ extrusion systems. To address the in vivo role of 
TRPV5 and calbindin-D28K in the maintenance of the Ca2+ balance, single and double 
knock-out mice of TRPV5 and calbindin-D28K (TRPV5-/-, calbindin-D28K-/- and TRPV5-/-
/calbindin-D28K-/-) were generated. Mice were fed two Ca2+ diets (0.02 % and 2 % w/w) to 
investigate the influence of the dietary Ca2+ content on the Ca2+ balance. Urinary 
analysis indicated that TRPV5-/-/calbindin-D28K-/- mice exhibit on both diets hypercalciuria 
compared to wild-type mice. Ca2+ excretion in TRPV5-/-/calbindin-D28K-/- mice was not 
significantly different from TRPV5-/- mice, whereas calbindin-D28K-/- mice did not show 
hypercalciuria. The similarity between TRPV5-/-/calbindin-D28K-/- and TRPV5-/- mice was 
further supported by a comparable increase in intestinal 45Ca2+ absorption due to up-
regulation of calbindin-D9K and TRPV6 expression in duodenum. This enhanced 
expression was accompanied by elevated serum parathyroid hormone and 1,25-
dihydroxyvitamin D3 levels. Intestinal Ca2+ absorption, expression of calbindin-D9K and 
TRPV6, as well as serum parameters of the calbindin-D28K-/- mice did not differ from wild-
type mice. Furthermore, dietary Ca2+ restriction did not affect urinary Ca2+ excretion, 
whereas intestinal Ca2+ absorption and the expression of calbindin-D9K and TRPV6 was 
increased in all mouse strains. These results demonstrate that TRPV5, and not 
calbindin-D28K, constitutes the rate limiting step of active Ca2+ reabsorption in kidney. 
 
INTRODUCTION 
Ca2+ homeostasis is of crucial importance for many physiological functions including 
neuronal excitability, muscle contraction, blood clotting and bone mineralization. 
Therefore, the Ca2+ balance is tightly controlled through constant regulation of three 
physiological processes: intestinal absorption, renal reabsorption and exchange of Ca2+ 
from the bone mass (9, 22). Both in intestine and kidney Ca2+ enters the interstitium by 
passive paracellular as well as active (re)absorption (3, 29). Active Ca2+ (re)absorption is 
critical in this process since it constitutes the primary target for regulation by calciotropic 
hormones, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and parathyroid hormone 
(PTH), enabling the organism to regulate the extracellular Ca2+ concentration on the 
body’s demand (13).  
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Active absorption of dietary Ca2+ occurs primarily in the proximal small intestine, 
whereas renal active Ca2+ reabsorption is restricted to the distal convoluted tubule (DCT) 
and the connecting tubule (CNT) (5, 8). Ca2+ absorption occurs also in bone where it is 
crucial for bone formation to achieve adequate bone quality and strength, as well as for 
osteoclastic bone resorption (28). At the cellular level active Ca2+ (re)absorption implies 
entry of Ca2+ across the luminal membrane through the epithelial Ca2+ channels, followed 
by intracellular buffering and facilitated diffusion with Ca2+-binding proteins and finally 
extrusion across the basolateral membrane by a Na+/Ca2+ exchanger and/or a plasma 
membrane Ca2+ pump. Ca2+ influx occurs through two highly Ca2+-selective members of 
the transient receptor potential (TRP) cation channel family, TRPV5 and TRPV6, which 
constitute the gatekeepers of active Ca2+ (re)absorption in kidney and intestine, 
respectively (14, 20).  Interestingly, ablation of TRPV5 (TRPV5-/-) in mice impairs renal 
Ca2+ reabsorption resulting in robust hypercalciuria (15). As a consequence, TRPV5-/- 
mice develop compensatory dietary Ca2+ hyperabsorption in the intestine. Furthermore, 
the structure of the bones in these mice is significantly disturbed showing reduced 
trabecular and cortical bone thickness (19).  
Following influx through TRPV5 and TRPV6, Ca2+ binds to cytosolic proteins in 
order to diffuse towards the basolateral surface of the epithelial cell. Two Ca2+-binding 
proteins, calbindin-D28K and calbindin-D9K, are regarded as key components of Ca2+ 
(re)absorption (13). Calbindin-D28K is primarily expressed in kidney, whereas calbindin-
D9K is abundantly present in small intestine (6). The physiological importance of 
calbindin-D28K in renal Ca2+-transporting epithelia is underlined by the consistent co-
expression with TRPV5 and their co-regulation by calciotropic hormones including PTH, 
1,25(OH)2D3 and also dietary Ca2+ (11, 26).  
The aim of the present study was to investigate whether calbindin-D28K deficiency 
is critical for active reabsorption in the presence or absence of TRPV5. To this end, 
single and double knock-out mice of calbindin-D28K and TRPV5 (calbindin-D28K-/-, TRPV5-
/- and TRPV5-/-/calbindin-D28K-/-) were generated. All mice were phenotypically 
characterized including measurements of expression levels of Ca2+ transporter proteins 
at mRNA and protein level. 
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MATERIALS AND METHODS 
Animal experiments 
TRPV5-/- mice were generated as described previously (15). Calbindin-D28K-/- mice were 
kindly provided by Dr. Michael Meyer (Physiologisches Institut, Ludwig Maximilians 
Universität München, Munich, Germany) (1). Crossbreeding of TRPV5-/-/calbindin-D28K+/+ 
with TRPV5+/+/calbindin-D28K-/- mice resulted in offspring heterozygous for both TRPV5 
and calbindin-D28K (TRPV5+/-/calbindin-D28K+/-). This offspring was subsequently 
intercrossed to obtain TRPV5-/-/calbindin-D28K-/- mice. Genotypes were determined by 
polymerase chain reaction (PCR) analysis using specific primers for TRPV5 (as 
described previously (7, 15)) and for calbindin-D28K: two sense primers 5’-
TGCAGCGGCTAGTTTGAGAGTG-3’ to detect the wild-type allele and 5’-
TGACTAGGGGAGGAGTAGAAG-3’ to detect the null allele in addition to a common 
anti-sense primer 5’-GCAAGTAACTAATGGCATCG-3’. At the age of 4 weeks mice were 
fed ad libitum two diets containing either 0.02 % or 2 % (w/w) Ca2+ for 5 weeks and 
subsequently placed in metabolic cages (Techniplast, Buggiate, Italy), which enabled  
24-hour collection of urine. At the end of the experiment, blood samples were taken and 
the mice were sacrificed. Subsequently, kidney and duodenum were sampled. Urine and 
serum Ca2+ concentrations were analyzed using a colorimetric assay kit (Roche, 
Mannheim, Germany). Serum PTH was measured using an immunoradiometric assay 
(Immutopics Inc., San Clemente, CA, USA). Serum Vitamin D levels were determined  
by an [I125]1,25(OH)2D3 RIA assay (IDS Inc., Fountain Hills, AZ, USA). The animal ethics 
board of the Radboud University Nijmegen approved all animal experimental 
procedures. 
Real-time quantitative PCR analysis 
Renal and duodenal mRNA expression levels of calbindin-D28K, calbindin-D9K, TRPV5 
and TRPV6 were quantified by real-time quantitative PCR as described previously (21), 
using the ABI Prism 7700 Sequence Detection System (PE Biosystems, Rotkreuz, 
Switzerland). The expression level of the housekeeping gene hypoxanthine-guanine 
phosphoribosyl transferase (HPRT) was used as an endogenous control. 
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Immunoblotting 
Total kidney and duodenum lysates of all mice groups were prepared as described 
previously (21). Briefly, protein concentrations of the homogenates were determined by  
the Bio-Rad protein assay (Bio-Rad, München, Germany) and 10 μg of each sample was 
loaded on 12 % or 16.5 % (wt/v) sodium dodecyl sulfate-polyacrylamide electrophoresis 
(SDS-PAGE) gels and blotted to PDVF-nitrocellulose membranes (Immobilon-P, 
Millipore Corporation, Bedford, MA). Blots were incubated with a rabbit anti-calbindin-
D28K polyclonal antibody (1:10,000; Sigma, St Louis, MO, USA), a rabbit anti-calbindin-
D9K polyclonal antibody (1:5,000; Swant, Bellinzona, Switzerland) or a rabbit β-actin 
polyclonal antibody (1:20,000; Sigma, St Louis, MO, USA) at 4°C for 16 hours. 
Subsequently, blots were incubated with a goat anti-rabbit peroxidase-labeled secondary 
antibody (1:10,000; Sigma, St Louis, MO, USA). Immunoreactive protein was detected 
by the chemiluminescence method (Pierce, Rockford, IL, USA). The immunopositive 
protein bands were scanned and the pixel density was determined by using the 
Molecular Analyst Software of BioRad Laboratories (Hercules, CA, USA). 
In vivo 45Ca2+ absorption assay  
Ca2+ absorption was assessed by measuring serum 45Ca2+ at early time points after oral 
gavage as described previously (15). Briefly, mice were fasted 12 hours before the test 
and a 45Ca2+ solution was administrated by oral gavage. Blood samples were obtained at 
indicated time intervals and serum (10 μl) was analyzed by liquid scintillation counting. 
Differences in serum Ca2+ concentration were calculated from the 45Ca2+ content in the 
samples and the specific activity of the administrated Ca2+.  
 
Statistical analyses 
Values are expressed as means ± SEM. Statistical significance (p<0.05) between 
groups was determined by analysis of variance (ANOVA) followed by pair-wise 
comparisons using the method of least significant difference. All analyses were 
performed using the SPSS software (SPSS Inc, Chicago, Illinois, USA). 
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RESULTS 
Serum parameters 
Wild-type, TRPV5-/-, calbindin-D28K-/- and TRPV5-/-/calbindin-D28K-/- mice of 4 weeks old 
were fed a diet containing 0.02 % or 2 % (w/w) Ca2+ for 5 weeks. All mouse strains were 
fertile and had similar average litter sizes (Table 1). Furthermore, serum analysis 
showed that TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice on 0.02 % (w/w) Ca2+ diet 
exhibit increased PTH and 1,25(OH)2D3 levels compared to wild-type mice. In contrast, 
serum PTH and 1,25(OH)2D3 levels in calbindin-D28K-/- mice were not significantly 
different from wild-type mice. The increased PTH and 1,25(OH)2D3 levels were 
normalized in TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice fed the high Ca2+ diet. Serum 
Ca2+ levels were not altered between the mice genotypes, regardless of the dietary 
treatment (Table 1).  
 
Table 1. Physiological parameters of TRPV5 and calbindin-D28K single and double knock-out mice on 
0.02 % or 2 % (w/w) Ca2+ diet. 
aP<0.05 versus wild-type of the same diet; bP<0.05 versus 0.02 % (w/w) Ca2+ diet of the same mice group. 
cP<0.05 versus TRPV5-/- on 0.02 % Ca2+ diet. 
 
mRNA expression of epithelial Ca2+ transporters 
To evaluate the putative regulation of Ca2+ transporters mRNA expression levels in 
kidney and duodenum, the quantitative real-time PCR assay was applied. In kidney, 
calbindin-D9K mRNA expression levels were increased in TRPV5-/- and TRPV5-/-
/calbindin-D28K-/- mice fed the 0.02 % w/w Ca2+ diet compared to wild-type mice. 
Furthermore, renal calbindin-D9K expression was similar in calbindin-D28K-/- compared to 
 wild-type TRPV5-/- calbindin-D28K-/- 
TRPV5-/-/  
calbindin-D28K-/- 
Ca2+ diet (w/w) 0.02 % 2 % 0.02 % 2 % 0.02 % 2 % 0.02 % 2 % 
body weight (g) 
25.6 ± 
1.4 
26.1 ± 
1.4 
25.5 ± 
1.7 
25.5 ± 
1.4 
23.2 ± 
1.7 
22.3 ± 
1.9 
23.6 ± 
0.9 
24.7 ± 
1.4 
Serum Ca2+ 
(mM) 2.0 ± 0.1 
2.0 ± 
0.1 
2.0 ± 
0.2 
2.1 ± 
0.1 
2.0 ± 0 1.9 ± 0 
2.0 ± 
0.1 
2.2 ± 
0.1 
PTH (pg/ml) 
25.3 ± 
6.7 
6.4 ± 
2.9 
182.1 ± 
75.7a 
2.6 ± 
1.4b 
47.9 ± 
33.4 
6.5 ± 
4.2 
114.6 ± 
43.7a 
2.4 ± 
1.7b 
1,25(OH)2D3 
(pmol/l) 561 ± 94 
139 ± 
26 
1302 ± 
207a 
283 ± 
74b 
595 ± 
86 
155 ± 
33 
2190 ± 
192ac 
659 ± 
160b 
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wild-type mice. Exposure of the mice to the high Ca2+ diet resulted in down-regulation of 
renal calbindin-D9K mRNA in TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice (figure 1A). On 
the other hand, dietary Ca2+ content did not affect renal expression of calbindin-D28K 
mRNA which was less in TRPV5-/- than wild-type mice (figure 1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Renal mRNA expression of Ca2+ reabsorption proteins. Expression of calbindin-D9K (A) and 
calbindin-D28K (B) mRNA in kidney of wild-type, TRPV5-/-, calbindin-D28-/- and TRPV5-/-/Calbindin-D28K-/- mice 
(n=10), was analyzed by quantitative real-time PCR analysis. Mice were fed with a 0.02 % (w/w) (closed 
bars) or 2 % (w/w) (open bars) Ca2+ diet. Values are calculated as a ratio to HPRT expression in relative 
percentages to the wild-type mice on 0.02 % (w/w) Ca2+ diet. Data are presented as means ± SEM. *P<0.05 
versus wild-type on the same diet. #P<0.05 versus the same group on 0.02 % (w/w) Ca2+ diet. 
 
In duodenum, TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice fed with the 0.02 % (w/w) 
Ca2+ diet demonstrated an up-regulation in calbindin-D9K and TRPV6 mRNA expression 
in comparison to wild-type mice. On the same Ca2+ diet, calbindin-D9K and TRPV6 
expression remained unchanged in calbindin-D28K-/- compared to wild-type mice. 
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Interestingly, the high Ca2+ diet reduced intestinal calbindin-D9K and TRPV6 mRNA 
expression in all mouse strains (figure 2A, B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Duodenal mRNA expression of Ca2+ reabsorption proteins. Expression of calbindin-D9K (A) 
and TRPV6 (B) mRNA in duodenum of wild-type, TRPV5-/-, calbindin-D28-/- and TRPV5-/-/ calbindin-D28K-/- 
mice (n=10), was assessed by quantitative real-time PCR analysis. Mice were fed with a 0.02 % (w/w) 
(closed bars) or 2 % (w/w) (open bars) Ca2+ diet. Values are calculated as a ratio to HPRT expression in 
relative percentages to the wild-type mice on 0.02 % (w/w) Ca2+ diet.  Data are presented as means ± SEM. 
*P<0.05 versus wild-type on the same diet. #P<0.05 versus the same group on 0.02 % (w/w) Ca2+ diet. 
Protein expression of epithelial Ca2+ transporters 
To validate whether the changes in renal and duodenal mRNA levels Ca2+ transporters 
resulted in altered protein expression, the protein abundance of the Ca2+ transporters 
was semi-quantified by immunoblot analysis. In kidney, calbindin-D9K protein expression 
was increased in TRPV5-/- mice fed the 0.02 % (w/w) Ca2+ diet compared to wild-type 
mice. On the same diet, calbindin-D28K-/- and TRPV5-/-/calbindin-D28K-/- mice expressed 
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wild-type levels of calbindin-D9K protein in kidney. However, an increase in the dietary 
Ca2+ concentration from 0.02 % to 2 % (w/w) resulted in down-regulation of renal 
calbindin-D9K in TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice (figure 3A, B). Furthermore, 
renal calbindin-D28K protein abundance was significantly decreased in TRPV5-/- mice in 
accordance with the reduction of mRNA levels. Variations in dietary Ca2+ did not affect 
renal calbindin-D28K protein expression in both wild-type and TRPV5-/- mice (Figure 3C, 
D).  
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Figure 3. Renal protein expression of Ca2+ reabsorption proteins. Immunoblot of total kidney 
homogenates from wild-type, TRPV5-/-, calbindin-D28K-/- and TRPV5-/-/calbindin-D28K-/- mice (n=6) in a 0.02 % 
(w/w) and a 2 % (w/w) Ca2+ diet probed with anti-calbindin-D9K antibody (A) or anti-calbindin-D28K antibody 
(C). Intensity of the 9 kDa or 28 kDa immunopositive band was quantified by densitometry and presented as 
a ratio to β-actin expression in relative percentages to wild-type mice fed with a 0.02 % (w/w) diet for 
calbindin-D9K (B) or calbindin-D28K (D) respectively. Mice were fed with a 0.02 % (w/w) (closed bars) or 2 % 
(w/w) (open bars) (w/w) Ca2+ diet. Data are presented as means ± SEM. *P<0.05 versus wild-type on the 
same diet. #P<0.05 versus the same group on 0.02 % (w/w) Ca2+ diet. 
 
In duodenum, calbindin-D9K protein expression was increased in TRPV5-/- and TRPV5-/-
/calbindin-D28K-/- mice compared to wild-type and calbindin-D28K-/- in line with measured 
mRNA expression levels. Finally, dietary Ca2+ restriction resulted in a significant increase 
of duodenal calbindin-D9K protein in TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice, which 
was consistent with the calbindin-D9K mRNA expression data (Figure 4A, B). 
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Figure 4. Duodenal protein expression of Ca2+ reabsorption proteins. Immunoblot of duodenum 
homogenates from wild-type, TRPV5-/-, calbindin-D28K-/- and TRPV5-/-/calbindin-D28K-/- mice (n=6) on a 0.02 
% (w/w) and a 2 % (w/w) Ca2+ diet probed with anti- calbindin-D9K antibody (A). Intensity of the 9 kDa 
immunopositive band was quantified by densitometry and presented as a ratio to β-actin expression in 
relative percentages to wild-type mice fed with a 0.02 % (w/w) Ca2+ diet (B). Mice were fed with a 0.02 % 
(w/w) (closed bars) or 2 % (w/w) (open bars) Ca2+ diet. Data are presented as means ± SEM. *P<0.05 
versus wild-type on the same diet. #P<0.05 versus the same group on 0.02 % (w/w) Ca2+ diet. 
 
Functional analysis of Ca2+ (re)absorption 
The various mouse strains were functionally characterized by measuring their urinary 
Ca2+ excretion and intestinal Ca2+ absorption. On both Ca2+ diets, urinary Ca2+ excretion 
was increased in TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice compared to wild-type 
mice. On the other hand, Ca2+ excretion was not significantly different in calbindin-D28K-/- 
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compared to wild-type mice. Dietary Ca2+ restriction did not affect the amount of Ca2+ 
excreted in the urine (figure 5A). Subsequently, intestinal Ca2+ absorption was 
investigated by measuring serum 45Ca2+ at early time points after oral gavage. On the 
0.02 % (w/w) Ca2+ diet the time curves of 45Ca2+ absorption did not differ between the 
four mouse strains (figure 5B). On the 2 % (w/w) Ca2+ diet intestinal 45Ca2+ absorption 
was reduced in all groups compared to mice exposed to the low Ca2+ diet. However, the 
amount of 45Ca2+ absorption remained significantly higher in TRPV5-/- and TRPV5-/-
/calbindin-D28K-/- mice compared to wild-type and calbindin-D28K-/- mice (figure 5C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Renal and intestinal phenotypic characterization of single and double knock-out mice for 
TRPV5 and calbindin-D28K. 24-hour urinary Ca2+ excretion in wild-type, TRPV5-/-, calbindin-D28K-/- and 
TRPV5-/-/calbindin-D28K-/- mice (n=10) fed with a 0.02 % (closed bars) or 2 % (open bars) (w/w) Ca2+ diet (A). 
Changes in serum Ca2+ (ΔμM) within 10 minutes of 45Ca2+ administration by oral gavage in wild-type (closed 
diamond), TRPV5-/- (open square), calbindin-D28K-/- (closed triangle) and TRPV5-/-/calbindin-D28K-/- (open 
circle) mice (n=6) fed with a 0.02 % (B) or 2 % (C) (w/w) Ca2+ diet. Data are presented as means SEM. 
*P<0.05 versus wild-type of the same diet.  
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DISCUSSION 
The present study demonstrated that TRPV5 but not calbindin-D28K constitutes the 
critical component in active Ca2+ reabsorption. This conclusion is based on the following 
experimental data. First, TRPV5-/- and TRPV5-/-/calbindin-D28K-/- mice showed a 
comparable hypercalciuria and compensatory Ca2+ hyperabsorption in comparison to 
wild-type mice. Second, the expression of calbindin-D9K in kidney as well as calbindin-
D9K and TRPV6 in duodenum increased equally in TRPV5-/-/calbindin-D28K-/- and TRPV5-/- 
mice compared to wild-type mice. Third, up-regulation of calbindin-D9K and TRPV6 in 
TRPV5-/-/calbindin-D28K-/- and TRPV5-/- mice was accompanied by an analogous increase 
in serum PTH and 1,25(OH)2D3 levels. Fourth, urinary Ca2+ excretion, intestinal Ca2+ 
absorption, expression levels of epithelial Ca2+ transporters and serum parameters in 
calbindin-D28K-/- mice were comparable to wild-type mice. Fifth, dietary Ca2+ restriction 
did not influence the calciuria in any mouse strain, while it enhanced intestinal Ca2+ 
absorption in TRPV5-/-/calbindin-D28K-/- and TRPV5-/- mice. The observed 
hyperabsorption was awaited given the up-regulation in duodenal calbindin-D9K and 
TRPV6 expression. 
 Calbindin-D28K contains six high affinity binding sites for Ca2+ and is 
predominantly present in kidney, intestine (birds only), pancreas, placenta, bone and 
brain (6, 13). In these tissues, calbindin-D28K is widely regarded as a key component in 
cellular Ca2+ handling by acting as a cytosolic Ca2+ buffer to protect cells against large 
fluctuations in the intracellular Ca2+ concentration (10), as well as a shuttle facilitating 
Ca2+ diffusion from the luminal to the basolateral surface (13). In mouse kidney, 
calbindin-D28K co-localizes with TRPV5, which constitutes the apical Ca2+ entry 
mechanism in DCT and CNT (13, 16). Taking into account that calbindin-D28K expression 
is regulated by calciotropic hormones in a similar way than TRPV5 (12, 13), both 
proteins could be functionally linked in the process of active Ca2+ reabsorption. Indeed, 
TRPV5-/- mice displayed a profound renal Ca2+ wasting combined with significant 
reduction of renal calbindin-D28K expression levels. This suggested that the impaired 
TRPV5-mediated Ca2+ influx suppresses the expression of calbindin-D28K. Our previous 
experiments in primary cultures of rabbit DCT/CNT cells demonstrated that blockade of 
TRPV5-mediated Ca2+ influx by ruthenium red down-regulates calbindin-D28K expression, 
indicating that regulation of the latter protein is highly dependent on the magnitude of the 
Ca2+ influx through TRPV5 (26). Previous reports have indicated that Ca2+ is important 
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for gene transcription. A Ca2+-responsive element was identified in the promoter 
sequence of calbindin-D28K that partly underlies the Purkinje cell-specific expression of 
calbindin-D28K (2). However, it is not known whether this element is active in kidney or 
whether additional intracellular signaling molecules are involved. Together, these 
findings underline the TRPV5-coordinated expression of calbindin-D28K. 
 In contrast to TRPV5-/- mice that displayed a significant hypercalciuria, calbindin-
D28K-/- mice had normal Ca2+ excretion values. In line with our data are two previous 
studies showing that genetic ablation of calbindin-D28K does not modulate Ca2+ excretion 
in mice fed a 1% (30) or 0.02 % (w/w) Ca2+ diet (17, 24). However, this was not observed 
by Sooy et al. and Lee et al. who fed calbindin-D28K-/- mice a 1% Ca2+ diet showing a two 
to three-fold increase in the urinary Ca2+ excretion compared to wild-type controls (17, 
24). In addition, Ca2+ excretion in TRPV5-/- mice was ten-fold higher than in wild-type 
mice and thus three to five times more severe compared to calbindin-D28K-/- mice. We 
showed that the renal Ca2+ leak in TRPV5-/- mice does not aggravate in the TRPV5-/-
/calbindin-D28K-/- mice. These findings suggest that TRPV5 determines the Ca2+ 
reabsorption in DCT/CNT.  
Although the aforementioned studies demonstrate increased Ca2+ excretion in 
calbindin-D28K-/- mice, no significant differences were observed in serum Ca2+, PTH, and 
1,25(OH)2D3  levels compared to wild-type mice (24). A compensatory intestinal Ca2+ 
hyperabsorption or increased high bone turnover could occur in these mice. In contrast, 
we found similar intestinal 45Ca2+ absorption rates, as well as intestinal TRPV6 and 
calbindin-D9K expression in calbindin-D28K-/- and wild-type mice. Previous studies by Sooy 
et al. (24) and Zheng et al. (30) are in line with our data on intestinal calbindin-D9K 
expression. Zheng and co-workers demonstrated a modest decrease in bone mineral 
density in calbindin-D28K-/- mice (30). In addition, detailed structural analysis of teeth and 
bones showed that mineralization was unaffected in calbindin-D28K-/- mice (24). 
Consequently, neither a disturbed Ca2+ absorption nor an abnormal bone phenotype can 
account for the excess of urinary Ca2+ observed in their calbindin-D28K-/- mice. These 
observations suggest that calbindin-D28K deficiency might be compensated by other Ca2+ 
binding proteins possibly calbindin-D9K. In mice, the specific co-expression of calbindin-
D9K and calbindin-D28K in DCT cells (11) hint to a comparable function in Ca2+ 
reabsorption. Therefore, calbindin-D9K could play a compensatory role in calbindin-D28K-/- 
mice explaining the absence of renal Ca2+ wasting.  
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In the present study, we observed that the expression of renal and duodenal Ca2+ 
transporters is regulated by the dietary Ca2+ content. However, it is difficult to study the 
effects of dietary Ca2+ itself, without affecting serum PTH and 1,25(OH)2D3 levels. Indeed, 
dietary Ca2+ restriction was accompanied by a compensatory increase in serum PTH and 
1,25(OH)2D3 levels. This increase could explain the enhanced renal and duodenal 
calbindin-D9K expression in mice on the 0.02 % (w/w) diet. Apparently, dietary Ca2+ 
regulates renal and duodenal calbindin-D9K both in a vitamin D-dependent and -
independent manner. Likewise, in vitamin D receptor knock-out (VDR-/-) mice renal 
calbindin-D9K expression was significantly reduced without an obvious response to 
dietary Ca2+ alteration (18, 27). Intestinal TRPV6 and calbindin-D9K expression was 
suppressed by a rescue diet, suggesting the presence of both vitamin D-dependent and 
Ca2+-dependent/vitamin D-independent regulation of active Ca2+ reabsorption (4, 23, 25). 
Interestingly, our previous studies also demonstrated that a reduction in the expression 
of Ca2+ transport proteins can be normalized by a high Ca2+ diet in 1α-OHase knock-out 
mice (11).  
In conclusion, the expression of calbindin-D28K depends on the presence of 
TRPV5. However, calbindin-D28K-/- mice in contrary to TRPV5-/- mice display wild-type 
serum parameters, intestinal Ca2+ absorption and renal Ca2+ excretion. Moreover, as the 
additional knock-out of calbindin-D28K in TRPV5-/- mice does not aggravate the TRPV5-/-
phenotype, TRPV5 can be characterized as the principal gatekeeper of active Ca2+ 
reabsorption. 
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…Η Ιθάκη σ' έδωσε το ωραίο ταξίδι.  
Χωρίς αυτήν δεν θάβγαινες στον δρόμο.  
Άλλο δεν έχει να σε δώσει πια… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…For Ithaca has given you the lovely trip. 
Without her you would not have set your course. 
There is no more that she can give... 
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INTRODUCTION 
Many physiological functions rely on the exact maintenance of body Ca2+ balance. 
Therefore, the extracellular Ca2+ concentration is kept under strict control by the 
concerted action of intestine, bone and kidney. Ca2+ can pass through renal epithelial 
tissues and then, reach the blood compartment via two pathways. The major one is by 
passive paracellular transport together with Na+ in the proximal tubules and the second 
is by active transcellular Ca2+ transport in the distal convoluted (DCT) and connecting 
tubular (CNT) cells which are unique in their ability to mediate active reabsorption of 
Ca2+. Even though the distal part of the nephron realizes only ~15 % of total renal Ca2+ 
reabsorption, it is generally regarded as the site for fine-tuning of the urinary Ca2+ 
excretion. Active Ca2+ reabsorption allows the body to regulate Ca2+ reabsorption 
independently of the Na+ balance and thus the organism can respond immediately to 
dietary fluctuations in nutritional Ca2+, while it can also adapt to the body’s demand 
during processes as growth, pregnancy, lactation and aging (37). This transport is 
mediated by Ca2+ entry across the apical membrane through the specialized epithelial 
Ca2+ channel, transient receptor potential vanilloid 5 (TRPV5), intracellular buffering of 
Ca2+ and facilitated diffusion of Ca2+ bound to Ca2+-binding proteins (calbindins) and 
finally Ca2+ extrusion across the basolateral membrane by a Na+/Ca2+ exchanger (NCX1) 
and a plasma membrane Ca2+-ATPase (PMCA1b). In this process, the physiological role 
of TRPV5 has been substantiated by several mouse models of Ca2+-related disorders 
(16, 35, 39). Therefore, a tight regulation of TRPV5 is of particular importance since it 
determines active Ca2+ reabsorption and affects consequently Ca2+ homeostasis. In this 
respect, the hormonal regulation of TRPV5 was extensively studied and established that 
the activation of TRPV5 transcription/translation by parathyroid hormone (PTH), 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3), dietary Ca2+ and 17β-estradiol enhances active Ca2+ 
reabsorption (35, 66, 75, 76). However, channel regulation is not governed only by the 
long-term action of hormones on the abundance of the channel protein, but also by 
short-term regulation via partner proteins in order to control its activity (23). A number of 
auxiliary proteins was recently identified as critical components modulating the activity of 
other channels such as, the Epithelial Na+ Channel (ENaC) (27), the K+ channel K2P 
(64) and the canonical channels of the TRP superfamily (44). The characterization of 
these channel accessory proteins provided insights in important molecular pathways 
modulating ion transport processes. This thesis describes the identification and the 
characterization of four TRPV5 regulatory proteins. 80K-H (chapter 3), FK506-binding 
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protein (FKBP) 52 (chapter 4) and calbindin-D28K (chapter 6) were identified by 
microarrays (chapter 2) while tissue kallikrein (TK) (chapter 5) was selected on 
previously published data. In this final chapter, the individual research projects will be 
discussed and summarized.   
 
IDENTIFICATION OF NOVEL REGULATORY PROTEINS  
Technical approach 
The microarray technique used in chapter 2 constitutes a novel strategy to identify 
regulatory partner proteins for an ion channel. The strategies classically employed for 
this purpose rely on the screening of protein-protein interactions. For instance, van de 
Graaf et al. applied the yeast two-hybrid (Y2H) approach and isolated novel TRPV5 
channel-associated proteins from a pool of kidney proteins (19, 61, 78, 79, 81). The 
disadvantage of the Y2H assay is the large number of false-positive and false-negatives 
generated (42, 56). Further binding studies by pull-down and co-immunoprecipitation 
assays may circumvent the problem of false-positives, nevertheless different 
methodological approaches should be used to detect putative interactions. Over the last 
years, several additional methodologies have been developed to map protein-protein 
interactions including the protein fragment complementation, the tandem affinity 
purification and the protein arrays (20, 63). All these approaches belong to the so called 
proteomic era that constitutes an emerging research field. However, large-scale specific 
protein measurements remain more expensive and complicated than cDNAs. In this 
respect, cDNA microarrays is the most commonly used high-throughput method to 
measure gene expression profiles since the transcriptome in contrast to the proteome, is 
subject to regulatory processes. Here, the cDNA microarray approach was chosen for its 
advantage over the proteomic techniques of detecting a wider range of partner 
candidates since it is not based on protein-protein interaction but in gene regulation. 
More in detail, the microarray technique described in chapter 2 was based on a previous 
study demonstrating that gene expression of proteins involved in the TRPV5-mediated 
Ca2+ reabsorption was up-regulated by both 1,25(OH)2D3 and dietary Ca2+ content (35) 
(Figure 1). Our hypothesis was therefore that genes showing similar regulation by 
1,25(OH)2D3 and dietary Ca2+ content might be involved in active Ca2+ reabsorption. 
Indeed, the microarray assay pointed to eighteen candidates, including known Ca2+ 
transport proteins such as calbindin-D28K, calmodulin and NCX1, as well as potential 
regulatory proteins previously not linked to Ca2+ transport.  
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Figure 1. Cellular model depicting the transcriptional regulation of the active Ca2+ reabsorption in 
DCT cells by vitamin D3 (1,25(OH)2D3) and dietary Ca2+: 1,25(OH)2D3 and dietary Ca2+ content up-
regulate the gene transcription and consequently the expression of the proteins participating in active Ca2+ 
reabsorption, including TRPV5, TRPV6, calbindin-D28K, calbindin-D9K, NCX1 and PMCA1b, which implies 
that these proteins belong to the same functional group. 
 
Selection of candidates 
Of the eighteen candidates four proteins were selected on their molecular features and 
tissue localization known from the literature: the G-protein-coupled Receptor Kinase 
(GRK) 5, the 80K-H protein, the FKBP52 protein and the calbindin-D28K protein. These 
four proteins were either already related to channel regulation (GRK5) or Ca2+ 
homeostasis (calbindin-D28K), or their molecular characteristics suggested such an 
involvement (FKBP52, 80K-H). GRK5 is a serine/threonine kinase implicated in receptor 
desensitization and its function is inhibited by the Ca2+-sensor calmodulin (69), which is 
well-known to play a central role in channel inactivation (9). Calbindin-D28K was 
previously suggested to facilitate cytosolic Ca2+ diffusion in active Ca2+ reabsorption (45). 
FKBP52 was not directly correlated to Ca2+ homeostasis, but it is a substrate for the 
immunosuppressive drug FK506, which was previously associated to increased urinary 
Ca2+ excretion and intratubular calcification (1). 80K-H has not been implicated in Ca2+-
related processes, however its molecular structure predicted two EF-hand domains (5). 
Established ion channel regulators, such as calmodulin and calbindin-D28K contain EF-
hand structures which allow them to sense and buffer Ca2+ (6). Further selection among 
these candidates was achieved by analysis of their localization in kidney sections. Given 
that 80K-H, FKBP52 and calbindin-D28K co-localized with TRPV5 (Figure 2), we 
proceeded with the detailed characterization as putative regulatory proteins of TRPV5. 
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Figure 2. Validation of candidate proteins by immunohistochemical analysis in the kidney: Kidneys 
sections were co-stained with antibodies against each candidate protein, GRK5, 80K-H, FKBP52 and 
calbindin-D28K (red), and TRPV5 (green). Co-localization of 80K-H, FKBP52 and calbindin-D28K with TRPV5 
in DCT/CNT is depicted in yellow in the merged panels.  
 
MODULATION OF TRPV5 ACTIVITY BY ACCESSORY PROTEINS 
80K-H 
80K-H was initially identified as a protein kinase C (PKC) substrate and subsequently 
implicated in intracellular signaling (33). However, its biological function is poorly 
understood and there were no previous indications for a role in Ca2+ homeostasis or ion 
channel regulation. 80K-H was identified in the microarray assay described in chapter 2 
TRPV5FKBP52 merge
TRPV5
TRPV580K-H
GRK5
merge
merge
TRPV5Calbindin-D28K merge
General Discussion 
 135
and was selected because it contains two putative Ca2+-binding domains commonly 
found in regulatory proteins of Ca2+ channels. Following the demonstration of 80K-H co-
localization with TRPV5 in renal epithelia, 80K-H was characterized in chapter 3 as Ca2+-
dependent regulator of TRPV5 channel activity. 80K-H is an ~80 kDa cytosolic protein 
and its sequence analysis predicted several potential threonine and tyrosine 
phosphorylation sites, two EF-hand domains, a highly acidic domain and a potential 
endoplasmic reticulum (ER) targeting sequence (5). The overall structure of 80K-H 
suggests two potential Ca2+ interacting motifs including a pair of EF-hand motifs and an 
acidic stretch of glutamates. In this study, we demonstrated that 80K-H binds Ca2+ with 
the EF-hand pair, while the highly negatively charged poly-glutamate stretch did not 
account for Ca2+ binding. This new Ca2+-binding feature of 80K-H explains its function in 
TRPV5 regulation since inactivation of the EF-hand pair reduced the TRPV5-mediated 
Ca2+ current. In addition, TRPV5 is subject to Ca2+-dependent feedback inhibition. 
Elevation of Ca2+ influx through the channel increases [Ca2+]i in a microdomain near the 
pore which reduces the TRPV5 current amplitude (59, 83). Interestingly, the EF-hand 
mutation increased the TRPV5 sensitivity to intracellular Ca2+ with consequent 
acceleration of the channel’s feedback inhibition. 80K-H would thus act as a Ca2+ sensor 
facilitating the Ca2+ influx through TRPV5. This latter statement was substantiated by 
showing that 80K-H formed a heteromeric complex with TRPV5 along the plasma 
membrane. The sequence within the TRPV5 protein corresponding to the binding site of 
80K-H was restricted to the short region between the positions 598 and 608 of the 
TRPV5 carboxyl-terminal tail. Remarkably, three additional proteins bind to this region of 
TRPV5, namely S100A10 (79), Rab11a (78) and NHERF4 (80), suggesting a critical role 
of this domain in the channel regulation. The occupancy of this site would thus imply 
binding competition among multiple associated proteins depending on their relative 
concentrations and affinities. Consequently, 80K-H constitutes one component of a 
complex protein network regulating TRPV5 activity through binding to this important 
regulatory site in the carboxyl-terminal tail. Besides 80K-H role as a Ca2+ channel 
regulator in kidney, it should be noted that 80K-H is widely expressed and therefore 
implicated in diverse biological processes, ranging from vesicular transport and ER 
quality control to receptor signaling and cyst formation (5, 18, 52, 74). This would mean 
that 80K-H presents different functions depending on the tissue. For instance, in muscle 
and adipose tissues, 80K-H increases glucose transport by targeting GLUT4 to the 
plasma membrane upon insulin stimulation (34). In epithelial breast tissue, 80K-H is 
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over-expressed during carcinogenesis and in liver, 80K-H mutation is linked with 
autosomal dominant polycystic liver disease (ADPLD) (18, 51). It should be noted that 
ADPLD is distinct from the autosomal dominant polycystic kidney disease (ADPKD), 
which is genetically linked to the polycystic kidney disease (PKD)1 or PKD2 loci (85). 
Indeed, patients presenting both liver and renal cyst formation had no mutation of 80K-H 
gene (17). However, PKD1 and PKD2 encode for the Ca2+ channels TRPP1 and TRPP2 
which belong together with TRPV5 to the TRP channel superfamily. Therefore, the 
regulation of TRPP1 and TRPP2 by 80K-H and its involvement in renal cyst formation 
cannot be excluded and remains to be investigated. Noteworthy, all truncation mutants 
in 80K-H leading to the ADPLD lack the highly conserved terminal four amino acid motif 
HDEL. The HDEL motif is essential in 80K-H function since in chapter 3 we showed that 
deletion of the HDEL motif resulted in an increased TRPV5 channel open probability.  
 
FKBP52 
FKBP52 is a ubiquitous cytosolic enzyme which belongs to the FKBP subfamily of 
immunophilin proteins (29, 43, 67). FKBPs are characterized by their peptidyl-prolyl cis-
trans isomerase (PPIase), as well as by their strong affinity to the immunosuppressive 
drug FK506 (43). The PPIase has a chaperoning activity that often constitutes a rate-
limiting step in protein folding and can be inhibited by FK506 (43). Here, FKBP52 was 
one of the candidates identified in the microarray assay of chapter 2 and was selected 
for the reason that it binds the FK506 drug, known to cause hypercalciuria. Since 
FKBP52 co-localized with TRPV5, it was characterized in chapter 4 (25). To investigate 
the putative role of FKBP52 in TRPV5 regulation a small-interference (si)RNA approach 
was developed. The knock-down of FKBP52 gene expression resulted in an enhanced 
TRPV5-mediated Ca2+ influx suggesting an inhibitory role for FKBP52 on TRPV5 activity. 
Consistent with our findings on the FKBP52 inhibitory role in TRPV5 Ca2+ influx, is a 
previous study that identified the FKBP52 Drosophila homologue, FKBP59, as a 
physiological regulator of TRPL channel activity (26). In addition, we demonstrated that 
ablation of the FKBP52 PPIase activity either by FK506 administration or by mutation of 
the FKBP52 catalytic site resulted in the inhibition of TRPV5 channel. It is possible that 
FKBP52 affects TRPV5 activity by targeting the channel to the cell surface. FKBP52 co-
localizes with microtubules of the cytoskeleton and binds to cytoplasmic dynein (15, 70), 
a motor protein responsible for movement of vesicles along microtubules. Association of 
dynein to FKBP52 depends on the PPIase domain and defines the trafficking of steroid 
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receptors to the nucleus (22, 70). Similarly, FKBP52 would participate in the TRPV5 
plasma membrane localization through its PPIase activity by binding to microtubules 
cytoskeleton. In this respect, a recent report has demonstrated association of TRPV1 
channel to the microtubule cytoskeleton, while TRPV1 activation results in the de-
polymerization of microtubules affecting pain transmission (28). On the physiological 
level, co-localization of FKBP52 with TRPV5 in kidney and functional studies with FK506 
in DCT/CNT primary cells substantiated the relevance of this process. Our results in 
DCT/CNT primary cells implied that submicromolar concentrations (10 nM) of FK506 
stimulate active Ca2+ reabsorption while higher concentrations were toxic for the cells. 
This dose-dependent effect could explain the nephrotoxicity observed in patients treated 
with the immunosuppressive drug FK506 (2, 4). FK506-induced nephrotoxicity includes 
intratubular calcification and tubular basophilia as shown in rats (1). In addition, FK506 
treatment of rats following 28 days resulted in increased bone turnover with net 
resorption (14). Since our results demonstrated that FK506 enhances TRPV5 activity, 
and taking into account that TRPV5 is essential in bone turnover (82), FK506 would 
enhance osteoclastic bone resorption by increasing TRPV5-mediated active Ca2+ 
transport. However, FK506 administration results also in hypercalciuria (57). It should be 
noted here that the doses and time of treatment can not be compared between the 
experiments performed in the DCT/CNT primary cells and in rats since the range is 
different. The molecular mechanism proposed for this reduced Ca2+ reabsorption is that 
FK506 acts through the down-regulation of calbindin-D28K (1) and TRPV5 (57) 
expression. A hypothesis for the different effect of FK506 in bone and kidney could be 
that the high Ca2+ influx induced primarily by FK506, leads to a secondary down-
regulation of the proteins mediating TRPV5 Ca2+ reabsorption. Indeed, it is known that 
increased Ca2+ concentration besides the feedback inhibition on TRPV5 activity, can 
also regulate transcription of TRPV5 (37). Certainly, given the complexity of the in vivo 
situation, the FK506-induced hypercalciuria awaits further investigation particularly 
concerning the putative role of other FKBP proteins. 
 
Tissue kallikrein 
The serine protease TK was investigated as a putative regulatory protein of TRPV5 due 
to its striking co-localization with TRPV5 (39) and mostly because of the hypercalciura 
observed in TK knock-out (TK-/-) mice (62). Chapter 5 delineated the molecular 
mechanism of the renal Ca2+ wasting in TK-/- mice. TK activated active Ca2+ reabsorption 
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in DCT/CNT primary cultures. The stimulatory effect of TK was mimicked by bradykinin 
(BK) and could be blocked by administration of the BK 2 receptor (B2R) antagonist 
peptide JE049. These results indicated that TK action is mediated by the B2R. The 
molecular action of TK frequently involves B2R, since this serine protease is the main 
enzyme forming kinins such as BK (8, 13). Of interest are the recent studies showing 
direct activation of B2R by TK independently of BK release (30, 31). B2R belongs to the 
seven-transmembrane domain G protein-coupled receptor superfamily (32) and signals 
via Gαq protein and subsequent activation of phospholipase C (PLC). PLC is known to 
catalyze the hydrolysis of phosphatidylinositol-4,5-biphosphate (PIP2) and yield inositol 
triphoshpate (IP3) and diacylglycerol (DAG). IP3 releases Ca2+ from the ER while DAG 
activates PKC. The effect of these compounds on TRPV5 activity was investigated in 
chapter 5 by pharmacological means and mutagenesis of the six TRPV5 PKC sites, 
resulting in the elucidation of TK action signaling pathway. It was demonstrated using 
the PLC inhibitor U73122 and the synthetic analogue of DAG 1-oleoyl-acetyl-sn-glycerol 
(OAG), that TK acts through the PLC/DAG pathway. Previous studies showed that TRP 
channels can be activated by different signaling molecules of the PLC pathway. For 
example, the three canonical TRP members TRPC3, 6 and 7 are characterized by their 
sensitivity to DAG (40). Alternatively, the vanilloid and melastatine members of TRP 
family, TRPV1 (12), TRPV5 (50), TRPM4 (58), TRPM5 (54), TRPM7 (68) and TRPM8 
(53) can be directly regulated by PIP2. For TRPV5 activation mechanisms by PIP2 (50) 
and by DAG/PKC as demonstrated here, one should consider that in vivo, both 
pathways could be balanced to adjust TRPV5 activity to physiological fluctuations. In 
addition, the Ca2+ entering the cell through TRPV5 could prevent the electrostatic 
interaction between the negatively charged PIP2 and the channel, by screening the 
negative charge on the lipid head group, as proposed for Mg2+ and Mg2+-permeable 
channel TRPM7 (46). Subsequently, it was demonstrated that OAG increased TRPV5 
activity via PKC phosphorylation of the channel since mutation of TRPV5 for the 
potential PKC phosphorylation sites S299 and S654 prevented the TK effect. 
Importantly, TRPV5 closest homologue, TRPV6, did not respond to TK. Because the 
second serine (S654) is not conserved in TRPV6, the findings suggest that both serines 
are critical for the TRPV5 stimulation by TK. Moreover, TK constitutes a specific 
regulator of TRPV5 in contrast to other molecular partners, such as S100A10 (79), 
Rab11a (78) and NHERF4 (80), that are involved in the regulation of both TRPV5 and 
TRPV6. Furthermore, cell surface labeling with biotin revealed that TK enhances the 
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amount of TRPV5 channels at the plasma membrane by delaying its retrieval. At 
present, this is the first evidence implicating the DAG/PKC signaling pathway in TRPV5 
activation by channel accumulation at the plasma membrane. Co-localization of TK with 
B2R (21) and TRPV5 (39) in kidney underlines the physiological relevance of these 
functional data and suggests an autocrine/paracrine extracellular mechanism for TK on 
the TRPV5 channel. 
 
Calbindin-D28K 
Ca2+ entry into the cell is followed by rapid binding to cytosolic buffers in order to confine 
the concentration and spatial limits of intracellular Ca2+ (6). In TRPV5-mediated active 
Ca2+ reabsorption, calbindin-D28K is proposed as the cytosolic ferry, buffering and 
diffusing Ca2+ from the apical to the basolateral side of the cell (37). This assumption is 
based on the strict co-localization of calbindin-D28K with TRPV5 in the distal nephron 
(38), the concomitant up-regulation of the two proteins by 1,25(OH)2D3 and dietary Ca2+ 
(35), and the enhanced Ca2+ reabsorption upon 1,25(OH)2D3 stimulation of the calbindin-
D28K expression (45). Chapter 6 addressed whether calbindin-D28K deficiency is critical 
for active Ca2+ reabsorption in the presence or absence of TRPV5. To investigate this 
question, single and double knock-out mice of TRPV5 and calbindin-D28K (TRPV5-/-, 
calbindin-D28K-/- and TRPV5-/-/calbindin-D28K-/-) were generated. Characterization of these 
mice demonstrated that TRPV5 and not calbindin-D28K is the critical component in renal 
active Ca2+ reabsorption. Calbindin-D28K-/-, on the contrary to TRPV5-/- mice, did not 
display a renal Ca2+ leak. This study clarifies the controversy present in the literature 
about the hypercalciuria of calbindin-D28K-/- mice (49, 72, 87) by characterization of the 
TRPV5-/-/calbindin-D28K-/- mice. Renal Ca2+ wasting in TRPV5-/- mice is not aggravated by 
the additional ablation of calbindin-D28K in these TRPV5-/- mice. Moreover, a 
compensatory increase in intestinal Ca2+ absorption or high bone turnover are expected 
in order to explain the excess of Ca2+ excreted in the urine of the calbindin-D28K-/- mice 
for which a hypercalciuria was reported (49, 72). Our results showed that there was no 
significant difference in intestinal Ca2+ absorption between calbindin-D28K-/- and wild-type 
mice while Zheng et al. showed no alteration in the bone histology and structure of these 
knock-out mice except for a modest decrease in bone mineral density (87). In addition, 
detailed structural analysis of teeth and bones confirmed that mineralization was 
unaffected in calbindin-D28K-/- mice (72). Consequently, neither a disturbed Ca2+ 
absorption nor an abnormal bone phenotype can account for the excess of urinary Ca2+ 
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observed in the calbindin-D28K-/- mice of these studies. However, calbindin-D28K 
deficiency might be compensated by other Ca2+ binding proteins most likely calbindin-
D9K. In mice, the specific co-expression of calbindin-D9K and calbindin-D28K in DCT cells 
(35) hint to a comparable function in Ca2+ reabsorption. Therefore, calbindin-D9K could 
play a compensatory role in calbindin-D28K-/- mice explaining the absence of renal Ca2+ 
wasting. Furthermore, the similarity between the phenotype of TRPV5-/-/calbindin-D28K-/- 
and TRPV5-/- mice, as well as of calbindin-D28K-/- and wild-type mice was demonstrated 
on the molecular level. In duodenum, Ca2+ absorption is mediated by the epithelial Ca2+ 
channel TRPV6 and calbindin-D9K (37). The mRNA and protein expression of duodenal 
TRPV6 and calbindin-D9K increases equally in TRPV5-/-/calbindin-D28K-/- and TRPV5-/- 
mice compared to wild-type mice, whereas the expression levels in calbindin-D28K-/- mice 
remain unchanged. This up-regulation in TRPV6 and calbindin-D9K in TRPV5-/-/calbindin-
D28K-/- and TRPV5-/- mice can be explained by a comparable increase in serum PTH and 
1,25(OH)2D3  levels accompanied by hyperabsorption in these mice. In conclusion, 
TRPV5 constitutes the gatekeeper of active Ca2+ reabsorption whereas calbindin-D28K is 
not essential for the determination of urinary Ca2+ excretion in the absence of TRPV5. 
 
INTEGRATION OF TRPV5 CHANNEL REGULATION 
The total cellular Ca2+ flux is determined by three key characteristics: the number of 
channels located at the plasma membrane, the single channel conductance and the 
opening and closing of the channel (channel gating). Consequently, the whole current of 
a cell (I) is directly proportional to the number of surface channels (N), the unitary 
channel current (i) and the open probability (Po) of each channel or I (Amperes) = N * I 
(Amperes) * Po. Regulatory partner proteins can mainly modulate two components of this 
equation: the channel’s number at the plasma membrane and the open probability, while 
the unitary channel current depends mostly on the biophysical properties of the 
particular channel. Here, it will be discussed how accessory proteins of TRPV5 
characterized in this thesis can be integrated in the context of the literature into a model 
in line with the aforementioned equation. 
  
Channel’s open probability 
Ca2+ influx through TRPV5 increases the intracellular Ca2+ concentration in a 
microdomain near the pore region, resulting in a fast inactivation of the channel (83). 
This phenomenon stresses the importance of intracellular Ca2+ buffering proteins at the 
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plasma membrane, since their presence decreases the local concentration of free Ca2+ 
resulting in a prolonged Ca2+ influx via TRPV5. Two proteins fulfill this function in the 
case of TRPV5: 80K-H and calbindin-D28K. In chapter 3, 80K-H was characterized as a 
Ca2+-sensing subunit of TRPV5 facilitating Ca2+ influx through the channel after binding 
Ca2+ with its two EF-hand structures (24). Because two additional regions, the highly 
negatively charged poly-glutamate stretch and the HDEL motif, were implicated in the 
inactivation processes of TRPV5 channel activity, a multifaceted role could be proposed 
for 80K-H. A dual function has also been proposed for the Ca2+ sensor calmodulin which 
mediates both Ca2+-dependent facilitation and inactivation of L-type Ca2+ channels (48). 
However, it is unlikely that calmodulin plays such a role in active Ca2+ reabsorption as it 
does not affect TRPV5 activity (47). Ca2+ sensors (calmodulin and troponin C), in 
contrast to Ca2+ buffers (parvalbumin, calretinin and calbindin-D28K), do not only bind 
Ca2+ next to the channel’s inner mouth, but also activate various downstream effectors 
(9). Besides, considering the involvement of 80K-H in signal transduction cascades, 
indeed a Ca2+ sensing role of this PKC substrate can be postulated. 
Calbindin-D28K contains six EF-hand structures four of which present high affinity 
for Ca2+ (84) and has therefore a higher capacity to bind Ca2+ than 80K-H which has only 
one EF-hand pair. Lambers et al. (personal communication) used a dominant negative 
mutant of calbindin-D28K six EF-hands to show that this inactivated calbindin-D28K 
increased Ca2+ transport in primary renal cells. Calbindin-D28K would hence buffer the 
flux of Ca2+ entering the cell via TRPV5 by facilitating high Ca2+ transport rates and 
possibly by preventing channel inactivation. It thus seems that calbindin-D28K constitutes 
one of the Ca2+-binding proteins participating in transepithelial Ca2+ reabsorption. 
However, as demonstrated in chapter 6, calbindin-D28K does not constitute a limiting 
factor in vivo but would rather share together with calbindin-D9K the buffering and 
cytosolic diffusion of Ca2+. It remains elusive though how this process occurs in other 
species, since only in mouse calbindin-D9K is expressed in kidney. Regarding this point, 
the Ca2+ buffer parvalbumin might be also a good candidate based on its expression in 
DCT (55). 
 
Number of surface channels  
The amount of functional channel units on the cell surface is determined by both 
intracellular channel membrane insertion and channel retrieval. These processes can be 
controlled by several factors. Intracellularly, the S100A10-annexin 2 complex (79) and 
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Rab11a (78) are crucial for plasma membrane trafficking of TRPV5 to the membrane. 
Interestingly, it has been demonstrated that the S100A10-annexin 2 complex controls 
the distribution of Rab11-positive endosomes, involved in the transport of internalized 
membrane proteins back to the cell surface (10, 88). These proteins seem therefore to 
be involved in a continuous process of the channel’s incorporation at the plasma 
membrane. The extracellular action of enzymes such as klotho (11) and TK (chapter 5), 
involve delayed retrieval at the cell surface. Klotho hydrolyses extracellular N-linked 
oligosaccharides of TRPV5 resulting in accumulation of channel units and therefore, 
increased Ca2+ flux into the cell (11). In line with these results is a previous analysis of 
the primary structure of TRPV5 which revealed a conserved N-glycosylation sequence in 
the first extracellular loop (36). Furthermore, co-localization of klotho and TRPV5 in 
DCT/CNT would suggest an auto- and/or paracrine action of klotho. A similar way of 
action is proposed in chapter 5 for TK. However, what differentiates TK action on 
channel activity from the β-glucuronidase klotho is that TK stimulates TRPV5 indirectly 
via the activation of B2R. It is well known that TRPV5 is subjected to hormonal 
regulation. For instance, PTH, 1,25(OH)2D3 and 17β-estradiol have been shown to act 
on gene transcription of TRPV5 (35, 75). On the other hand, TK does not regulate the 
abundance of TRPV5 expression but activates the plasma membrane receptor B2R to 
induce a redistribution of TRPV5 channels at the plasma membrane by delaying channel 
retrieval. Although this mechanism is new for TRPV5, other members of the TRP family 
are regulated by hormonal receptors. In this context the nociceptor TRPV1 is one of the 
most extensively studied channel among the TRPVs. TRPV1 membrane currents are 
enhanced by BK (65), insulin-like growth factor (77) and nerve growth factor (86), which 
cause translocation of the channel to the plasma membrane. The concept emerging here 
is that extracellular hormonal activation has the potential to delay TRP channel retrieval 
resulting in the accumulation of channels at the plasma membrane.  
 
Channel’s plasma membrane stabilization 
TK and klotho enzymes establish a new concept of TRPV5 regulation according to which 
extracellular action of partner proteins leads to the stabilization of the channel units to 
the membrane. This would mean that channels may be sequestered into vesicles and 
recycled to the plasma membrane when and where they are required in order to provide 
spatio-temporally restricted Ca2+ entry through TRPV5 and avoid Ca2+ overload. In line 
with this hypothesis is the sub-membrane vesicular distribution of TRPV5 (78). This 
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mechanism is even more appealing because it appears to constitute a general way of 
TRP channel regulation. Indeed, recent studies on TRP channels provided exciting data 
on rapid vesicular channel insertion to the plasma membrane. TRPC5 translocates to the 
plasma membrane within two minutes after growth factor stimulation (7), while in the 
same lapse of time, TRPM7 accumulates at the cell surface in response to shear stress 
(60). Interestingly, in both cases of TRPC5 and TRPV5 accumulation of the channels 
implicates the PLC pathway after receptor activation. However, TK increases the amount 
of TRPV5 channels at the plasma membrane by delaying the channel’s retrieval. Thus, 
PKC activation and possible phosphorylation of TRPV5 upon TK stimulation would tip 
the balance between constitutive insertion and retrieval in favor of the former leading to 
the accumulation of TRPV5 in the cell surface. Similarly, Smyth et al. suggested in a 
recent report that the epidermal growth factor prevents the internalization of TRPC3 in 
the plasma membrane (71). The role of the cytoskeleton in this translocation process is 
at present unknown. It is possible that PKC phosphorylation of TRPV5 leads to activation 
of motor proteins that transport the channel toward the plasma membrane. This process 
could involve the FKBP52 protein characterized in chapter 4 since it is known to interact 
with the motor protein dynein (15, 70). For TRPC5, the protein synaptotagmin has been 
proposed to regulate the channel exocytosis, in part because of their co-localization (73). 
However, the cytoskeletal elements and the motor proteins participating in the plasma 
membrane channel incorporation remain to be determined. Finally, it should be 
mentioned that besides the role of proteins in this process, phosphatidylinositides, in 
particular PIP2, play an important role since in neuroendocrine cells PIP2 is required for 
docking and fusing vesicles in stimulated exocytosis (41). Therefore, trafficking 
constitutes an important component of the channel regulation mechanism.  
 
FUTURE PERSPECTIVES 
The recent elucidation of TRPV5 regulatory partner proteins provides molecular insight 
in the molecular mechanisms controlling channel activity and consequently the 
modulation of the apical Ca2+ influx in epithelial cells. In summary, partner proteins 
regulate TRPV5 by handling the local Ca2+ concentration around the inner mouth of the 
channel and by modulating the amount of channels on the plasma membrane. These 
conclusions are based on the characterization of each partner protein individually and 
constitute the basis in understanding the regulation of channel physiology. The major 
future challenge is to characterize entire networks of proteins regulating the TRPV5 
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channel and explaining hence the hypercalciuria of TRPV5-/- mice. In order to address 
this question, studies on specific and precise temporal and spatial coordination of 
TRPV5 channel activation are crucial. Considering that such protein complexes are at 
present believed to function in spatially distinct microdomains, scaffold proteins should 
play a central role in the assembly of proteins participating in the regulation of Ca2+ influx 
(3). Indeed, it was shown for TRPC channels that the interaction of regulatory and 
scaffolding proteins contributes to the diversity and segregation of (in)activation signals 
to the channels (44). Finally, of great interest for in vivo physiological studies would be to 
identify mutated associated partners of TRPV5 that could be linked to Ca2+-related 
diseases. Likewise, this might lead to a better understanding of the significance of such 
proteins in the regulation of TRPV5 and consequently in the daily Ca2+ balance.  
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…Κι αν πτωχική την βρεις, η Ιθάκη δεν σε γέλασε.  
Έτσι σοφός που έγινες, με τόση πείρα,  
ήδη θα το κατάλαβες η Ιθάκες τι σημαίνουν.” 
 
Ιθάκη, Κ. Π. Καβάφης 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
...If Ithaca seems then too lean, you have not been deceived. 
As wise as you are now become, of such experience, 
you will have understood what Ithaca stands for.” 
 
Ithaca, K. P. Kavafis 
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SUMMARY 
 
CHAPTER 1 
INTRODUCTION 
Ca2+ is an essential ion in all organisms, where it plays a crucial role in processes 
ranging from formation and maintenance of the skeleton to temporal and spatial 
regulation of neuronal function. The Ca2+ balance is maintained by the concerted action 
of three organ systems, namely the gastrointestinal tract, bone and kidney. An adult 
ingests on average 1 g Ca2+ daily, from which 0.35 g is absorbed in the small intestine 
by a mechanism that is controlled primarily by 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 
To maintain the Ca2+ balance, the kidney must excrete the same amount of Ca2+ that the 
small intestine has absorbed. In kidney, the distal convoluted (DCT) and connecting 
tubular (CNT) cells are unique in their ability to mediate transcellular transport of Ca2+. 
The latter allows the organism to respond to fluctuation in dietary Ca2+ and adapt to the 
body’s demand during process as growth, pregnancy, lactation and aging. This transport 
is mediated by Ca2+ entry across the apical membrane through the specialized epithelial 
Ca2+ channel, vanilloid-related transient receptor potential member 5 (TRPV5). The 
physiological role of TRPV5 has been substantiated by several mouse models of Ca2+-
related disorders. Importantly, the knockout of TRPV5 (TRPV5-/-) in mice results in a 
significant hypercalciuria, demonstrating the critical role of TRPV5 in renal Ca2+ 
handling. Furthermore, these mice display a significant decrease in bone density and a 
compensatory hyperabsorption of Ca2+. Therefore, a tight regulation of TRPV5 is of 
particular physiological importance since it determines transmembrane Ca2+ flux and 
consequently affects Ca2+ homeostasis. In this respect, the hormonal regulation of 
TRPV5 has been extensively studied. TRPV5 transcription/translation is activated by 
parathyroid hormone (PTH), 1,25(OH)2D3, dietary Ca2+ and 17β-estradiol enhances 
transcellular Ca2+ reabsorption. However, the ion flux through a channel does not 
depend only on its relative abundance but is also determined by other characteristics 
including the number of channels located at the plasma membrane, the single channel 
conductance and the opening and closing of the pore (channel gating). While the single 
channel current depends mostly on the biophysical properties of the channel, partner 
proteins are important to control the channel’s number on the plasma membrane and 
open probability. As, little information is available concerning the molecular players 
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involved in TRPV5 regulation, the aim of this PhD project was to identify partner proteins 
of TRPV5 and to elucidate their functional role. 
 
CHAPTER 2 
PARTNER PROTEIN IDENTIFICATION 
In order to find TRPV5 regulatory proteins, a differential microarray analysis was applied 
in 25-hydroxyvitamin D3-1α-hydroxylase knock-out mice on normal Ca2+ diet versus on 
enriched Ca2+ diet. The advantage of cDNA microarrays over more classical techniques, 
like the yeast-two-hybrid, is that it detects a wider range of partner proteins since it is not 
based on protein-protein interaction but on gene regulation. More in detail, the 
microarray assay described in this thesis is based on the fact that gene expression of 
proteins involved in the TRPV5-mediated Ca2+ transport is up-regulated by both 
1,25(OH)2D3 and dietary Ca2+. The hypothesis was, therefore, to identify genes involved 
in transcellular Ca2+ transport that show similar regulation by 1,25(OH)2D3 and dietary 
Ca2+. Indeed, the microarray assay pointed to seventeen candidates, including known 
Ca2+ transport proteins such as calbindin-D28K, calmodulin and Na+-Ca2+-exchanger 1 
(NCX1), as well as proteins previously unrelated to Ca2+ transport. Of the seventeen 
candidates four proteins were selected on their molecular features and tissue localization 
known from the literature. Subsequently, the candidates that co-localized with TRPV5 
were analyzed for their functional interaction with the channel by binding assays, 
immunohistological studies, RNA interference, gene targeting and functional assays in 
human embryonic kidney (HEK) 293 and primary DCT/CNT cells. Using these 
approaches, four partner proteins were characterized in detail including the PKC 
substrate 80K-H, the FK506-binding protein (FKBP) 52, the serine protease tissue 
kallikrein (TK) and the Ca2+ transport protein calbindin-D28K.  
 
CHAPTER 3 
80K-H AS A NOVEL CA2+ SENSOR FACILITATING TRPV5 ACTIVITY 
80K-H was identified and characterized as the first Ca2+-sensor of TRPV5 channel 
activity. 80K-H was initially considered as a protein kinase C substrate, but its biological 
function remained to be established. Specific interaction between 80K-H and TRPV5 
was demonstrated as well as co-localization of both proteins in kidney and similar 
transcriptional regulation by 1,25(OH)2D3 and dietary Ca2+. Furthermore, 80K-H directly 
bound Ca2+ and inactivation of its two EF-hand structures totally abolished this Ca2+ 
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binding. Electrophysiological studies using 80K-H mutants showed that three domains of 
80K-H (the two EF-hand structures, the highly acidic glutamic stretch and the HDEL 
sequence) are critical determinants for TRPV5 activity. Importantly, inactivation of the 
EF-hand pair reduced the TRPV5-mediated Ca2+ current and increased the TRPV5 
sensitivity to intracellular Ca2+, accelerating the feedback inhibition of the channel. None 
of the 80K-H mutants altered the TRPV5 plasma membrane localization nor the 
association of 80K-H with TRPV5, suggesting that 80K-H has a direct effect on channel 
activity. 80K-H would act thus as a Ca2+ sensor facilitating the Ca2+ influx through 
TRPV5. 
 
CHAPTER 4 
FKBP52 AS AN INHIBITOR OF TRPV5 ACTIVITY 
FKBP52 is a widely expressed cytosolic enzyme characterized for the ability to catalyze 
the cis-trans isomerization of cis-peptidyl-prolyl bonds, as well as for the strong affinity to 
the immunosuppressive drug FK506. Following its identification in the microarray assay, 
FKBP52 was shown to specifically interact and co-localize in the distal part of the 
nephron with TRPV5. On the functional level, FKBP52 decreased Ca2+ influx through 
TRPV5 as demonstrated by radioactive 45Ca2+ uptake measurements and 
electrophysiological studies using TRPV5-overexpressing HEK293 cells. On the other 
hand, gene-silencing of FKBP52 or administration of the FKBP52 blocker, FK506, 
enhanced Ca2+ influx through TRPV5. The inhibitory action of FKBP52 on TRPV5 
activity was blunted by mutation of its peptidyl-prolyl cis-trans isomerase domain, 
showing that the FKBP52 catalytic property is critical for channel activity. Furthermore, 
the generated results in the primary cell model implied that while submicromolar 
concentrations of FK506 stimulated transcellular Ca2+ transport, high concentrations 
were toxic for the cells. This dose-dependent effect could explain the nephrotoxicity 
observed in patients treated with the FK506. Certainly, given the complexity of the in vivo 
situation, the FK506-induced hypercalciuria awaits further investigation particularly 
concerning the putative role of other FKBP proteins. 
 
CHAPTER 5 
TISSUE KALLIKREIN AS A STIMULATOR OF TRPV5 
As previously mentioned, TRPV5-/- mice exhibit hypercalciuria due to impaired active 
renal Ca2+ reabsorption. A similar phenotype was observed in mice with genetic ablation 
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of the serine protease TK. In this thesis, it was demonstrated that TK expression 
correlates with the amount of Ca2+ excretion. Furthermore, the molecular mechanism 
through which TK affects transcellular Ca2+ transport was delineated. Using TRPV5-
expressing primary DCT/CNT cultures it was shown that TK stimulates transcellular Ca2+ 
transport. The stimulatory effect of TK was mimicked by bradykinin (BK) and could be 
reversed by application of JE049, a BK receptor type 2 (B2R) antagonist peptide. The 
effect of these compounds on TRPV5 activity was validated in TRPV5-transfected 
HEK293 cells by electrophysiological measurements. Furthermore, it was demonstrated 
using the phospholipase C (PLC) inhibitor U73122 and the synthetic analogue of 
diacylglycerol (DAG) 1-oleoyl-acetyl-sn-glycerol (OAG), that TK activates the PLC/DAG 
pathway. OAG increased TRPV5 activity apparently via protein kinase C (PKC) 
phosphorylation of the channel since mutation of TRPV5 for the potential PKC 
phosphorylation sites S299 and S654 prevented the TK effect. Moreover, cell surface 
labeling with biotin revealed that TK enhances the amount of TRPV5 channels at the 
plasma membrane by delaying its retrieval. TK stimulates thus Ca2+ reabsorption via the 
PLC/DAG/PKC pathway and subsequent stabilization of the TRPV5 channel at the 
plasma membrane. Consequently, this study supports that the plasma membrane 
cycling of TRPV5 protein provides a novel mechanism for channel regulation.  
 
CHAPTER 6 
ROLE OF CALBINDIN-D28K IN ACTIVE Ca2+ REABSORPTION 
In order to maintain low cytosolic Ca2+ concentrations, the Ca2+ entering the cell through 
TRPV5 is rapidly buffered by calbindin-D28K and then transported through the cytosol to 
the basolateral membrane. To address whether calbindin-D28K is essential in TRPV5-
mediated Ca2+-transport, an in vivo approach was followed. In this study, single and 
double knockout mice of TRPV5 and calbindin-D28K (TRPV5-/-, calbindin-D28K-/- and 
TRPV5-/-/calbindin-D28K-/-) were generated. All mice were fed two Ca2+ diets (0.02 % w/w 
and 2 % w/w) to investigate the influence of the dietary Ca2+ content on the Ca2+ 
balance. Characterization of these mouse strains showed that TRPV5-/-/calbindin-D28K-/- 
mice display a similar hypercalciuria compared to TRPV5-/- mice on both diets versus 
wild-type mice. Calbindin-D28K-/- mice excrete analogous amount of Ca2+ in urine to wild-
type mice on both diets. The overlap of the TRPV5-/-/calbindin-D28K-/- and TRPV5-/- 
phenotype was further supported by their comparable increase in intestinal 45Ca2+ 
absorption due to up-regulation of calbindin-D9K and TRPV6 in duodenum. This up-
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regulation of Ca2+-transport proteins can be explained by the observed increase in 
serum PTH and 1,25(OH)2D3 levels. Intestinal absorption, expression of calbindin-D9K 
and TRPV6, as well as serum parameters of the calbindin-D28K-/- mice presented wild-
type levels. Furthermore, the decrease in dietary Ca2+ content from 2 % w/w to 0.02 % 
did not affect the Ca2+ excretion whereas it increased intestinal Ca2+ absorption together 
with the expression of TRPV6 and calbindin-D9K. These results demonstrated a 
phenotypical similarity between TRPV5-/-/calbindin-D28K-/- and TRPV5-/- mice, as well as 
between calbindin-D28K-/- and wild-type mice, suggesting that TRPV5, and not calbindin-
D28K, constitutes the gatekeeper of active Ca2+ reabsorption. 
 
CHAPTER 7 
CONCLUSION AND FUTURE PERSPECTIVES 
The aim of this thesis was to identify and characterize associated regulatory proteins of 
TRPV5. Indeed, four molecular partners of TRPV5 were identified and delineated for 
their regulatory activity. 80K-H facilitates the Ca2+ influx through TRPV5 by affecting the 
channel gating, while FKBP52 determines recycling of the channel at the plasma 
membrane. Of particular interest is the molecular pathway of TK action on TRPV5, since 
it operates through a hormonal receptor, activating the PLC/DAG/PKC pathway that 
ultimately results in accumulation of cell surface channels by decreasing retrieval from 
the plasma membrane. Finally, the study with TRPV5-/-/calbindin-D28K-/- mice proves that 
TRPV5 and not calbindin-D28K constitutes the rate-limiting Ca2+ influx step in renal active 
Ca2+ reabsorption. Consequently, the elucidation of TRPV5 partner proteins described in 
this thesis provides molecular insight in the regulatory mechanisms controlling channel 
activity in epithelial cells. Partner proteins regulate TRPV5 at different levels: by 
controlling the local Ca2+ concentration around the inner mouth of the channel (80K-H 
and calbindin-D28K) or by modulating the number of channels at the plasma membrane 
(FKBP52 and TK). These conclusions are based on the characterization of each partner 
protein and constitute the molecular basis for understanding the physiology of channel 
regulation. Future investigations, on the characterization of entire network of proteins 
regulating TRPV5 will elucidate the mechanism through which cells achieve specificity 
and precise temporal and spatial coordination of channel activation. 
 
Chapter 8 
 158
SAMENVATTING 
 
HOOFDSTUK 1 
INTRODUCTIE 
Ca2+ is een essentieel ion voor alle organismes, en speelt een cruciale rol in processen 
variërend van de vorming en het onderhoud van het skelet tot de korte- en lange termijn 
regulatie van de neurale functie. De Ca2+ balans wordt in stand gehouden door een goed 
gereguleerde samenwerking tussen drie organen, namelijk het spijsverteringsstelsel, het 
botweefsel en de nier. Een volwassen persoon neemt dagelijks gemiddeld 1 gram Ca2+ 
tot zich, waarvan ongeveer 0,35 gram wordt geabsorbeerd in de dunne darm via een 
mechanisme dat hoofdzakelijk gereguleerd wordt door 1,25-dihydroxyvitamine D3 
(1,25(OH)2D3). Voor behoud van de Ca2+ balans, dient eenzelfde hoeveelheid Ca2+ door 
de nier uitgescheiden te worden als is opgenomen in de darm. De niercellen van het 
distaal convoluut en de verbindingsbuis zijn uniek in hun vermogen om Ca2+ 
transcellulair te transporteren. Hierdoor kan het organisme reageren op fluctuaties in de 
Ca2+ hoeveelheid in het voedsel en kan het lichaam zich aanpassen aan 
omstandigheden zoals groei, zwangerschap, lactatie, en ouder worden. Bij dit renale 
transport komt Ca2+ via een Ca2+-specifiek kanaal, TRPV5,  in de luminale membraan de 
cel binnen. De fysiologische rol van TRPV5 werd verduidelijkt door diverse muis-
modellen voor Ca2+-gerelateerde ziektes. Vooral de in TRPV5 knock-out (TRPV5-/-) 
muizen waargenomen hypercalciurie geeft een goede indicatie van de rol van TRPV5 in 
het renaal Ca2+ transport. Daarbij is in deze knock-out muizen de dichtheid van de botten 
significant verminderd en vertonen ze een compenserende hyperabsorptie van Ca2+. 
Daarom is een goede regulatie van TRPV5 van groot belang, aangezien dit kanaal de 
transcellulaire Ca2+ flux bepaalt, en daarmee invloed heeft op de Ca2+ balans. De 
hormonale regulatie van TRPV5 werd eerder al uitgebreid bestudeerd. De transcriptie en 
translatie van TRPV5 worden geactiveerd door het parathyroïd hormoon (PTH), terwijl 
1,25(OH)2D3, de hoeveelheid Ca2+ in het voedsel, en 17β-estradiol de transcellulaire 
Ca2+ reabsorptie bevorderen. Echter, de ionflux door een kanaal is niet alleen afhankelijk 
van de relatieve hoeveelheid kanalen, maar ook van factoren zoals het aantal kanalen 
dat zich in de plasmamembraan bevindt, de geleiding per kanaal, en of de porie van het 
kanaal open of gesloten is. Waar de geleiding per kanaal vooral afhankelijk is van de 
biofysische eigenschappen van het kanaal, bepalen interacterende eiwitten het aantal 
kanalen dat zich in de plasmamembraan bevindt, en of het kanaal open, dan wel 
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gesloten is. Aangezien weinig bekend is over het moleculaire mechanisme dat TRPV5 
reguleert, was het doel van het promotieonderzoek om TRPV5-regulerende eiwitten te 
identificeren, en hun functie te achterhalen.   
 
HOOFDSTUK 2  
IDENTIFICATIE VAN INTERACTERENDE EIWTITEN 
Om nieuwe eiwitten te vinden die TRPV5 reguleren, werd een differentiële microarray 
analyse toegepast op 25-hydroxyvitamine D3-1α-hydroxylase knock-out muizen op een 
normaal of een Ca2+-rijk dieet. Het voordeel van cDNA microarrays ten opzichte van 
klassieke technieken zoals yeast-two-hybrid is dat een breder scala aan regulerende 
eiwitten gedetecteerd kan worden, aangezien microarray niet gebaseerd is op eiwit-eiwit 
interacties, maar op gen-regulatie. De microarray in dit proefschrift is gebaseerd op het 
feit dat de gen-expressie van eiwitten die betrokken zijn bij het TRPV5-gemedieerde 
Ca2+ transport worden opgereguleerd door zowel 1,25(OH)2D3 als Ca2+ in het voedsel. 
Daarom was de hypothese dat genen betrokken bij het transcellulaire Ca2+ transport een 
soortgelijke regulatie door 1,25(OH)2D3 als voor Ca2+ zouden vertonen. Analyse van de 
microarray leverde 17 kandidaten op, waaronder reeds bekende Ca2+-transporterende 
eiwitten zoals calbindin-D28K, calmoduline en de Na+-Ca2+-exchanger 1 (NCX1), maar 
ook eiwitten waarvan het voorheen onbekend was dat ze betrokken waren bij het Ca2+ 
transport. Gebaseerd op literatuuronderzoek werden vier kandidaat-eiwitten 
geselecteerd vanwege hun moleculaire eigenschappen en weefsellocalisatie. 
Vervolgens werden de kandidaten die met TRPV5 co-lokaliseerden in de nier getest 
voor hun functionele interactie met het kanaal door middel van immunohistologische 
studies, RNA interference, gene targeting en functionele studies in HEK293 en primaire 
DCT/CNT cellen. Het PKC substraat 80K-H, het FK506-bindend eiwit FKBP52, 
kallikreïne en het Ca2+ transporterend eiwit calbindin-D28K, werden met behulp van deze 
technieken in detail gekarakteriseerd.  
 
HOOFDSTUK 3 
80K-H IS EEN NIEUWE CA2+-SENSOR DIE DE ACTIVITEIT VAN TRPV5 BEVORDERT 
80K-H werd geïdentificeerd en gekarakteriseerd als de eerste Ca2+-sensor voor de 
activiteit van TRPV5. 80K-H werd aanvankelijk beschouwd als een substraat voor PKC, 
maar zijn biologische functie was niet bekend. Een specifieke interactie tussen 80K-H en 
TRPV5 en co-lokalisatie van beide eiwitten in de nier werden aangetoond. Tevens 
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werden beide eiwitten op eenzelfde manier transcriptioneel gereguleerd door 
1,25(OH)2D3 en Ca2+ in het dieet. Daarnaast bond 80K-H direct aan Ca2+ en leidde 
inactivatie van beide EF-hand structuren van 80K-H tot een volledige afwezigheid van 
Ca2+ binding. Electrofysiologische studies met 80K-H mutanten toonden aan dat drie 
domeinen van 80K-H (de beide EF-hand structuren, een zuur-rijk glutamine gebied, en 
de HDEL sequentie) de belangrijkste determinanten voor de activiteit van TRPV5 zijn. 
Belangrijk hierbij is, dat de-activering van de EF-hand structuren leidde tot een 
verminderde TRPV5-gemedieerde Ca2+ stroom, waarbij de gevoeligheid van TRPV5 
voor intracellulair Ca2+ verhoogd werd, waardoor de negatieve terugkoppeling op het 
kanaal versneld werd. Geen van de 80K-H mutanten had invloed op de 
plasmamembraan lokalisatie van TRPV5, noch op de binding van 80K-H aan TRPV5, 
hetgeen suggereert dat 80K-H een direct effect heeft op de activiteit van het kanaal. 
Zodoende werkt 80K-H dus als een Ca2+-sensor die de Ca2+ influx door TRPV5 
bevordert.  
 
HOOFDSTUK 4 
FKBP52 REMT DE ACTIVITEIT VAN TRPV5 
FKBP52 is een cytosolisch enzym dat gekarakteriseerd wordt door zijn vermogen om de 
cis-trans isomerisatie van cis-peptidyl-prolyl bindingen te katalyseren. Daarnaast heeft 
het een hoge affiniteit voor de immunosuppressor FK506. Na zijn identificatie in de 
microarray assay, werd aangetoond dat FKBP52 specifiek bindt aan TRPV5, en tevens 
met TRPV5 co-lokaliseert in het distale deel van het nefron. Met behulp van radioactieve 
45Ca2+ opname metingen en electrofysiologische studies in HEK293 cellen werd 
aangetoond dat FKBP52 een vermindering van de Ca2+ influx veroorzaakt. Daarentegen 
leidde onderdrukking van het FKBP52 gen, of toediening van de FKBP52 remmer tot 
een toename van de Ca2+ influx via TRPV5. De remmende werking van FKBP52 op de 
activiteit van TRPV5 kon teniet worden gedaan door het peptidyl-prolyl cis-trans domein 
te muteren, waarmee aangetoond werd dat de katalytische werking van FKBP52 
noodzakelijk is voor de activiteit van het kanaal. Verder duidden de resultaten van het 
primaire celmodel er op dat submicromolaire concentraties FK506 het transport van Ca2+ 
stimuleren, terwijl hogere concentraties toxisch zijn voor de cellen. Dit concentratie-effect 
zou een verklaring kunnen zijn voor het nefrotoxisch effect dat wordt waargenomen in 
patiënten die behandeld worden met FK506. Gezien de complexiteit van de in vivo 
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situatie, dient de FK506-geïnduceerde hypercalciurie verder onderzocht te worden, en 
met name de rol van andere FKBP eiwitten. 
 
 
 
 
HOODSTUK 5 
KALLIKREÏNE STIMULEERT TRPV5 
Zoals hierboven beschreven, vertonen TRPV5-/- muizen hypercalciurie vanwege hun 
onmogen Ca2+ te resorberen in de nier. Een gelijksoortig fenotype werd waargenomen in 
muizen met een gendefect in het serine-protease kallikreïne. In dit proefschrift staat 
bescheven hoe de expressie van kallikreïne correlleert met de uitgescheiden 
hoeveelheid Ca2+. Verder werd het moleculaire mechanisme waarmee kallikreïne 
transcellulair Ca2+ transport beïnvloedt achterhaald. In TRPV5-expresserende primaire 
celculturen van DCT/CNT cellen werd aangetoond dat kallikreïne het transcellulaire Ca2+ 
transport stimuleert. Toevoeging van bradykinine (BK) resulteerde in een soortgelijk 
effect, en kon teniet gedaan worden door JE049, een BK receptor type 2 antagonist. 
Door middel van electrofysiologische studies met HEK293 cellen getransfecteerd met 
TRPV5 werd het effect van deze stoffen op TRPV5 gevalideerd. Verder werd met behulp 
van de fosfolipase C (PLC) remmer U73122 en 1-oleoyl-acetyl-sn-glycerol (OAG), een 
synthetisch analoog van diacylglycerol (DAG), aangetoond dat kallikreïne via PLC en 
DAG signaleert. OAG stimuleerde de activiteit van TRPV5 via fosforylering van het 
kanaal via het proteïne kinase C (PKC), aangezien mutatie van de potentieel door PKC 
gefosforyleerde aminozuren S299 en S654 het effect van kallikreïne ophief. Biotinylering 
van eiwitten aan het cel-oppervlak toonde aan dat kallikreïne de hoeveelheid TRPV5 
kanalen in de plasmamembraan vergroot door hun internalisatie te vertragen. Zodoende 
stimuleert kallikreïne de Ca2+ reabsorptie via PLC/DAG/PKC signalering, en de 
daaropvolgende stabilisatie van TRPV5 op de plasmamembraan. Dientengevolge 
ondersteunt deze studie dat circulatie van TRPV5 eiwitten van en naar de 
plasmamembraan een nieuw mechanisme is voor de regulatie van deze kanalen. 
 
HOOFDSTUK 6 
DE ROL VAN CALBINDIN-D28K IN DE TRANSCELLULAIRE REABSORPTIE VAN Ca2+  
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Om de cytosolaire Ca2+ concentratie laag te houden, wordt Ca2+ dat de cel binnenkomt 
via TRPV5 gebufferd door te binden aan calbindin-D28K en wordt vervolgens zo door het 
cytosol getransporteerd naar de basolaterale membraan. Om te bestuderen of calbindin-
D28K essentiëel is voor TRPV5-gemedieerd Ca2+ transport, werd gebruik gemaakt van 
een in vivo aanpak. In deze studie werden enkel en dubbel knock-out muizen van 
TRPV5 en calbindin-D28K (TRPV5-/-, calbindin-D28K-/- en TRPV5-/-/calbindin-D28K-/-) 
gegenereerd. Alle muizen kregen twee Ca2+-diëten (0,02% w/w en 2% w/w) om de 
invloed van Ca2+ in het voedsel op de Ca2+ balans te onderzoeken. Karakterisatie van 
deze muizenstammen toonde aan dat voor beide diëten de TRPV5-/-/calbindin-D28K-/- 
muizen een vergelijkbare hypercalciurie laten zien als de TRPV5-/- muizen ten opzichte 
van de wild-type muizen. Bij beide diëten scheidden de calbindin-D28K-/- muizen 
hoeveelheden Ca2+ uit die vergelijkbaar waren met de wild-type muizen. De overlap 
tussen het fenotype van de TRPV5-/-/calbindin-D28K-/- and TRPV5-/- muizen werd verder 
ondersteund door een vergelijkbaar toegenomen 45Ca2+ opname in de darm door een 
verhoogde expressie van calbindine-D9K en TRPV6 in het duodenum. Deze stimulatie 
werd verklaard door een toename van PTH en 1,25(OH)2D3 serumniveaus. Voor de 
calbindin-D28K-/- muizen waren  Ca2+ opname in de darm, expressie van calbindin-D9K en 
TRPV6, en de serumwaarden van PTH en 1,25(OH)2D3  gelijk aan die van wild-type 
muizen. De afname van de hoeveelheid Ca2+ in het voedsel van 2% w/w naar 0.02% had 
geen invloed op de Ca2+ excretie, maar leidde wel tot een verhoging van de Ca2+ 
absorptie in de darm, hetgeen vergezeld ging van een verhoogde expressie van TRPV6 
en calbindin-D9K. Deze resultaten laten een vergelijkbaar fenotype zien tussen de 
TRPV5-/-/calbindin-D28K-/- en de TRPV5-/- muizen enerzijds, en de calbindin-D28K-/- en de 
wild-type muizen anderzijds, hetgeen suggereert dat TRPV5, en niet calbindin-D28K de 
bepalende factor is voor actieve Ca2+ reabsorptie.  
 
Hoofdstuk 7 
Conclusies en toekomstperspectieven 
Het doel van dit proefschrift was het identificeren en karakteriseren van TRPV5-
geassocieerde en –regulerende eiwitten. Vier moleculaire partners van TRPV5 werden 
geïdentificeerd en hun regulerende functie werd bepaald. 80K-H verhoogt de Ca2+ influx 
via TRPV5 door de channel gating te verhogen, terwijl FKBP52 de recycling van het 
kanaal aan de plasmamembraan bepaalt. De moleculaire werking van kallikreïne op 
TRPV5 is van groot belang, aangezien dit proces gereguleerd wordt door een hormonale 
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receptor, die via PLC/DAG/PKC signalering de internalisatie van kanalen remt en zo een 
toename van kanalen aan het celoppervlak tot gevolg heeft. Als laatste, toont de studie 
met de calbindin-D28K-/- en wild-type muizen aan dat TRPV5, en niet calbindin-D28K de 
beperkende stap is voor de Ca2+ influx in de actieve renale Ca2+ reabsorptie. Zodoende 
vergroten de in dit proefschrift beschreven partners van TRPV5 ons inzicht in de 
moleculaire en cellulaire regulatie van de kanaal-activiteit in epitheliale cellen. De 
regulatie van TRPV5 door partner-eiwitten gebeurt op verschillende niveaus: door de 
lokale Ca2+ concentratie rond de intracellulaire monding van het kanaal te controleren 
(80K-H en calbindin-D28K), of door het aantal kanalen aan de plasma membraan te 
moduleren (FKBP52 en kallikreïne). Deze conclusies zijn gebaseerd op de karakterisatie 
van elk van de hier beschreven interacterende eiwitten, en vormen de moleculaire basis 
voor de fysiologie van de regulatie van kanalen. Toekomstig onderzoek zal zich moeten 
richten op het gehele eiwit-netwerk dat TRPV5 reguleert om het mechanisme te 
ontrafelen waarmee cellen specifiek en nauwkeurig de tijdelijke en ruimtelijke activiteit 
van het kanaal coördineren. 
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ΠΕΡΙΛΗΨΗ 
 
ΚΕΦΑΛΑΙΟ 1  
ΕΙΣΑΓΩΓΗ 
Το ασβέστιο είναι ένα κρίσιμο ιόν για όλους τους οργανισμούς. Συμμετέχει σε διαδικασίες 
που κυμαίνονται από το σχηματισμό και τη συντήρηση του σκελετού ως το χρονικό και 
χωρικό κανονισμό της νευρωνικής λειτουργίας. Η ομοιόσταση του ασβεστίου διατηρείται 
από τις συντονισμένες ενέργειες τριών οργάνων, το γαστροεντερικό σωλήνα, τα οστά  
και τα νεφρά. Ένας ενήλικος λαμβάνει κατά μέσον όρο 1 γραμμάριο ασβεστίου 
καθημερινά, από το οποίο 0.35 γραμμάρια απορροφώνται στο λεπτό έντερο από έναν 
μηχανισμό που ελέγχεται κυρίως από την 1,25-διυδροξυβιταμίνη D3 (1,25(OH)2D3). Για 
να διατηρηθεί η ισορροπία ασβεστίου, το νεφρό πρέπει να εκκρίνει το ίδιο ποσό 
ασβεστίου που έχει απορροφηθεί στο λεπτό έντερο. Στο νεφρό, τα άπω εσπειραμένα και 
τα αθροιστικά σωληνάρια, είναι μοναδικά για τη δυνατότητά τους να μεσολαβούν τη 
διακυτταρική μεταφορά του ασβεστίου. Έτσι επιτρέπεται στον οργανισμό να 
ανταποκριθεί στη διαιτητική διακύμανση του ασβεστίου και να προσαρμοστεί σε 
συνθήκες αυξημένης απαίτησης ασβεστίου όπως κατά τη διάρκεια της σωματικής 
αύξησης, εγκυμοσύνης, γαλακτοπαραγωγής και γήρανσης. Κατά τη διάρκεια αυτής της 
μεταφοράς το ασβέστιο εισέρχεται από την κορυφαία μεμβράνη μέσω του εξειδικευμένου 
επιθηλιακού καναλιού ασβεστίου TRPV5. Ο φυσιολογικός ρόλος TRPV5 σε αναταραχές 
σχετικές με την ομοιόσταση του ασβεστίου έχει τεκμηριωθεί με τη χρήση διαφόρων 
προτύπων ποντικιών. Κnock-out του καναλίου TRPV5 (TRPV5-/-) σε ποντίκια προκαλεί 
υπερασβεστιουρία, που καταδεικνύει τον κρίσιμο ρόλο TRPV5 στο νεφρικό χειρισμό 
ασβέστιου. Επιπλέον, αυτά τα ποντίκια επιδεικνύουν μια σημαντική μείωση στην οστική 
πυκνότητα και αντισταθμιστική υπεραπορρόφηση ασβεστίου στο έντερο. Επομένως, η 
ακριβής ρύθμιση του TRPV5 είναι ιδιαίτερα σημαντική, δεδομένου ότι καθορίζει τη 
διακυτταρική ροή ασβεστίου και έχει επιπτώσεις συνεπώς στην ομοιόσταση του 
ασβεστίου. Από αυτή την άποψη, η ορμονική ρύθμιση του TRPV5 έχει μελετηθεί 
εκτενώς. Η μεταγραφή/μετάφραση του TRPV5 ενεργοποιείται από την παραθυροειδή 
ορμόνη (PTH), τη 1,25(OH)2D3, το διαιτητικό ασβέστιο και την 17β-εστραδιόλη 
ενισχύοντας έτσι τη διακυτταρική επαναρρόφηση ασβεστίου. Εντούτοις, η ιονική ροή 
μέσω ενός καναλιού δεν εξαρτάται μόνο από τη σχετική αφθονία της, αλλά καθορίζεται 
επίσης από άλλα χαρακτηριστικά συμπεριλαμβανομένου του αριθμού καναλιών που 
βρίσκονται στη κυτταρική μεμβράνη, την αγωγιμότητα των καναλιών, καθώς και από το 
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άνοιγμα και το κλείσιμο του πόρου κάθε καναλιού (gating). Ενώ η αγωγιμότητα των 
καναλιών εξαρτάται συνήθως από τις βιοφυσικές ιδιότητες του καναλιού, βοηθητικές 
πρωτεΐνες είναι σημαντικές για τον έλεγχο του αριθμού των καναλιών στη κυτταρική 
μεμβράνη και την πιθανότητα ανοίγματος τους. Δεδομένου ότι, λίγες πληροφορίες είναι 
διαθέσιμες σχετικά με τους μοριακούς φορείς που συμμετέχουν στη ρύθμιση του TRPV5, 
ο στόχος αυτού του διδακτορικού προγράμματος ήταν να προσδιοριστούν οι πρωτεΐνες 
συνεργάτες του TRPV5 και να διευκρινιστεί ο λειτουργικός ρόλος τους. 
 
ΚΕΦΑΛΑΙΟ 2  
ΠΡΩΤΕΪΝΙΚΟΣ ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΣΥΝΕΡΓΑΤΩΝ 
Προκειμένου να βρεθούν οι ρυθμιστικές πρωτεΐνες του TRPV5, μια διαφορική ανάλυση 
μικροσυστοιχίας (microarray) εφαρμόστηκε σε ποντίκια με knock-out της 25-
υδροξυβιταμίνη D3-1α-υδροξυλάσης, στα οποία παρέχονταν κανονική ή εμπλουτισμένη 
διατροφή ασβεστίου. Το πλεονέκτημα του cDNA microarrays ως προς τις περισσότερες 
κλασσικές τεχνικές, όπως το σύστημα διαλογής σε διπλά υβρίδια ζυμομυκήτων, είναι ότι 
ανιχνεύει ένα ευρύτερο φάσμα πρωτεϊνών συνεργατών,δεδομένου ότι δεν είναι 
βασισμένο στην διαπρωτεϊνική αλληλεπίδραση, αλλά στην ρύθμιση γονιδίων. 
Συγκεκριμένα, το πείραμα microarray που περιγράφεται σε αυτήν την διατριβή είναι 
βασισμένο στο γεγονός ότι η γονιδιακή έκφραση των πρωτεϊνών που συμμετέχουν στη 
μεταφορά ασβεστίου μέσω του ΤRPV5 παρουσιάζουν παρόμοια αποτελέσματα. 
Επομένως, η ταυτοποιήση του συνόλου των γονίδιων με παρόμοια ρύθμιση από τη 
1,25(OH)2D3 και το διαιτητικό ασβέστιο θα οδηγήσει υποθετικά στον προδιορισμό νέων 
πρωτεϊνών της διακυτταρικής μεταφοράς ασβεστίου μέσω του ΤRPV5 Πράγματι, το 
microarray έδειξε δεκαεπτά υποψηφίους συνέργατες, συμπεριλαμβανομένων γνωστών 
πρωτεΐνών μεταφοράς ασβεστίου, όπως η calbindin-D28K, η calmodulin και ο 
ανταλλάκτης 1 Nατρίου- Ασβεστίου (NCX1), καθώς επίσης και πρωτεΐνες οι οποίες 
προηγουμένως ήταν ανεξάρτητες της μεταφοράς ασβεστίου. Από τις δεκαεπτά 
υποψήφιες τέσσερις πρωτεΐνες επιλέχτηκαν με βάση τα μοριακά χαρακτηριστικά 
γνωρίσματά τους και τον ιστολογικό εντοπισμό τους. Στη συνέχεια, οι υποψήφιες 
πρωτεΐνες που εντοπίζονται με το TRPV5, αναλύθηκαν για τη λειτουργική 
αλληλεπίδρασή τους με το κανάλι με δοκιμές αλληλεπίδρασης, ανοσοϊστολογικές 
μελέτες, χρήση μικρομοριακού RNA παρεμβολής (siRNA), στοχοθέτηση γονιδίων και τις 
λειτουργικές δοκιμές μέσα σε HEK 293 και πρωτογενής καλλιέργιας κύτταρα 
απομονωμένα από τα άπω εσπειραμένα και τα αθροιστικά σωληνάρια. 
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Χρησιμοποιώντας αυτές τις προσεγγίσεις, τέσσερις πρωτεΐνες συνεργάτες 
χαρακτηρίστηκαν λεπτομερώς συμπεριλαμβανομένου του υποστρώματος πρωτεΐνικής 
κινάσης PKC 80K-Η, της FK506-δεσμευτικής πρωτεΐνης (FKBP) 52, της πρωτεάσης 
σερίνης καλλικρεΐνης (TK) και της πρωτεΐνης μεταφοράς calbindin-D28K.  
 
ΚΕΦΑΛΑΙΟ 3 
Η 80K-Η ΩΣ ΝΕΟΣ ΑΙΣΘΗΤΗΡΑΣ ΑΣΒΕΣΤΙΟΥ ΠΟΥ ΔΙΕΥΚΟΛΥΝΕΙ ΤΗ ΔΡΑΣΤΗΡΙΟΤΗΤΑ ΤΟΥ 
TRPV5 
Η 80K-Η προσδιορίστηκε και χαρακτηρίστηκε ως ο πρώτος αισθητήρας ασβεστίου της 
δραστηριότητας του καναλιού TRPV5. Η 80K-Η θεωρήθηκε αρχικά ως υπόστρωμα PKC, 
αλλά η βιολογική λειτουργία της δεν είχε προηγουμένως καθιερωθεί. Στο κεφάλαιο 3 η 
συγκεκριμένη αλληλεπίδραση μεταξύ της 80K-Η και του TRPV5 αποδείχθηκε καθώς 
επίσης και ο συνεντοπισμός των δύο πρωτεϊνών στο νεφρό. Επιπλέον, η 80Κ-Η εχει τη 
δυνατότητά άμεσης σύνδεσης του ασβεστίου ενώ η αδρανοποίηση των δύο δομών της, 
EF-hand, κατάργησε την ικανότητα σύνδεσης ασβεστίου της πρωτεΐνης. Οι 
ηλεκτροφυσιολογικές μελέτες που πραγματοποιήθηκαν στις μεταλλαγμένες μορφές του 
80K-Η, έδειξαν ότι τρεις περιοχές (οι δύο δομές EF-hand, το ιδιαίτερα όξινο γλουταμινικό 
πολυπεπτίδιο και η ακολουθία HDEL) είναι κρίσιμοι καθοριστικοί παράγοντες για τη 
δραστηριότητα του καναλιού TRPV5. Η αδρανοποίηση του ζευγαριού EF-hand μείωσε 
σημαντικά το ρεύμα ασβεστίου μέσω του TRPV5 και επιπλέον επιτάχυνε την 
απενεργοποίηση του καναλιού αυξάνοντας την ευαισθησία του στο ενδοκυτταρικό 
ασβέστιο. Καμία από τις μεταλλάξεις 80K-Η δεν άλλαξε τον εντοπισμό του TRPV5 στην 
κυτταρική μεμβράνη, ούτε την ένωση του 80K-Η με το TRPV5, αποδεικνύοντας ότι η 
80K-Η έχει άμεση επίδραση στη δραστηριότητα του καναλιού. Το 80K-Η ενεργεί δηλαδή 
ως αισθητήρας ασβεστίου διευκολύνοντας την ασβεστική εισροή μέσω TRPV5. 
 
ΚΕΦΑΛΑΙΟ 4 
Η FKBP52 ΩΣ ΑΝΑΣΤΑΛΤΙΚΟΣ ΠΑΡΑΓΟΝΤΑΣ ΤΗΣ ΔΡΑΣΤΗΡΙΟΤΗΤΑΣ ΤΟΥ TRPV5 
Η FKBP52 είναι ένα ευρέως εκφρασμένο κυτταροπλασματικό ένζυμο που 
χαρακτηρίζεται για την ικανότητά του να καταλύει τον cis-trans ισομερισμό cis-πεπτιδυλ-
προλυλ δεσμών, καθώς επίσης και για την ισχυρή συγγένεια της στο ανοσοκατασταλτικό 
φάρμακο FK506. Μετά από τον προσδιορισμό της στη microarray δοκιμή, η FKBP52 
αποδείχθηκε ότι αλληλεπιδράει ειδικά και να συνεντοπίζεται στη μεμβράνη πρός το 
σωληναριακό μέρος του νεφρώνα με το κανάλι TRPV5. Στο λειτουργικό επίπεδο, η 
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FKBP52 μείωσε τη ροή ασβεστίου μέσω TRPV5 όπως αποδεικνύεται από ραδιενεργές 
μετρήσεις ασβεστίου και από ηλεκτροφυσιολογικές μελέτες σε κύτταρα HEK293 με 
υπερέκφραση του καναλιού TRPV5. Επίσης, η γονιδιακή σίγαση (gene-silencing) της 
FKBP52 ή η χρήση του FKBP52 αναστολέα, FK506, ενίσχυσε την εισροή ασβεστίου 
μέσω TRPV5. Η ανασταλτική δράση της FKBP52 στη δραστηριότητα του TRPV5 
αμβλύθηκε από τη μεταλλαγή της περιοχή της πεπτιδυλ-προλυλ cis-trans ισομεράσης, 
υποδηλώνοντας ότι η καταλυτική ιδιότητα της FKBP52 είναι κρίσιμη για τη 
δραστηριότητα καναλιών. Επιπλέον, τα αποτελέσματα που παράχθηκαν στη πρωτογενή 
καλλιέργεια κυττάρων υποδεικνύουν ότι ενώ οι υπομικρομοριακές συγκεντρώσεις FK506 
πρόαγουν τη διακυτταρική μεταφορά του ασβεστίου, οι υψηλές συγκεντρώσεις FK506 
ήταν τοξικές για τα κύτταρα. Αυτή η αναλογία μεταξύ συγκέντρωσης FK506 και δράσης 
θα μπορούσε να εξηγήσει τη νεφροτοξικότητα που παρατηρείται στους ασθενείς που 
θεραπεύθηκαν με το FK506. Βεβαίως, λαμβάνοντας υπόψη την πολυπλοκότητα ενός 
ζωντανού οργανισμού η FK506-προκληθείσα υπερασβεστιουρία απαιτεί περαιτέρω 
έρευνα, ιδιαίτερα σε ό,τι αφορά τον υποθετικό ρόλο άλλων πρωτεϊνών FKBP. 
 
ΚΕΦΑΛΑΙΟ 5  
Η ΚΑΛΛΙΚΡΕΪΝΗ ΩΣ ΔΙΕΓΕΡΤΙΚΟ ΤΟΥ TRPV5 
Όπως αναφέρθηκε προηγουμένως, η υπερασβεστιουρία των TRPV5-/- ποντικιών 
προκαλείται λόγω της εξασθενισμένης ενεργούς νεφρικής επαναρρόφησης ασβεστίου. 
Ένας παρόμοιος φαινότυπος παρατηρήθηκε στα ποντίκια με knock-out της πρωτεάσης 
σερίνης TK. Σε αυτήν τη διατριβή, αποδείχθηκε ότι η έκφραση TK σχετίζεται με το ποσό 
της ασβεστιακής έκκρισης και επιπλέον σκιαγραφήθηκε ο μοριακός μηχανισμός 
επιρροής της TK στη διακυτταρική μεταφορά ασβεστίου. Η χρησιμοποίηση πρωτογενούς 
καλλιέργειας κυττάρων που έχουν απομονοθεί από τα άπω εσπειραμένα και τα 
αθροιστικά σωληνάρια και εκφράζουν ενδογενώς ΤRPV5, αποκάλυψε ότι η TK προάγει 
τη διακυτταρική μεταφορά ασβεστίου. Επιπλέον, η διεγερτική επίδραση της TK μπορεί 
να αντιγραφεί από τη βραδυκινίνη (bradykinin, BK) και να αντιστραφεί από την εφαρμογή 
JE049, ενός αναστολέα του υποδεχέα 2 της BK (B2R). Η επίδραση αυτών των ενώσεων 
στη δραστηριότητα TRPV5 επιβεβαιώθηκε με ηλεκτροφυσιολογικές μετρήσεις TRPV5-
διαμολυνσμένα κυττάρων HEK293. Επιπλέον, χρησιμοποιώντας τον ανασταλτικό 
παράγοντα φωσφολιπάσης C (PLC), U73122 και το συνθετικό ανάλογο της διακυλ-
γλυκερόλης (DAG ) OAG, αποδείχτηκε ότι η TK ενεργοποιεί τη δραστηριότητα TRPV5 
μέσω μοριακού μονοπατιού PLC/DAG. Το OAG ενεργεί προφανώς μέσω 
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φωσφορυλίωσης της πρωτεϊνικής κινάσης C (PKC) του καναλιού, δεδομένου ότι η 
μεταλλαγή του TRPV5 για τις πιθανές PKC θέσεις φωσφορυλίωσης, S299 και S654, 
απέτρεψε την επίδραση της TK. Στη συνέχεια, το μαρκάρισμα της κυτταρικής επιφάνειας 
με βιοτίνη, αποκάλυψε ότι η TK ενισχύει το ποσό καναλιών TRPV5 στην κυτταρική 
μεμβράνη μέσω καθυστέρησης της ανάκτησής του πίσω στο κυτταρόπλασμα. Η TK 
υποκινεί έτσι την επαναρρόφηση ασβεστίου μέσω του σηματοδοτικού μονοπατιού 
PLC/DAG/PKC και επομένως σταθεροποιεί το κανάλι TRPV5 στην κυτταρική μεμβράνη. 
Συνεπώς, αυτή η μελέτη υποστηρίζει ότι η ανακύκλωση κυτταρικών μεμβρανών της 
πρωτεΐνης TRPV5 αποτελεί έναν νέο μηχανισμό ρύθμισης ιονικών καναλιών.  
 
ΚΕΦΑΛΑΙΟ 6 
ΡΟΛΟΣ ΤΗΣ CALBINDIN-D28K ΣΤHN ΕΝΕΡΓH ΕΠΑΝΑΡΡΟΦΗΣΗ ΑΣΒΕΣΤΙΟΥ 
Προκειμένου να διατηρηθεί χαμηλή η συγκέντρωση ασβεστίου στο κυτταρόπλασμα, η 
είσοδος του ασβεστίου στο κύτταρο μέσω TRPV5 ακολουθείται από τη γρήγορη 
δέσμευση του με την πρωτεΐνη calbindin-D28K και την επακόλουθη κυτταροπλασματική 
μεταφορά του προς στη πλαγιοβασική κυτταρική μεμβράνη. Για να εξεταστεί η 
κρισιμότητα του ρόλου της calbindin-D28K διακυτταρικής μεταφοράς ασβεστίου μέσω του 
ΤRPV5, ακολουθήθηκε η in vivo προσέγγιση. Απλά και διπλά knoc-kout ποντίκια 
παρήχθηκαν για τα γονίδια TRPV5 και calbindin-D28K (TRPV5-/-, calbindin-D28K-/- και 
TRPV5-/-/calbindin-D28K-/-). Όλα τα ποντίκια σιτίστηκαν με δύο διατροφές ασβεστίου 
(0.02% w/w και 2% w/w) για να ερευνηθεί η επιρροή του διαιτητικού ασβεστίου στην 
ομοιόσταση ασβεστίου. Ο χαρακτηρισμός αυτών των ποντικιών έδειξε ότι τα TRPV5-/-
/calbindin-D28K-/- ποντίκια επιδεικνύουν παρόμοιο υπερασβεστιουρία με τα TRPV5-/- 
ποντίκια και στις δύο διατροφές ως προς αυτή των ποντικιών αγρίου τύπου. Τα 
calbindin-D28K-/- ποντίκια εκκρίνουν ανάλογο ποσό ασβεστίου στα ούρα με τα ποντίκια 
αγρίου τύπου και στις δύο διατροφές. Η ομολογία των TRPV5-/-/calbindin-D28K-/- και 
TRPV5-/- φαινοτύπων υποστηρίζεται περαιτέρω από τη συγκρίσιμη αύξηση της εντερικής 
τους απορρόφησης ασβεστίου, η οποία οφείλεται στήν αύξηση έκφρασης της calbindin-
D9K και του TRPV6 στο δωδεκαδάκτυλο. Αυτή η αύξηση έκφρασης των πρωτεΐνών 
μεταφοράς ασβεστίου μπορεί να εξηγηθεί από την παρατηρηθείσα αύξηση στον ορό του 
επιπέδου των ορμονών PTH και 1,25(OH)2D3. Η εντερική απορρόφηση, η έκφραση της 
calbindin- D9K και του TRPV6, καθώς επίσης και οι παράμετροι ορού των ποντικιών 
calbindin- D28K-/- παρουσιάζουν επίπεδα αγρίου τύπου. Επιπλέον, η μείωση ασβεστίου 
στη δίαιτα από 2% w/w σε 0.02% w/w δεν είχε επιπτώσεις στην έκκριση ασβεστίου στα 
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ούρα ενώ αύξησε την εντερική απορρόφηση ασβεστίου, όπως και την έκφραση του 
TRPV6 και του calbindin-D9K. Αυτά τα αποτελέσματα απέδειξαν τη φαινοτυπική 
ομοιότητα μεταξύ TRPV5-/-/calbindin-D28K-/- και TRPV5-/- ποντικιών, καθώς επίσης και 
μεταξύ των calbindin-D28K-/- και ποντικιών αγρίου τύπου, υποδηλώνοντας ότι το 
κανάλιTRPV5, και όχι η calbindin-D28K, αποτελεί το κρίσιμο βήμα στην ενεργή 
επαναρρόφηση ασβεστίου. 
 
ΚΕΦΑΛΑΙΟ 7 
ΣΥΜΠΕΡΑΣΜΑΤΑ ΚΑΙ ΜΕΛΛΟΝΤΙΚΕΣ ΠΡΟΟΠΤΙΚΕΣ 
Ο στόχος αυτής της διατριβής ήταν να προσδιοριστούν και να χαρακτηριστούν οι 
ρυθμιστικές πρωτεΐνες συνεργάτες του καναλιού TRPV5. Πράγματι, τέσσερις μοριακοί 
συνεργάτες του TRPV5 προσδιορίστηκαν και σκιαγραφήθηκαν για τη ρυθμιστική 
δραστηριότητά τους. Η 80K-Η διευκολύνει την εισροή ασβεστίου μέσω του TRPV5 
ενεργώντας στο gating του καναλικού πόρου, ενώ η FKBP52 καθορίζει την ανακύκλωση 
του καναλιού στη κυτταρική μεμβράνη. Ιδιαίτερο ενδιαφέρον παρουσιάζει η μοριακή 
δράσης της TK στο TRPV5, δεδομένου ότι λειτουργεί μέσω ενός ορμονικού υποδοχέα. Η 
ενεργοποίηση του Β2Ρ οδηγεί τελικά στη συσσώρευση καναλιών στην κυτταρική 
επιφάνεια μέσω του σηματοδοτικού μονοπατιού PLC/DAG/PKC, το οποίο εμποδίζει την 
ανάκτηση καναλιών από τη κυτταρική μεμβράνη. Τέλος, η μελέτη των TRPV5-/-
/calbindin-D28K-/- ποντικιών αποδεικνύει ότι το TRPV5 και όχι η calbindin-D28K αποτελεί 
τον περιοριστικό παράγοντα της ενεργής επαναρρόφησης ασβεστίου. Συνεπώς, ο 
προσδιορισμός των πρωτεϊνών συνεργατών του TRPV5 που περιγράφεται σε αυτήν την 
διατριβή παρέχει μοριακή διορατικότητα στους ρυθμιστικούς μηχανισμούς που ελέγχουν 
τη δραστηριότητα καναλιών στα επιθηλιακά κύτταρα. Οι πρωτεΐνες συνεργάτες 
ρυθμίζουν το TRPV5 σε διαφορετικά επίπεδα: α) ελέγχοντας την τοπική συγκέντρωση 
ασβεστίου γύρω από το εσωτερικό στόμιο του καναλιού (80K-Η και calbindin-D28K) και β) 
με τη διαμόρφωση του αριθμού καναλιών στην κυτταρική μεμβράνη (FKBP52 και TK). 
Αυτά τα συμπεράσματα είναι βασισμένα στο χαρακτηρισμό κάθε πρωτεΐνης συνεργάτη 
και αποτελούν τη μοριακή βάση για τη φυσιολογία ρύθμισης ιονικών καναλιών. Οι 
μελλοντικές έρευνες, πάνω στο χαρακτηρισμό ολόκληρου του δικτύου πρωτεϊνών που 
ρυθμίζουν το TRPV5 θα διευκρινίσουν το μηχανισμό μέσω του οποίου τα κύτταρα 
επιτυγχάνουν τον ακριβή χρονικό και χωρικό συντονισμό για να επιτευχθεί η 
ενεργοποίηση ιονικών καναλιών. 
 
Chapter 8 
 170
 
 
 
 
 
 
 
List of abbreviations 
List of publications 
Curriculum Vitae 
Acknowledgements 
 
 
 
 
 172
 
List of abbreviations 
 173
LIST OF ABBREVIATIONS 
1,25(OH)2D3 1,25-dihydroxy-vitamin D3  
[Ca2+]i intracellular Ca2+ concentration 
1α-OHase 25-hydroxyvitamin D3-1α-hydroxylase 
1α-OHase-/- 1α-OHase knock-out 
ADPKD autosomal dominant polycystic kidney disease 
ADPLD autosomal dominant polycystic liver disease 
AGE advanced glycosylation end products 
ANOVA analysis of variance 
ATP adenosine 5' -triphosphate 
B2R bradykinin 2 receptor 
BAPTA-AM 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid  
 acethoxymethylester 
BK bradykinin 
bp basepairs 
BSA bovine serum albumin 
calbindin-D28K-/- calbindin-D28K-/- knock-out 
CAP channel activating protease 
CaSR Ca2+-sensing receptor 
CCD cortical collecting duct 
CFTR cystic fibrosis transmembrane regulator  
CIPP channel-interacting PDZ domain protein 
CNT connecting tubules 
CTRL Control 
DAG Diacylglycerol 
DCT distal convoluted tubules 
DVF divalent free 
ECaC epithelial Ca2+ channel 
EDTA Ethylenediaminetetraacetate 
EGTA ethylene glycol-bis(b-aminoethyl ether)-N,N,N',N'-tetra acetic acid 
ENaC epithelial Na+ channel 
ER endoplasmic reticulum  
FGF fibroblast growth factor 
FKBP FK506-binding protein 
GFP green fluorescent protein 
GPCR G protein-coupled receptor 
GRK G protein-coupled receptor kinase 
GST Glutathione S-transferase 
HEK 293 human embryonic kidney 293 
HPRT hypoxanthine-guanine phosphoribosyl transferase 
i unitary channel current 
I whole cell current  
IP3 inositol triphoshpate  
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I-V current-voltage 
MAPK mitogen-activated protein kinases 
NCX1 Na+-Ca2+-exchanger 1 
NHE Na+-H+ exchanger 
NHERF NHE regulating factor  
OAG 1-oleoyl-acetyl-sn-glycerol  
PAGE polyacrylamide electrophoresis gel 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDDR pseudovitamin D-deficiency rickets  
PDZ PSD95/DLG/ZO-1 
PIP2 phosphatidylinositol-4,5-biphosphate 
PKC  protein kinase C 
PKD polycystic kidney disease 
PLC phospholipase C 
PMA phorbol 12-myristate 13-acetate 
PMCA1b Ca2+-ATPase 1b 
Po open probability  
PPIase peptidyl-prolyl cis-trans isomerase 
PT proximal tubules 
PTH  parathyroid hormone 
ROMK renal outer medullary K+ 
SDS sodium dodecyl sulphate 
SGK serine/threonine kinase 
siRNA small interference RNA 
SNARE soluble N-ethylmaleimide-sensitive-factor attachment proteins  
 Receptor 
TBS tris buffered saline 
TCA trichloroacetic acid 
TK tissue kallikrein 
TK-/-  TK knock-out 
Tris tris(hydroxy-methyl)aminomethane 
TRP transient receptor potential  
TRPC TRP canonical  
TRPL TRP like 
TRPM TRP melastatin  
TRPV TRP vanilloid 
TRPV5-/-  TRPV5 knock-out  
VDDR-1 vitamin D-dependent rickets type I 
VDR vitamin D receptor 
Y2H yeast two-hybrid 
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